Endogenous Metabolite 

Metabolite results when a drug is metabolized into a modified form which continues to produce effects. A metabolome in a givenbody fluid is influenced by endogenous factors such as age, sex, body composition and genetics as well as underlyingpathologies.The levels of the enormous array of unique small-molecule metabolites are usually kept tightly regulated by the activityof a very large array of enzymes and transporters responsible for the production, transformation, degradation, andcompartmentalization of these small molecules.The levels of the endogenous small molecules present in the brain are normallytightly regulated.

www.MedChemExpress.com 1

Endogenous Metabolite Chemicals

(+)-Borneol (d-Borneol) Cat. No.: HY-N1368A

(+)-Borneol (d-Borneol) is a natural bicyclicmonoterpene used for analgesia and anesthesia intraditional Chinese medicine; enhances GABA

activity with an of 248 μM.receptor EC50

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(+)-LongifoleneCat. No.: HY-N6662

(+)-Longifolene is a sesquiterpenoid and ametabolite in rabbits. (+)-Longifolen is convertedto primary, secondary or tertiary alcohols inrabbits, among which the primary alcohol ispredominant.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(-)-(S)-EquolCat. No.: HY-100583

(-)-(S)-Equol is a high affinity ligand for with a of 0.73 nM.estrogen receptor β Ki

Purity: 98.78%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

(-)-Aspartic acid ((R)-Aspartic acid; D-(-)-Aspartic acid) Cat. No.: HY-42068

(-)-Aspartic acid is an endogenous NMDAreceptor agonist.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

(-)-Epicatechin ((-)-Epicatechol; Epicatechin; epi-Catechin) Cat. No.: HY-N0001

(-)-Epicatechin inhibits cyclooxygenase-1 ( )COX-1with an of 3.2 μM. (-)-Epicatechin inhibitsIC50

the IL-1β-induced expression of iNOS by blockingthe nuclear localization of the p65 subunit ofNF-κB.

Purity: 99.00%Clinical Data: Phase 2Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

(-)-Epigallocatechin Gallate (EGCG; Epigallocatechol Gallate) Cat. No.: HY-13653

(-)-Epigallocatechin Gallate is a tea flavonoidwith potent antioxidant, antiinflammatory, andanticarcinogenic properties. (-)-EpigallocatechinGallate is reported to inhibit signaling andEGFRthereby exert anticancer effects.

Purity: 99.91%Clinical Data: Phase 4Size: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg

(-)-Fucose (6-Desoxygalactose; L-(-)-Fucose; L-Galactomethylose) Cat. No.: HY-N1480

(-)-Fucose is classified as a member of thehexoses, plays a role in A and B blood groupantigen substructure determination,selectin-mediated leukocyte-endothelial adhesion,and host-microbe interactions.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(-)-MentholCat. No.: HY-75161

(-)-Menthol is a key component of peppermint oilthat binds and activates transient receptorpotential melastatin 8 ( ), aTRPM8Ca -permeable nonselective cation channel, to2+

increase [Ca ] . Antitumor activity.2+i

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

(-)-α-PineneCat. No.: HY-N0549

(-)-α-Pinene is a monoterpene and shows sleepenhancing property through a direct binding toGABAA-benzodiazepine (BZD) receptors by acting asa partial modulator at the BZD binding site.

Purity: 99.63%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 1 g, 5 g

(1R,2S,3S,4R,5S)-6,8-Dioxabicyclo[3.2.1]octane-2,3,4-triolCat. No.: HY-W050145

(1R,2S,3S,4R,5S)-6,8-Dioxabicyclo[3.2.1]octane-2,3,4-triol is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

(2-Aminoethyl)phosphonic acidCat. No.: HY-W006371

(2-Aminoethyl)phosphonic acid is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(2R)-2-Hydroxypropanoate sodiumCat. No.: HY-111095B

(2R)-2-Hydroxypropanoate sodium is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-

diyl ditetradecanoate Cat. No.: HY-W013078

(2R)-3-(((2-Aminoethoxy)(hydroxy)phosphoryl)oxy)propane-1,2-diyl ditetradecanoate is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg, 250 mg, 500 mg

(2R,3R)-Butane-2,3-diolCat. No.: HY-W015954

(2R,3R)-Butane-2,3-diol is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(2R,3S,4R,5S)-2,3,4,5-Tetrahydroxyhexanedioic acidCat. No.: HY-W014410

(2R,3S,4R,5S)-2,3,4,5-Tetrahydroxyhexanedioic acidis an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(2S,3R,4S,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal

hydrochloride Cat. No.: HY-W021425

(2S,3R,4S,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanalhydrochloride is an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(3-Carboxypropyl)trimethylammonium chloride (γ-Butyrobetaine hydrochloride) Cat. No.: HY-113270A

(3-Carboxypropyl)trimethylammonium chloride isangiopathic substance produced as an intermediarymetabolite by gut microbiota that feed oncarnitine in dietary red meat.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-oneCat. No.: HY-W040240

(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one is anendogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(3S,4S,5R)-1,3,4,5,6-Pentahydroxyhexan-2-one (Tagatose, D- (8CI)) Cat. No.: HY-42680

(3S,4S,5R)-1,3,4,5,6-Pentahydroxyhexan-2-one is anendogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

(E)-Ferulic acid ((E)-Coniferic acid) Cat. No.: HY-N0060B

(E)-Ferulic acid is a isomer of Ferulic acid whichis an aromatic compound, abundant in plant cellwalls.

Purity: 99.20%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 3

 

(E)-m-Coumaric acidCat. No.: HY-N7127

(E)-m-Coumaric acid (3-Hydroxycinnamic acid) is anaromatic acid that highly abundant in food.(E)-m-Coumaric acid (3-Hydroxycinnamic acid) is anantioxidant.

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(E)-Oct-2-enoic acidCat. No.: HY-W046906

(E)-Oct-2-enoic acid is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(Ethoxymethyl)benzeneCat. No.: HY-W017613

(Ethoxymethyl)benzene is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

(R)-(+)-Citronellal ((+)-Citronellal) Cat. No.: HY-111664

(R)-(+)-Citronellal, isolated from citrus,lavender and eucalyptus oils, is a monoterpenoidand main component of citronellal oil with adistinct lemon scent. A flavouring agent. Used forinsect repellent and antifungal properties.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(R)-(-)-1,3-ButanediolCat. No.: HY-77490

(R)-(-)-1,3-Butanediol is used to regulate themetabolism of carbohydrate and lipid.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(R)-3-Hydroxy-4,4-dimethyldihydrofuran-2(3H)-oneCat. No.: HY-W010396

(R)-3-Hydroxy-4,4-dimethyldihydrofuran-2(3H)-oneis an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

(R)-3-Hydroxybutanoic acidCat. No.: HY-W051723

(R)-3-Hydroxybutanoic acid is a metabolite, andconverted from acetoacetic acid catalyzed by3-hydroxybutyrate dehydrogenase.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

(R)-3-Hydroxyisobutyric acidCat. No.: HY-113108

(R)-3-Hydroxyisobutyric acid is an intermediate inthe pathways of l-valine and thymine and plays animportant role in the diagnosis of the very rareinherited metabolic diseases 3-hydroxyisobutyricaciduria and methylmalonic semialdehydedehydrogenase deficiency.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(R)-5-Oxopyrrolidine-2-carboxylic acidCat. No.: HY-W002304

(R)-5-Oxopyrrolidine-2-carboxylic acid is anendogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(R)-Citronellol (D-Citronellol; (R)-(+)-β-Citronellol) Cat. No.: HY-124257

(R)-Citronellol (D-Citronellol) is an alcoholicmonoterpene found in geranium essential oil.(R)-Citronellol inhibits degranulation of mastcells and does not affect caffeine bitternessperception.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

4 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

(R)-Leucic acid (D-α-Hydroxyisocaproic acid) Cat. No.: HY-30216

(R)-Leucic acid is an amino acid metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

(R)-Ornithine hydrochlorideCat. No.: HY-34516

(R)-Ornithine hydrochloride is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

(R)-pyrrolidine-2-carboxylic acid ((+)-(R)-Proline;

(R)-(+)-Proline; (R)-2-Carboxypyrrolidine; (R)-Proline) Cat. No.: HY-75087

(R)-pyrrolidine-2-carboxylic acid is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

(R)-SerineCat. No.: HY-100808

(R)-Serine, an endogenous amino acid involved inglia-synapse interactions that has uniqueneurotransmitter characteristics, is a potentco-agonist at the .NMDA glutamate receptor

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

(R,R)-(+)-HydrobenzoinCat. No.: HY-59125

(R,R)-(+)-Hydrobenzoin is a organocatalysts.

Purity: 99.78%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

(S)-(+)-1,2-PropanediolCat. No.: HY-79334

(S)-(+)-1,2-Propanediol is an endogenousmetabolite.

Purity: 99.51%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

(S)-(-)-PhenylethanolCat. No.: HY-78093A

(S)-(-)-Phenylethanol is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

(S)-(−)-Perillyl alcoholCat. No.: HY-116514

(S)-(−)-Perillyl alcohol is a monoterpene found inlavender, inhibits farnesylation of Ras,upregulates the mannose-6-phosphate receptor andinduces . Anti-cancer activity.apoptosis

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(S)-2-acetamido-4-amino-4-oxobutanoic acidCat. No.: HY-W016798

(S)-2-acetamido-4-amino-4-oxobutanoic acid is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid

dihydrate Cat. No.: HY-W008437

(S)-2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid dihydrate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 5

 

(S)-2-Hydroxy-3-phenylpropanoic acidCat. No.: HY-30220

(S)-2-Hydroxy-3-phenylpropanoic acid is a productof phenylalanine catabolism. An elevated level ofphenyllactic acid is found in body fluids ofpatients with or phenylketonuria.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(S)-2-Hydroxysuccinic acidCat. No.: HY-Y1069

(S)-2-Hydroxysuccinic acid is a dicarboxylic acidin naturally occurring form, contributes to thepleasantly sour taste of fruits and is used as afood additive.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

(S)-3,4-Dihydroxybutyric acidCat. No.: HY-113304

(S)-3,4-Dihydroxybutyric acid is a normal humanurinary metabolite that is excreted in increasedconcentration in patients with succinicsemialdehyde dehydrogenase (SSADH) deficiency.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(S)-3-Hydroxy-2-(Phosphonooxy)Propanoic AcidCat. No.: HY-128736

(S)-3-Hydroxy-2-(Phosphonooxy)Propanoic Acid is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(S)-3-Hydroxybutanoic acid ((S)-β-Hydroxybutanoic acid;

L-(+)-3-Hydroxybutyric acid; L-β-Hydroxybutyric acid) Cat. No.: HY-W050031

(S)-3-Hydroxybutanoic acid is a normal humanmetabolite, that has been found elevated ingeriatric patients remitting from depression.

Purity: >97.0%Clinical Data:Size: 10 mM × 1 mL, 50 mg

(S)-3-Hydroxyisobutyric acidCat. No.: HY-113126

(S)-3-Hydroxyisobutyric acid is an importantinterorgan metabolite, an intermediate in thepathways of l-valine and thymine and a goodgluconeogenic substrate.

Purity: >92.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

(S)-b-aminoisobutyric acidCat. No.: HY-113380

(S)-b-aminoisobutyric acid is a non-protein aminoacid originating from the catabolism of thymineand valine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

(S)-Glutamic acid ((+)-L-Glutamic acid) Cat. No.: HY-14608

(S)-Glutamic acid acts as an excitatorytransmitter and an agonist at all subtypes ofglutamate receptors (metabotropic, kainate, NMDA,and AMPA). (S)-Glutamic acid shows a directactivating effect on the release of fromDAdopaminergic terminals.

Purity: >97.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

(S)-Higenamine ((S)-Norcoclaurine) Cat. No.: HY-N2037B

(S)-Higenamine ((S)-Norcoclaurine), a S-enantiomerof Higenamine, is the entry compound inbenzylisoquinoline alkaloid biosynthesis.(S)-Higenamine is produced by the condensation ofdopamine and 4-hydroxyphenylacetaldehyde (4-HPAA)by norcoclaurine synthase (NCS).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(S)-Higenamine hydrobromide ((S)-Norcoclaurine hydrobromide) Cat. No.: HY-N2037C

(S)-Higenamine ((S)-Norcoclaurine) hydrobromide, aS-enantiomer of Higenamine, is the entry compoundin benzylisoquinoline alkaloid biosynthesis.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

6 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

(S)-Leucic acidCat. No.: HY-30215

(S)-Leucic acid is an amino acid metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

(S)-(-)-Citronellal ((-)-Citronellal) Cat. No.: HY-111664A

(S)-(-)-Citronellal ((-)-Citronellal) is amonoterpenoid compound found in Corymbia

and essential oils.citriodora Cymbopogon nardus

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

(Z)-4-Amino-4-oxobut-2-enoic acidCat. No.: HY-128750

(Z)-4-Amino-4-oxobut-2-enoic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

(Z)-Aconitic acid (cis-Aconitic acid) Cat. No.: HY-W016814

(Z)-Aconitic acid (cis-Aconitic acid) is thecis-isomer of Aconitic acid. (Z)-Aconitic acid(cis-Aconitic acid) is an intermediate in thetricarboxylic acid cycle produced by thedehydration of citric acid.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

(±) AnabasineCat. No.: HY-W052144

(±) Anabasine is a biphasic muscle relaxant.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

(±)-Leucine (DL-Leucine; Leucine, DL- (8CI); (RS)-Leucine) Cat. No.: HY-B1674

(±)-Leucine (DL-Leucine), an isomer of Leucine,chemosterilant and dietary additive. (±)-Leucineinhibits growth of Escherichia coli HfrH by92.08%.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg, 5 g

(±)20-HDHA ((±)20-HDoHE) Cat. No.: HY-116663

(±)20-HDHA ((±)20-HDoHE) is a racemic mixture andis an autoxidation product of Docosahexaenoic acid(DHA). (±)20-HDHA is also formed by peroxidationprocess in human platelets and rat brainhomogenate.

Purity: >97.0%Clinical Data: No Development ReportedSize: 75 μg

(±)8-HETECat. No.: HY-112653A

(±)8-HETE is one of the six monohydroxy fattyacids produced by the non-enzymatic oxidation ofarachidonic acid (HY-109590). The biologicalactivity of (±)8-HETE is likely to resemble thatof its constituent enantiomers (8(R)-HETE and8(S)-HETE).

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1,2-CyclohexanedioneCat. No.: HY-W007347

1,2-Cyclohexanedione is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 250 mg, 500 mg

1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamineCat. No.: HY-W040268

1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamineis an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 7

 

1,2-Dipalmitoyl-sn-glycerolCat. No.: HY-W010736

1,2-Dipalmitoyl-sn-glycerol is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1,2-Dipalmitoyl-sn-glycerol 3-phosphateCat. No.: HY-113437

1,2-Dipalmitoyl-sn-glycerol 3-phosphate (compound3-F7) is a phosphatidic acid and a humanendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1,2-Dipalmitoyl-sn-glycerol 3-phosphate sodiumCat. No.: HY-113437A

1,2-Dipalmitoyl-sn-glycerol 3-phosphate sodium(compound 3-F7) is a phosphatidic acid and a humanendogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (DSPE) Cat. No.: HY-112530

1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine(DSPE) is a phosphoethanolamine (PE) lipid thatcan be used in the synthesis of liposomes.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

1,3-ButanediolCat. No.: HY-77490A

1,3-Butanediol, an ethanol dimer providing asource of calories for human nutrition.1,3-Butanediol is converted in the body toβ-hydroxybutyrate and has cerebral protective andhypoglycaemic effect.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1,3-DimethyluracilCat. No.: HY-W008343

1,3-Dimethyluracil is a pyrimidone derives from auracil. 1,3-Dimethyluracil found occasionally inhuman urine. 1,3-Dimethyluracil shows inhibitionactivity against and (human carbonichCA I hCA IIanhydrase) with of 316.2 μM and 166.4 μM,Ki

respectively.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

1,3-Dimethyluric acidCat. No.: HY-W014993

1,3-Dimethyluric acid is a product of theophyllinemetabolism in man. 1,3-Dimethyluric acid is one ofthe purine components in urinary calculi.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

1,3-DithianeCat. No.: HY-W001189

1,3-Dithiane is a protected formaldehyde anionequivalent that could serve as a useful labeledsynthon. 1,3-Dithiane is also a sulfur-containingMaillard reaction products (MRPs) found in boiledbeef extracts.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

1,4-CineoleCat. No.: HY-N7117

1,4-Cineole is a widely distributed, natural,oxygenated monoterpene. 1,4-Cineole, present ineucalyptus oil, activates both human andTRPM8human .TRPA1

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

1,4-D-GulonolactoneCat. No.: HY-118840

1,4-D-Gulonolactone is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

8 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

1,4-Diaminobutane dihydrochlorideCat. No.: HY-Y1781

1,4-Diaminobutane dihydrochloride is an endogenousmetabolite, acts as an indicator ofpollution-induced stress in higher plants: barleyand rape stressed with Cr(III) or Cr(VI) .1,4-Diaminobutane dihydrochloride is an importantsource of GABA.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

1,4-DimethoxybenzeneCat. No.: HY-W015780

1,4-Dimethoxybenzene is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

1,4-Dioxane-2,5-diolCat. No.: HY-W004661

1,4-Dioxane-2,5-diol is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

1,5-AnhydrosorbitolCat. No.: HY-113075

1,5-Anhydrosorbitol is a short-term marker forglycemic control.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1-Aminocyclopropane-1-carboxylic acidCat. No.: HY-30004

1-Aminocyclopropane-1-carboxylic acid is anendogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

1-Arachidoyl-sn-glycero-3-phosphocholineCat. No.: HY-113010

1-Arachidoyl-sn-glycero-3-phosphocholine is alysophospholipid (LyP).

Purity: >99.0%Clinical Data:Size: 10 mM × 1 mL, 10 mg

1-DodecanolCat. No.: HY-Y0289

1-Dodecanol is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

1-HexadecanolCat. No.: HY-B1465

1-Hexadecanol is a fatty alcohol, a lipophilicsubstrate.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

1-Hydroxy-2-naphthoic acidCat. No.: HY-W016103

1-Hydroxy-2-naphthoic acid is an endogenousmetabolite.

Purity: 99.57%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

1-HydroxyoctadecaneCat. No.: HY-Y1809

1-Hydroxyoctadecane is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 9

 

1-HydroxypyreneCat. No.: HY-W014075

1-Hydroxypyrene, a biomarker of exposure topolycyclic aromatic hydrocarbons (PAHs), isanalyzed in urine samples. 1-Hydroxypyrene is themajor biomarker of exposure to pyrenes.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

1-KestoseCat. No.: HY-N2579

1-Kestose, the smallest fructooligosaccharidecomponent, which efficiently stimulates

as well asFaecalibacterium prausnitziiBifidobacteria.

Purity: 99.01%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg

1-Methyl-L-histidineCat. No.: HY-W017006

1-Methyl-L-histidine is an objective indicator ofmeat ingestion and exogenous 3-methylhistidine(3MH) intake.

Purity: 99.77%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg

1-MethyladenineCat. No.: HY-113306

1-Methyladenine is a product of alkylation damagein DNA which can be repaired by damage reversal byoxidative demethylation.

Purity: 98.49%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

1-MethyladenosineCat. No.: HY-113081

1-Methyladenosine is an RNA modificationoriginating essentially from two differentreaction types, one catalyzed by enzymes and theother the result of the reaction of RNA withcertain alkylating agents.

Purity: 98.16%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

1-Methylguanidine hydrochlorideCat. No.: HY-W005028

1-Methylguanidine hydrochloride is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1-MethylguanosineCat. No.: HY-113136

1-Methylguanosine is a methylated nucleosideoriginating from RNA degradation.1-Methylguanosine is a tumour marker.

Purity: 98.39%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

1-MethylhistamineCat. No.: HY-W062542

1-Methylhistamine is a histamine (Him) metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1-Methylhistamine dihydrochlorideCat. No.: HY-W053787

1-Methylhistamine dihydrochloride is a histaminemetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg, 50 mg

1-Methylinosine (N1-Methylinosine) Cat. No.: HY-113139

1-Methylinosine is a modified nucleotide found atposition 37 in tRNA 3' to the anticodon ofeukaryotic tRNA.

Purity: 99.96%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

10 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

1-Methyluric acidCat. No.: HY-W010031

1-Methyluric acid acts on the urinary bladdermucosa and increases the blood glucose, insulin,triglyceride, and cholesterol levels.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

1-MethylxanthineCat. No.: HY-W008449

1-Methylxanthine, a caffeine derivative, is anessential human urinary metabolite of caffeine andtheophylline (1,3-dimethylxanthine, TP).1-Methylxanthine enhances the radiosensitivity oftumor cells.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

1-MonomyristinCat. No.: HY-N2512

1-Monomyristin, extracted from ,Serenoa repensinhibits the hydrolysis of 2-oleoylglycerol( =32 μM) and fatty acid amide hydrolase (FAAH)IC50

activity ( =18 μM).IC50

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mg

1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholineCat. No.: HY-W019833

1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholineis an endogenous metabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

1-Naphthol (Furro ER; NSC 9586; Nako TRB) Cat. No.: HY-Y1309

1-naphthol is an excited state proton transfer(ESPT) fluorescent molecular probe.

Purity: 99.84%Clinical Data: No Development ReportedSize: 500 mg, 5 g

1-Octanol (Octanol) Cat. No.: HY-W032013

1-Octanol (Octanol), a saturated fatty alcohol, isa inhibitorT-type calcium channels (T-channels)with an of 4 μM for native T-currents.IC50

1-Octanol is a highly attractive biofuel withdiesel-like properties.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholineCat. No.: HY-126356

1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholineCat. No.: HY-126359

1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholineis an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

10-Undecenoic acid (Undecylenic acid) Cat. No.: HY-B0914

10-Undecenoic acid was used as a starting reagentin the syntheses of Pheromone (11Z)-hexadecenal.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

10Z-Nonadecenoic acidCat. No.: HY-113450

10Z-Nonadecenoic acid is a kind of long-chainfatty acid with anti-tumor activity.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

www.MedChemExpress.com 11

 

11-Beta-hydroxyandrostenedione (4-Androsten-11β-ol-3,17-dione) Cat. No.: HY-114464

11-Beta-hydroxyandrostenedione(4-Androsten-11β-ol-3,17-dione) is a steroidmainly found in the the adrenal origin(11β-hydroxylase is present in adrenal tissue, butabsent in ovarian tissue).

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

11-cis-Vaccenyl acetateCat. No.: HY-128900

11-cis-Vaccenyl acetate is male-specific lipidthat mediates aggregation behavior in both maleand female flies, which activates a few dozenolfactory neurons located in T1 sensilla on theantenna of both male and female flies.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg

11-Oxo etiocholanolone (11-Ketoetiocholanolone) Cat. No.: HY-113457

11-Oxo etiocholanolone (11-Ketoetiocholanolone) isa metabolite of Etiocholanolone. Etiocholanoloneis the excreted metabolite of testosterone and hasanticonvulsant activity.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

11beta-Hydroxyprogesterone (11β-Hydroxyprogesterone) Cat. No.: HY-N2337

11beta-Hydroxyprogesterone is a potent inhibitorsof ; also11β-Hydroxysteroid dehydrogenaseactivates human mineralocorticoid receptor inCOS-7 cells with an of 10 nM.ED50

Purity: 99.60%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

11β-HydroxyandrosteroneCat. No.: HY-113351

11β-Hydroxyandrosterone is a 11-oxygenatedandrogen metabolite of 11β-hydroxyandrostenedione.

Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg

12-Hydroxydodecanoic acidCat. No.: HY-128743

12-Hydroxydodecanoic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

12-Ketodeoxycholic acidCat. No.: HY-135772

12-Ketodeoxycholic acid is a bile acid, from kidney. 12-Ketodeoxycholic acidmetabolite

can be a detectable for evidence ofmarkerkidney injury.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

13-cis-Vitamin A palmitate (13-cis-Retinyl palmitate) Cat. No.: HY-N8356

13-cis-Vitamin A palmitate (13-cis-Retinylpalmitate) is a 13-cis isomer formed by vitamin Apalmitate in corn flakes. 13-cis-Vitamin Apalmitate has a biological activity of 75% ofall-trans-vitamin A palmitate, the mostbiologically ac-tive form of vitamin A.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

15-Deoxy-Δ-12,14-prostaglandin J2 (15d-PGJ2; 15-Deoxy-Δ12,14-PGJ2) Cat. No.: HY-108568

15-Deoxy-Δ-12,14-prostaglandin J2 (15d-PGJ2) is acyclopentenone prostaglandin and a metabolite ofPGD2. 15-Deoxy-Δ-12,14-prostaglandin J2 is aselective ( of 2 µM) and a covalentPPARγ EC50

agonist.PPARδ

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

16-DehydroprogesteroneCat. No.: HY-128378

16-Dehydroprogesterone is a steroidal progestin.

Purity: 99.53%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

12 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

17-Hydroxyprogesterone (17α-Hydroxyprogesterone; 17-OHP) Cat. No.: HY-B0891

17-Hydroxyprogesterone (17-OHP) is an endogenousprogestogen as well as chemical intermediate inthe biosynthesis of other steroid hormones,including the corticosteroids and the androgensand the estrogens.

Purity: 99.94%Clinical Data: LaunchedSize: 100 mg

17a-HydroxypregnenoloneCat. No.: HY-113263

17a-Hydroxypregnenolone is a pregnane steroid.17a-Hydroxypregnenolone is a prohormone in theformation of dehydroepiandrosterone (DHEA).

Purity: 98.06%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

18-HydroxycorticosteroneCat. No.: HY-W013179

18-Hydroxycorticosterone is a corticosteroid and aderivative of corticosterone, which can lead toserious electrolyte imbalances.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg

18-OxocortisolCat. No.: HY-113151

18-Oxocortisol is a derivative of cortisol that isproduced by aldosterone synthase (CYP11B2).18-Oxocortisol is a naturally occurring

agonist. 18-Oxocortisol is amineralocorticoidbiomarker in adrenal vein sampling.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

18β-Glycyrrhetinic acidCat. No.: HY-N0180

18β-Glycyrrhetinic acid is the major bioactivecomponent of Glycyrrhizae Radix and possessesanti-ulcerative, anti-inflammatory andantiproliferative properties.

Purity: 99.63%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

1H-pyrazoleCat. No.: HY-76228

1H-pyrazole is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

2',3'-cGAMP (2'-3'-cyclic GMP-AMP) Cat. No.: HY-100564

2',3'-cGAMP (2'-3'-cyclic GMP-AMP) is a endogenouscGAMP in mammalian cells. 2',3'-cGAMP binds to

with a high affinity and is a potent inducerSTINGof . 2',3'-cGAMP is produced ininterferon-β (IFNβ)mammalian cells in response to DNA in thecytoplasm.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2',3'-cGAMP sodium (2'-3'-cyclic GMP-AMP sodium) Cat. No.: HY-100564A

2',3'-cGAMP sodium (2'-3'-cyclic GMP-AMP sodium)is a endogenous cGAMP in mammalian cells.2',3'-cGAMP sodium binds to with a highSTINGaffinity and is a potent inducer of interferon-β

. 2',3'-cGAMP sodium is produced in mammalian(IFNβ)cells in response to DNA in the cytoplasm.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg

2',4'-Dihydroxyacetophenone (Resacetophenone; 1-(2,4-Dihydroxyphenyl)ethanone) Cat. No.: HY-Y0694

2',4'-Dihydroxyacetophenone (Resacetophenone) isacetophenone carrying hydroxy substituents atpositions 2' and 4'. A plant metabolite.

Purity: 99.89%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2',4'-DimethylacetophenoneCat. No.: HY-W015618

2',4'-Dimethylacetophenone is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

www.MedChemExpress.com 13

 

2'-DeoxyadenosineCat. No.: HY-W040329

2'-Deoxyadenosine is a nucleoside adenosinederivative, pairing with deoxythymidine (T) indouble-stranded DNA.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2'-Deoxyadenosine monohydrateCat. No.: HY-W011683

2'-Deoxyadenosine monohydrate is adeoxyribonucleoside. A building block in thechemical synthesis.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2'-Deoxyadenosine-5'-monophosphateCat. No.: HY-W016009

2'-Deoxyadenosine-5'-monophosphate is anendogenous metabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2'-Deoxyadenosine-5'-triphosphate (dATP) Cat. No.: HY-136648

2'-Deoxyadenosine-5'-triphosphate (dATP) is anucleotide used in cells for DNA synthesis (orreplication), as a substrate of DNA polymerase.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2'-Deoxyadenosine-5'-triphosphate trisodium (dATP trisodium) Cat. No.: HY-136648A

2'-Deoxyadenosine-5'-triphosphate trisodium (dATPtrisodium) is a nucleotide used in cells for DNAsynthesis (or replication), as a substrate of DNApolymerase.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2'-Deoxycytidine (Deoxycytidine; Cytosine deoxyriboside;

Deoxyribose cytidine) Cat. No.: HY-D0184

2'-Deoxycytidine, a deoxyribonucleoside, couldinhibit biological effects of Bromodeoxyuridine

.(Brdu)

Purity: 97.76%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg

2'-Deoxycytidine-5'-diphosphate trisodiumCat. No.: HY-W010861

2'-Deoxycytidine-5'-diphosphate trisodium salt isan endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2'-Deoxycytidine-5'-monophosphoric acidCat. No.: HY-W009216

2'-Deoxycytidine-5'-monophosphoric acid is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2'-Deoxyguanosine (Deoxyguanosine; Guanine deoxyriboside) Cat. No.: HY-17563

2'-Deoxyguanosine (Deoxyguanosine) is composed ofthe purine nucleoside guanine linked by its N9nitrogen to the C1 carbon of deoxyribose.

Purity: 99.91%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2'-Deoxyguanosine monohydrateCat. No.: HY-D0185

2'-Deoxyguanosine monohydrate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 50 mg, 100 mg

14 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

2'-DeoxyinosineCat. No.: HY-W008638

2’-deoxyadenosine inhibits the growth of humancolon-carcinoma cell lines and is found to beassociated with purine nucleoside phosphorylase(PNP) deficiency.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2'-DeoxyuridineCat. No.: HY-D0186

2'-Deoxyuridine could increase chromosome breakageand results in a decreased thymidylate synthetaseactivity. A known use of 2'-Deoxyuridine is as aprecursor in the synthesis of Edoxudine.

Purity: 98.43%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2'-O-MethyladenosineCat. No.: HY-W011552

2'-O-Methyladenosine, a methylated adenine residueis found in urine of normals as well as in urineof adenosine deaminase (ADA) deficient patients.2'-O-Methyladenosine exhibits unique hypotensiveactivities .

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

2,2-Dihydroxyacetic acidCat. No.: HY-W019724

2,2-Dihydroxyacetic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2,3,5-TrimethylpyrazineCat. No.: HY-W010476

2,3,5-Trimethylpyrazine is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

2,3-ButanediolCat. No.: HY-128387

2,3-Butanediol is a butanediol derived from thebioconversion of natural resources.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2,3-Diaminopropanoic acid hydrochlorideCat. No.: HY-W013674

2,3-Diaminopropanoic acid hydrochloride is anendogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2,3-Diaminopropionic acidCat. No.: HY-113379

2, 3-Diaminopropionic acid is a metabolite ofb-oxalyl-L-a, b-diaminopropionic acid a neurotoxicamino acid (ODAP).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2,4-Di-tert-butylphenol (2,4-DTBP) Cat. No.: HY-W014589

2,4-Di-tert-butylphenol is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

2,4-DihydroxybenzaldehydeCat. No.: HY-W007539

2,4-Dihydroxybenzaldehyde is an endogenousmetabolite.

Purity: 99.93%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

www.MedChemExpress.com 15

 

2,4-Dihydroxybenzoic acidCat. No.: HY-W012575

2,4-Dihydroxybenzoic acid is a degradation productof cyaniding glycoside from tart cheeries in cellculture.

Purity: 99.53%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2,4-Dihydroxypyrimidine-5-carboxylic AcidCat. No.: HY-66047

2,4-Dihydroxypyrimidine-5-carboxylic Acid is anendogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2,5-Dihydroxybenzoic acidCat. No.: HY-W001179

2,5-Dihydroxybenzoic acid is a derivative ofbenzoic and a powerful inhibitor of fibroblast

.growth factors

Purity: 99.97%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2,5-Dimethylpyrazine (NSC 49139) Cat. No.: HY-34439

2,5-Dimethylpyrazine is an endogenous metabolite.

Purity: 98.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2,5-Furandicarboxylic acidCat. No.: HY-W002105

2,5-Furandicarboxylic acid, detected in humanurine, is an important renewable biotechnologicalbuilding block because it serves as anenvironmentally friendly substitute forterephthalic acid in the production of polyesters.

Purity: 98.48%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2,6-Diaminoheptanedioic acidCat. No.: HY-128746

2,6-Diaminoheptanedioic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2,6-DibromophenolCat. No.: HY-Y1667

2,6-Dibromophenol is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2,6-DihydroxyacetophenoneCat. No.: HY-Y0106

2,6-Dihydroxyacetophenone is an endogenousmetabolite.

Purity: 98.93%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 250 mg, 500 mg

2,6-Dihydroxybenzoic acidCat. No.: HY-Y0801

2,6-Dihydroxybenzoic acid is a secondarymetabolite of salicylic acid which has beenhydrolyzed by liver enzymes during phase Imetabolism.

Purity: 99.83%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

2,6-Dimethoxybenzoic acidCat. No.: HY-76504

2,6-Dimethoxybenzoic acid is a member of organiccompounds known as o-methoxybenzoic acids andderivatives.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

16 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

2,6-DimethylhydroquinoneCat. No.: HY-W004874

2,6-Dimethylhydroquinone is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 250 mg, 500 mg

2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid hydrateCat. No.: HY-W016812

2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid hydrate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-(1H-Indol-3-yl)ethan-1-olCat. No.: HY-W010155

2-(1H-Indol-3-yl)ethan-1-ol is an endogenousmetabolite.

Purity: 96.78%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2-(2',3',4'-Trihydroxybutyl)quinoxalineCat. No.: HY-N7427

2-(2',3',4'-Trihydroxybutyl)quinoxaline is a foodmetabolite.2-(2',3',4'-Trihydroxybutyl)quinoxaline can beformed from homoglucans.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-(2-Methylbenzamido)acetic acidCat. No.: HY-W015060

2-(2-Methylbenzamido)acetic acid is a metabolitedetected in urine.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2-(2-Phenylacetamido)acetic acidCat. No.: HY-W015061

2-(2-Phenylacetamido)acetic acid is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

2-(4-Methoxyphenyl)acetic acid (4-Methoxyphenylacetic acid) Cat. No.: HY-W004206

2-(4-Methoxyphenyl)acetic acid is a plasmametabolite, with high sensitivity and specificityvalue as a biomarker for discriminating betweenNSCLC and healthy controls.

Purity: 99.80%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine) Cat. No.: HY-101412

2-(Methylamino)-1H-purin-6(7H)-one(N2-Methylguanine) is a modified nucleoside.2-(Methylamino)-1H-purin-6(7H)-one is anendogenous methylated nucleoside found in humanfluids.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mg

2-AcetonaphthoneCat. No.: HY-Y1819

2-Acetonaphthone is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

2-Acetyl-3-ethylpyrazineCat. No.: HY-W039157

2-Acetyl-3-ethylpyrazine is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

www.MedChemExpress.com 17

 

2-Amino-1-phenylethanolCat. No.: HY-59132

2-Amino-1-phenylethanol is an analogue ofnoradrenaline.

Purity: 95.69%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2-Amino-4-(2-aminophenyl)-4-oxobutanoic acidCat. No.: HY-W014504

2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-Amino-5-phenylpyridineCat. No.: HY-W002820

2-Amino-5-phenylpyridine is a mutagenicheterocyclic aromatic amine that is formed bypyrolysis of phenylalanine in proteins.2-Amino-5-phenylpyridine is in broiled sardinesand is considered as potentially carcinogenic.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

2-Amino-5-ureidopentanoic acidCat. No.: HY-W016734

2-Amino-5-ureidopentanoic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-Aminobenzenesulfonic acidCat. No.: HY-W015302

2-Aminobenzenesulfonic acid is an endogenousmetabolite.

Purity: 98.89%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2-Aminopyrimidin-5-olCat. No.: HY-W018339

2-Aminopyrimidin-5-ol is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

2-ArachidonoylglycerolCat. No.: HY-W011051

2-Arachidonoylglycerol is a second endogenouscannabinoid ligand in the central nervous system.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg (26.4 mM * 100 μL in Acetonitrile),

2-Deoxy-2-sulfoamino-D-glucose sodiumCat. No.: HY-107785

2-Deoxy-2-sulfoamino-D-glucose sodium is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-EthylpyrazineCat. No.: HY-W040948

2-Ethylpyrazine is an endogenous metabolite.

Purity: 99.67%Clinical Data: No Development ReportedSize: 500 mg

2-Furoic acid (Furan-2-carboxylic acid) Cat. No.: HY-W012946

2-Furoic acid (Furan-2-carboxylic acid) is anorganic compound produced through furfuraloxidation. 2-Furoic acid exhibits hypolipidemiceffet, lowers both serum cholesterol and serumtriglyceride levels in rats.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

18 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

2-FuroylglycineCat. No.: HY-113340

2-Furoylglycine, a urinary metabolite in human, isa putative biomarker for coffee consumption.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-Hydroxy-2-methylbutanoic acidCat. No.: HY-W015874

2-Hydroxy-2-methylbutanoic acid, an unusualmetabolite, is associated with 2-hydroxyglutaricaciduria and maple syrup urine disease.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2-Hydroxy-2-phenylacetic acidCat. No.: HY-W015591

2-Hydroxy-2-phenylacetic acid is an endogenousmetabolite.

Purity: 99.92%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2-Hydroxy-3-methylbutanoic acidCat. No.: HY-W008150

2-Hydroxy-3-methylbutanoic acid is a closestructure analogue of GHB, which is a naturallyoccurring neurotransmitter and a psychoactivedrug.

Purity: 98.57%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2-Hydroxy-4-methylbenzaldehydeCat. No.: HY-W007888

2-Hydroxy-4-methylbenzaldehyde is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

2-Hydroxyadipic acidCat. No.: HY-113101

2-Hydroxyadipic acid is an organic acid, formed bythe reduction of 2-ketoadipic acid.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg

2-Hydroxyhexanoic acidCat. No.: HY-75954

2-Hydroxyhexanoic acid is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

2-Hydroxyisobutyric acidCat. No.: HY-W015924

2-Hydroxyisobutyric acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-hydroxymethyl benzoic acidCat. No.: HY-W019358

2-hydroxymethyl benzoic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2-Hydroxyphenylacetic acidCat. No.: HY-W015590

2-Hydroxyphenylacetic acid is a potentialbiomarker for the food products, and found to beassociated with phenylketonuria .(PKU)

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 19

 

2-Ketoglutaric acid (Alpha-Ketoglutaric acid) Cat. No.: HY-W013636

2-Ketoglutaric acid (Alpha-Ketoglutaric acid) isan intermediate in the production of ATP or GTP inthe Krebs cycle. 2-Ketoglutaric acid also acts asthe major carbon skeleton fornitrogen-assimilatory reactions.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg, 1 g

2-Ketoglutaric acid Sodium (Alpha-Ketoglutaric acid Sodium) Cat. No.: HY-W013636A

2-Ketoglutaric acid Sodium (Alpha-Ketoglutaricacid Sodium) is an intermediate in the productionof ATP or GTP in the Krebs cycle. 2-Ketoglutaricacid Sodium also acts as the major carbon skeletonfor nitrogen-assimilatory reactions.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-MercaptobenzothiazoleCat. No.: HY-W017113

2-Mercaptobenzothiazole is an endogenousmetabolite.

Purity: 99.85%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

2-Methoxybenzoic acid (NSC 3778; O-Methylsalicylic acid;

Salicylic acid methyl ether) Cat. No.: HY-N1393

2-Methoxybenzoic acid (NSC 3778) is used as aninternal standard of salicylic acid and itsputative biosynthetic precursors in cucumberleaves. Another known use is in the synthesis ofBenextramine.

Purity: 99.06%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 1 g

2-Methoxyestradiol (2-ME2; NSC-659853) Cat. No.: HY-12033

2-Methoxyestradiol (2-ME2), an orally activeendogenous metabolite of 17β-estradiol (E2), is an

inducer and an inhibitor withapoptosis angiogenesispotent antineoplastic activity. 2-Methoxyestradiolalso destablize .microtubules

Purity: 99.82%Clinical Data: Phase 2Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 500 mg

2-MethoxyestroneCat. No.: HY-113252

2-Methoxyestrone is a methoxylated catecholestrogen and metabolite of estrone, with a pKa of10.81.

Purity: 98.05%Clinical Data: No Development ReportedSize: 5 mg

2-MethylacetophenoneCat. No.: HY-W012658

2-Methylacetophenone is an endogenous metabolite.

Purity: 99.18%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2-MethylbenzaldehydeCat. No.: HY-Y0442

2-Methylbenzaldehyde is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

2-MethylbenzoxazoleCat. No.: HY-W038287

2-Methylbenzoxazole is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

2-Methylcitric acid (Methylcitric acid) Cat. No.: HY-113371

2-Methylcitric acid (Methylcitric acid) is anendogenous metabolite in the 2-methylcitric acidcycle. 2-Methylcitric acid accumulates inmethylmalonic and propionic acidemias and acts asa marker metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

20 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

2-Methylcitric acid trisodium (Methylcitric acid trisodium) Cat. No.: HY-113371A

2-Methylcitric acid trisodium (Methylcitric acidtrisodium) is an endogenous metabolite in the2-methylcitric acid cycle. 2-Methylcitric acidtrisodium accumulates in methylmalonic andpropionic acidemias and acts as a markermetabolite.

Purity: >96.0%Clinical Data: No Development ReportedSize: 5 mg

2-MethylcyclohexanoneCat. No.: HY-W010549

2-Methylcyclohexanone is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-Methylpentanedioic acidCat. No.: HY-W017524

2-Methylpentanedioic acid is a metabolite ofsuccinic acid, a citric acid cycle intermediate.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2-Methylsuccinic acidCat. No.: HY-W010381

2-Methylsuccinic acid is a normal metabolite inhuman fluids and the main biochemical measurablefeatures in ethylmalonic encephalopathy.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2-Methylvaleric acid (2-Methylpentanoic acid) Cat. No.: HY-W010516

2-Methylvaleric acid (2-Methylpentanoic acid) is ashort-chain fatty acid isolated from

and dairy products.Campomanesia adamantium2-Methylvaleric acid is also found in animalfeces. 2-Methylvaleric acid is a flavor compoundused for food-flavor ingredient, fragrances.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

2-NaphtholCat. No.: HY-Y0110

2-Naphthol is a metabolite of naphthalene,catalyzed by cytochrome P450 (CYP) isozymes (CYP1A1, CYP 1A2, CYP 2A1, CYP 2E1 and CYP 2F2).

Purity: 99.85%Clinical Data: No Development ReportedSize: 100 mg

2-Naphthoxyacetic acidCat. No.: HY-W014796

2-Naphthoxyacetic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

2-O-MethylcytosineCat. No.: HY-69014

2-O-Methylcytosine, an O-alkylated analogue a DNAadduct, is the damaged nucleobase.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg

2-Oxobutanoic acidCat. No.: HY-W007926

2-Oxobutanoic acid is a product in the enzymaticcleavage of cystathionine.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2-Oxovaleric acidCat. No.: HY-113098

2-Oxovaleric acid is a keto acid that is found inhuman blood.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

www.MedChemExpress.com 21

 

2-PhenylacetaldehydeCat. No.: HY-W010489

2-Phenylacetaldehyde is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2-PhenylacetamideCat. No.: HY-W018197

2-Phenylacetamide is an endogenous metabolite.

Purity: 99.46%Clinical Data: No Development ReportedSize: 500 mg

2-Phenylbutanoic acidCat. No.: HY-W017194

2-Phenylbutanoic acid is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

2-PhenylethylamineCat. No.: HY-W010483

2-Phenylethanamine is believed to function as aneuromodulator or neurotransmitter.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg

2-Phenylglycine (DL-α-Phenylglycine) Cat. No.: HY-W010248

2-Phenylglycine (DL-α-Phenylglycine) is ametabolite in breast milk during the W2 to W4lactation period.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

2-Phenylpropionic acidCat. No.: HY-W015608

2-Phenylpropionic acid is an intermediate inalpha-Methylstyrene metabolism.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

2-Phospho-L-ascorbic acid trisodium (L-Ascorbic acid 2-phosphate trisodium) Cat. No.: HY-107837

2-Phospho-L-ascorbic acid trisodium acts as anantioxidant and a stimulator of hepatocyte growthfactor production.(HGF)

Purity: 99.36%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

2-PiperidoneCat. No.: HY-W042193

2-Piperidone is an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

2-ThiophenecarboxaldehydeCat. No.: HY-W012941

2-Thiophenecarboxaldehyde is an endogenousmetabolite.

Purity: 99.35%Clinical Data: No Development ReportedSize: 500 mg

20(S)-Ginsenoside Rg3 (20(S)-Propanaxadiol; S-ginsenoside Rg3) Cat. No.: HY-N0603

20(S)-Ginsenoside Rg3 is the main component of Redginseng. Ginsenoside Rg3 inhibits andNa+

channel with IC s of 32.2±4.5 and 32.6±2.2hKv1.4 50

μM, respectively. 20(S)-Ginsenoside Rg3 alsoinhibits levels, activity, and Aβ NF-κB COX-2expression.

Purity: 98.10%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

22 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

20(S)-Hydroxycholesterol (20α-Hydroxycholesterol) Cat. No.: HY-12316

20(S)-hydroxyCholesterol (20α-Hydroxycholesterol)is an allosteric activator of the oncoprotein

that activates the hedgehogsmoothened (Smo)(Hh) signaling pathway with an of 3 μM in aEC50

gene transcription reporter assay using NIH3T3cells.

Purity: 98.07%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

21-HydroxypregnenoloneCat. No.: HY-113020

21-Hydroxypregnenolone is an essentialintermediate in corticosterone synthesis.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

24(S)-Hydroxycholesterol (24S-OHC; 24S-HC; Cerebrosterol) Cat. No.: HY-16940

24(S)-Hydroxycholesterol (24S-OHC), the majorbrain cholesterol metabolite, plays an importantrole to maintain homeostasis of cholesterol in thebrain.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mg

24, 25-Dihydroxy VD3Cat. No.: HY-76915

24, 25-Dihydroxy VD3 is a compound which isclosely related to 1,25-dihydroxyvitamin D3, theactive form of vitamin D3, but like vitamin D3itself and 25-hydroxyvitamin D3 is inactive as ahormone both in vitro and in vivo.

Purity: 98.20%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

25,26-Dihydroxyvitamin D3 (25,26-Dihydroxycholecalciferol) Cat. No.: HY-15830

25,26-DihydroxyvitaminD3(25,26-dihydroxycholecalciferol) is a metaboliteof vitamin D3 with intestinal calcium transportactivity.

Purity: 98.08%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg

25-HydroxycholesterolCat. No.: HY-113134

25-Hydroxycholesterol is a metabolite ofcholesterol that is produced and secreted bymacrophages in response to Toll-like receptor(TLR) activation. 25-hydroxycholesterol is apotent (EC ≈65 nM) and selective suppressor of50

IgA production by B cells.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

27-HydroxycholesterolCat. No.: HY-N2371

27-Hydroxycholesterol is a selective estrogen modulator and an agonist of the receptor liver X.receptor

Purity: 99.38%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3'-Deoxyuridine-5'-triphosphate (3'-dUTP) Cat. No.: HY-135780

3'-Deoxyuridine-5'-triphosphate (3'-dUTP) is anucleotide analogue that inhibits DNA-dependent

and .RNA polymerases I II3'-Deoxyuridine-5'-triphosphate strongly andcompetitively inhibits the incorporations of UTPinto with a value of 2.0 μM.RNA Ki

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg

3,3'-Diiodo-L-thyronine (3,3'-T2) Cat. No.: HY-129974

3,3'-Diiodo-L-thyronine (3,3'-T2) is an of thyroid hormone.endogenous metabolite

3,3'-Diiodo-L-thyronine significantly enhances activity.COX

Purity: 98.21%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg

3,3-Dimethylglutaric acidCat. No.: HY-W008097

3,3-Dimethylglutaric acid, a member ofmethyl-branched fatty acids, is a endogenousmetabolite occasionally found in human urine.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

www.MedChemExpress.com 23

 

3,4,5-Trimethoxycinnamic acidCat. No.: HY-W012123

3,4,5-Trimethoxycinnamic acid is a phenylpropanoidisolated from the roots of Polygala tenuifoliaWILLD, with anti-stress effect, prolonging thesleeping time in animals.

Purity: 99.22%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3,4-Dicaffeoylquinic acid (3,4-Di-O-caffeoylquinic acid; Isochlorogenic acid B) Cat. No.: HY-N0057

3,4-Dicaffeoylquinic acid (3,4-Di-O-caffeoylquinicacid), naturally isolated from , hasLaggera alataantioxidative, DNA protective, neuroprotective andhepatoprotective properties.

Purity: 96.44%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

3,4-Dihydroxybenzeneacetic acidCat. No.: HY-W001080

3,4-Dihydroxybenzeneacetic acid is the mainneuronal metabolite of dopamine.

Purity: 99.74%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3,4-Dihydroxymandelic acidCat. No.: HY-113474

3,4-Dihydroxymandelic acid is a metabolite ofnorepinephrine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg

3,4-DimethoxyphenethylamineCat. No.: HY-Y0935

3,4-Dimethoxyphenethylamine is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

3,4-Dimethoxyphenylacetic acidCat. No.: HY-Y0771

3,4-Dimethoxyphenylacetic acid is a building blockin the chemical synthesis.

Purity: 99.46%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3,5-DihydroxyacetophenoneCat. No.: HY-W034065

3,5-Dihydroxyacetophenone is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

3,5-Dihydroxybenzoic acidCat. No.: HY-W015560

3,5-Dihydroxybenzoic acid a potential biomarkerfor the consumption of many food products,including beer, nuts, peanut, and pulses.

Purity: 99.74%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-(2-Hydroxyphenyl)propanoic acidCat. No.: HY-W017158

3-(2-Hydroxyphenyl)propanoic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-(3,4,5-Trimethoxyphenyl)propanoic acidCat. No.: HY-W022390

3-(3,4,5-Trimethoxyphenyl)propanoic acid is foundin herbs and spices.3-(3,4,5-Trimethoxyphenyl)propanoic acid is aconstituent of (long pepper) andPiper longum

(Javanese long pepper).Piper retrofractum

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

24 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

3-(3-Hydroxyphenyl)propionic acidCat. No.: HY-W005255

3-(3-Hydroxyphenyl)propionic acid is a flavonoidmetabolite formed by human microflora.3-(3-Hydroxyphenyl)propionic acid showsvasodilatory activity.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg

3-(3-Methoxyphenyl)propionic acidCat. No.: HY-W016482

3-(3-Methoxyphenyl)propionic acid is an organicacid, naturally occurring human metabolite andexcreted in human urine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-(Methylthio)propionic acid (3-Methylsulfanylpropionic acid) Cat. No.: HY-101401

3-(Methylthio)propionic acid is an intermediate inthe methionine metabolism.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Amino-2-methylpropanoic acidCat. No.: HY-W012974

3-Amino-2-methylpropanoic acid could inducebrowning of white fat and hepatic β-oxidation andis inversely correlated with cardiometabolic riskfactors.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Amino-2-oxazolidinone (AOZ) Cat. No.: HY-W012982

3-Amino-2-oxazolidinone (AOZ) is the metaboliteof Furazolidone (HY-B1336).3-Amino-2-oxazolidinone is always be detected as aindicator of furazolidone residues in vivo.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Amino-2-piperidinone (Cyclo-ornithine) Cat. No.: HY-21088

3-aminopiperidine-2-one is a frommetaboliteall living organisms. 3-aminopiperidine-2-one is adelta-lactam that is 2-piperidone substituted atposition 3 by an amino group.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Amino-4-hydroxybenzoic acidCat. No.: HY-W010224

3-Amino-4-hydroxybenzoic acid is an endogenousmetabolite.

Purity: 99.50%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Amino-4-methylpentanoic acidCat. No.: HY-W012708

3-Amino-4-methylpentanoic acid is a beta aminoacid and positional isomer of L-leucine which isnaturally produced in humans via the metabolism ofL-leucine by the enzyme leucine 2,3-aminomutase.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Carbamoyl-1-methylpyridin-1-ium chlorideCat. No.: HY-113527

3-Carbamoyl-1-methylpyridin-1-ium chloride is anendogenous metabolite.

Purity: 99.41%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Chloro-L-tyrosineCat. No.: HY-W041171

3-Chloro-L-tyrosine is a specific marker ofmyeloperoxidase-catalyzed oxidation, and ismarkedly elevated in low density lipoproteinisolated from human atherosclerotic intima.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 250 mg

www.MedChemExpress.com 25

 

3-Deoxy-galactosoneCat. No.: HY-118813

3-Deoxy-galactosone is a 1,2-dicarbonyl compoundoriginating from the degradation of galactose.3-Deoxy-galactosone is formed in food duringMaillard and caramelization reactions.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Ethoxy-3-oxopropanoic acidCat. No.: HY-Y1031

3-Ethoxy-3-oxopropanoic acid is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Furanoic acidCat. No.: HY-21075

3-Furanoic acid is an endogenous metabolite.

Purity: 99.27%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

3-Hydroxy-4-aminopyridineCat. No.: HY-W008188

3-Hydroxy-4-aminopyridine is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

3-Hydroxyanthranilic acidCat. No.: HY-W001171

3-Hydroxyanthranilic acid is a tryptophanmetabolite in the kynurenine pathway.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Hydroxybenzoic acidCat. No.: HY-W004049

3-Hydroxybenzoic acid is an endogenous metabolite.

Purity: 99.04%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Hydroxybutyric acid (β-Hydroxybutyric acid) Cat. No.: HY-113378

3-Hydroxybutyric acid (β-Hydroxybutyric acid) is ametabolite that is elevated in type I diabetes.3-Hydroxybutyric acid can modulate the propertiesof membrane lipids.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) Cat. No.: HY-W010452

3-Hydroxybutyric acid sodium (β-Hydroxybutyricacid sodium) is a metabolite that is elevated intype I diabetes. 3-Hydroxybutyric acid sodium canmodulate the properties of membrane lipids.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

3-Hydroxycapric acidCat. No.: HY-113057

3-Hydroxycapric acid is an inhibitor for mitoticprogression.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Hydroxydodecanoic acidCat. No.: HY-113107

3-Hydroxydodecanoic acid is a medium-chain fattyacid associated with fatty acid metabolicdisorders.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg

26 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

3-Hydroxyglutaric acidCat. No.: HY-113411

3-Hydroxyglutaric acid is a glutaric acidderivative.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Hydroxyhippuric acidCat. No.: HY-113085

3-Hydroxyhippuric acid is an acyl glycine. Acylglycines are normally minor metabolites of fattyacids.

Purity: 99.93%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

3-Hydroxyisovaleric acidCat. No.: HY-113409

3-Hydroxyisovaleric acid is a normal endogenous excreted in the urine. The urinarymetabolite

excretion of 3-hydroxyisovaleric acid is early andsensitive indicator of biotin deficiency.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

3-Hydroxymandelic AcidCat. No.: HY-W015326

3-Hydroxymandelic Acid, a metabolite of, Phenylephrine is a Phenylephrine α-receptor

agonist.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Hydroxyphenylacetic acidCat. No.: HY-W001083

3-Hydroxyphenylacetic acid is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Hydroxypicolinic acid (Picolinic acid, 3-hydroxy-

(6CI,7CI,8CI); 2-Carboxy-3-hydroxypyridine) Cat. No.: HY-Y0030

3-Hydroxypicolinic acid is a picolinic acidderivative, and belongs to the pyridine family.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

3-Hydroxyvaleric acidCat. No.: HY-113004

3-Hydroxyvaleric acid is a 5-carbon ketone body.3-Hydroxyvaleric acid is anaplerotic, meaning itcan refill the pool of TCA cycle intermediates.

Purity: >98.0%Clinical Data:Size: 50 mg, 100 mg, 250 mg

3-Indoleacetic acid (Indole-3-acetic acid; 3-IAA) Cat. No.: HY-18569

3-Indoleacetic acid (Indole-3-acetic acid) is themost common natural plant growth hormone of theauxin class. It can be added to cell culturemedium to induce plant cell elongation anddivision.

Purity: 99.89%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

3-Indoleacetic acid sodium (Indole-3-acetic acid sodium; 3-IAA sodium) Cat. No.: HY-18569A

3-Indoleacetic acid sodium (Indole-3-acetic acidsodium) is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-IndoleacetonitrileCat. No.: HY-Y0136

3-Indoleacetonitrile is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

www.MedChemExpress.com 27

 

3-Indolepropionic acidCat. No.: HY-W015229

3-Indolepropionic acid is shown to be a powerfulantioxidant and has potential in the treatment forAlzheimer’s disease.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

3-Methoxybenzoic acid (3-Anisic acid; 3-Methoxybenzoic acid;

NSC 27014; NSC 9264; m-Methoxybenzoic acid) Cat. No.: HY-Y0760

3-Methoxybenzoic acid can be used in the synthesisof 3-methoxybenzoates of europium (III) andgadolinium (III).

Purity: 97.73%Clinical Data: No Development ReportedSize: 500 mg, 5 g

3-Methoxytyramine (3-O-methyl Dopamine) Cat. No.: HY-103638A

3-Methoxytyramine, a well known extracellularmetabolite of 3-hydroxytyramine/dopamine, is aneuromodulator.

Purity: >97.0%Clinical Data: No Development ReportedSize: 100 mg, 250 mg, 500 mg

3-Methoxytyramine hydrochloride (3-O-methyl Dopamine hydrochloride) Cat. No.: HY-103638

3-Methoxytyramine hydrochloride is an inactivemetabolite of dopamine which can activate trace

( ).amine associated receptor 1 TAAR1

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 250 mg, 500 mg, 1 g

3-Methyl-2-buten-1-olCat. No.: HY-W013035

3-Methyl-2-buten-1-ol is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 500 mg

3-Methyl-2-cyclopenten-1-oneCat. No.: HY-W013014

3-Methyl-2-cyclopenten-1-one is an endogenousmetabolite.

Purity: 99.63%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

3-Methyl-2-oxobutanoic acidCat. No.: HY-W006057

3-Methyl-2-oxobutanoic acid is a precursor ofpantothenic acid in .Escherichia coli

Purity: 99.10%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Methyl-2-oxovaleric acidCat. No.: HY-113063

3-Methyl-2-oxovaleric acid is a neurotoxin, anacidogen, and a metabotoxin, and also an abnormalmetabolite that arises from the incompletebreakdown of branched-chain amino acids.

Purity: 99.81%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Methyl-L-histidineCat. No.: HY-W017007

3-Methyl-L-histidine is a biomarker for meatconsumption, especially chicken. It is also abiomarker for the consumption of soy products.

Purity: 99.85%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Methyladenine (3-MA) Cat. No.: HY-19312

3-Methyladenine (3-MA) is a inhibitor.PI3K3-Methyladenine is a widely used inhibitor of

via its inhibitory effect on class IIIautophagyPI3K.

Purity: 99.83%Clinical Data: No Development ReportedSize: 50 mg, 100 mg, 200 mg, 500 mg

28 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

3-Methyladipic acidCat. No.: HY-113277

3-Methyladipic acid is the final metabolite in theω-oxidation pathway.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

3-Methylbut-2-enoic acidCat. No.: HY-W010611

3-Methylbut-2-enoic acid is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

3-Methylbutanoic acidCat. No.: HY-W012980

3-Methylbutanoic acid is a natural fatty acid andknown to effect on neonatal death and possibleJamaican vomiting sickness in human.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-MethylcrotonylglycineCat. No.: HY-113232

3-Methylcrotonylglycine is an acyl glycine, anormal amino acid metabolite found in urine.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

3-Methylglutaric acidCat. No.: HY-113410

3-Methylglutaric acid, a leucine metabolite, is aconspicuous C6 dicarboxylic organic acidclassically associated with two distinct leucinepathway enzyme deficiencies(3-hydroxy-3-methylglutaryl CoA lyase (HMGCL),3-methylglutaconyl CoA hydratase (AUH)).

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

3-Methylhistamine dihydrochlorideCat. No.: HY-113412A

3-Methylhistamine dihydrochloride is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Methylindolin-2-oneCat. No.: HY-W017490

3-Methylindolin-2-one is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-Methyluridine (N3-Methyluridine) Cat. No.: HY-113138

3-Methyluridine (N3-Methyluridine) is a modified. 3-Methyluridine is often presentsRNA nucleoside

as RNA modification which can be detected in23S rRNA of archaea, 16S and 23SrRNA of eubacteria, and 18S, 25S, and 28S ofeukaryotic ribosomal RNAs.

Purity: 99.53%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

3-Methylvaleric AcidCat. No.: HY-W010513

3-Methylvaleric Acid is a flavouring ingredient.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-MethylxanthineCat. No.: HY-50723

3-Methylxanthine, a xanthine derivative, is acyclic guanosine monophosphate inhibitor,(GMP)with an of 920 μM on guinea-pig isolatedIC50

trachealis muscle.

Purity: 99.62%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 29

 

3-Nitro-L-tyrosineCat. No.: HY-113248

3-Nitro-L-tyrosine is a biomarker of nitrogen freeradical species modified proteins in systemicautoimmunogenic conditions.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

3-O-Methyldopa (3-Methoxy-L-tyrosine; 3-O-Methyl-L-DOPA) Cat. No.: HY-113468A

3-O-Methyldopa (3-Methoxy-L-tyrosine) is ametabolite of L-DOPA which is formed bycatechol-O-methyltransferase (COMT).3-O-Methyldopa competitively inhibits thepharmacodynamics of l-DOPA and .dopamine

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg

3-O-Methyldopa D3 (3-Methoxy-L-tyrosine D3; 3-O-Methyl-L-DOPA D3) Cat. No.: HY-113468AS

3-O-Methyldopa D3 (3-Methoxy-L-tyrosine D3) isdeuterium labeled 3-O-Methyldopa. 3-O-Methyldopais a metabolite of L-DOPA which is formed bycatechol-O-methyltransferase (COMT).3-O-Methyldopa competitively inhibits thepharmacodynamics of l-DOPA and .dopamine

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Oxopentanedioic acidCat. No.: HY-W007752

3-Oxopentanedioic acid is a simple dicarboxylicacid, which is well-known to be used in thetropinone synthesis.

Purity: >97.0%Clinical Data: No Development ReportedSize: 100 mg

3-Phenoxybenzoic acid (3-PBA) Cat. No.: HY-W014225

3-Phenoxybenzoic acid is an endogenous metabolite.

Purity: 99.81%Clinical Data: No Development ReportedSize: 500 mg

3-Phenylbutyric acidCat. No.: HY-W017189

3-Phenylbutyric acid is metabolized by initialoxidation of the benzene ring and by initialoxidation of the side chain. 3-Phenylbutyric acidcan be used to isolate PB1Rhodococcus rhodochrousfrom compost soil.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Pyridineacetic acidCat. No.: HY-W015806

3-Pyridineacetic acid is a higher homologue ofnicotinic acid, a breakdown product of nicotine(and other tobacco alkaloids).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3-Oxocholic acidCat. No.: HY-N7387

3-Oxocholic acid is an oxo-bile acid metaboliteand also a major degradation product from cholicby in the intestine. 3-Oxocholic acidC. perfringensis steroid acid found predominantly in bile ofmammals.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3b,17b-DihydroxyetiocholaneCat. No.: HY-113368

3b,17b-Dihydroxyetiocholane is known as androgensand derivatives.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

3b-Hydroxy-5-cholenoic acidCat. No.: HY-113315

3b-Hydroxy-5-cholenoic acid is a monohydroxy bileacid of endogenous origin and could be found inchildren with the syndrome of hepatic ductularhypoplasia.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

30 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

3α,12β-Dihydroxycholanoic acidCat. No.: HY-43470

3α,12β-Dihydroxycholanoic acid is a bile acid thatcan be isolated from urine specimens of healthyhumans.

Purity: 96.53%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

3α,7α-Dihydroxycoprostanic acidCat. No.: HY-113097

3α,7α-Dihydroxycoprostanic acid is an endogenousmetabolite. 3α,7α-Dihydroxycoprostanic acid, abile acid, is the precursor to chenodeoxycholicacid.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

4',7-Dimethoxyisoflavone (Dimethoxydaidzein) Cat. No.: HY-N2145

4',7-Dimethoxyisoflavone is isolated from theleaves of , which shows antifungalAlbizzia lebbeckactivity.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

4,4'-Disulfanediylbis(2-aminobutanoic acid)Cat. No.: HY-W009390A

4,4'-Disulfanediylbis(2-aminobutanoic acid) is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

4,4-Dimethoxy-2-butanoneCat. No.: HY-Y0035

4,4-Dimethoxy-2-butanone is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

4,5-Dicaffeoylquinic acid (Isochlorogenic acid C) Cat. No.: HY-N0058

4,5-Dicaffeoylquinic acid ( Isochlorogenic acid C)possesses potent hepatoprotective and anti-HBVeffects. IC50 value: Target: Anti-hepatitisnatural produce.

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

4,6-Dioxoheptanoic acidCat. No.: HY-W010184

4,6-Dioxoheptanoic acid is a potent inhibitor ofheme biosynthesis.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

4,6-O-Ethylidene-α-D-glucose (Ethylidene-glucose) Cat. No.: HY-N7433

4,6-O-ethylidene-α-D-glucose (Ethylidene-glucose),a glucose derivative, is a competitive exofacialbinding-site inhibitor on glucose transporter 1

with a of 12 mM for wild-type(GLUT1) Ki

2-deoxy-D-glucose transport.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

4,7,10,13,16-Docosapentaenoic acidCat. No.: HY-126355

4,7,10,13,16-Docosapentaenoic acid is anendogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

4-(1,2-Dihydroxyethyl)benzene-1,2-diolCat. No.: HY-W010066

4-(1,2-Dihydroxyethyl)benzene-1,2-diol, a normalnorepinephrine metabolite, is found to beassociated with Menkes syndrome.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 31

 

4-(2-Amino-1-hydroxyethyl)-2-methoxyphenol hydrochlorideCat. No.: HY-W008794

4-(2-Amino-1-hydroxyethyl)-2-methoxyphenolhydrochloride is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

4-Acetamidobutanoic acid (N-acetyl GABA) Cat. No.: HY-101411

4-Acetamidobutanoic acid (N-acetyl GABA) is aγ-aminobutyric acid ( ) derivative.GABA

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 200 mg

4-Amino-L-phenylalanineCat. No.: HY-W016480

4-Amino-L-phenylalanine is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

4-Aminobenzoic acid (PABA; Vitamin Bx; Vitamin H1) Cat. No.: HY-B1008

4-Aminobenzoic acid is an intermediate in thesynthesis of folate by bacteria, plants, andfungi.

Purity: 99.76%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

4-Aminohippuric acid (p-Aminohippuric acid) Cat. No.: HY-B1306

4-Aminohippuric acid is a diagnostic agent, usefulin medical tests involving the kidney, used in themeasurement of renal plasma flow.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-Bromo-3-hydroxybenzoic acidCat. No.: HY-W003445

4-Bromo-3-hydroxybenzoic acid is a metabolite ofBrocresine and a histidine decarboxylase (HDC)inhibitor with s of 1 mM for both IC50 rat fetaland .rat gastric HDC

Purity: 99.71%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-CarboxypyrazoleCat. No.: HY-W002065

4-Carboxypyrazole is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

4-EthoxyphenolCat. No.: HY-W015786

4-Ethoxyphenol is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

4-EthylbenzaldehydeCat. No.: HY-W012657

4-Ethylbenzaldehyde is an endogenous metabolite.

Purity: 97.17%Clinical Data: No Development ReportedSize: 500 mg

4-EthylphenolCat. No.: HY-W012836

4-Ethylphenol is a volatile phenolic compoundassociated with off-odour in wine.

Purity: 99.97%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

32 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

4-FormylaminoantipyrineCat. No.: HY-133588

4-Formylaminoantipyrine is an excreted of aminophenazone.metabolite

Aminophenazone is a pyrazolone with analgesic,anti-inflammatory, and antipyretic effects invivo.</br>.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

4-Guanidinobutanoic acidCat. No.: HY-113286

4-Guanidinobutanoic acid is a normal metabolitepresent in low concentrations.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-Hydroxy-3-methylbenzoic acidCat. No.: HY-W002587

4-Hydroxy-3-methylbenzoic acid is a normal organicacid identified in urine specimens from a healthypopulation.

Purity: 98.15%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-Hydroxybenzoic acidCat. No.: HY-Y0264

4-Hydroxybenzoic acid, a phenolic derivative ofbenzoic acid, could inhibit most gram-positive andsome gram-negative bacteria, with an of 160IC50

μg/mL.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

4-Hydroxybenzyl alcoholCat. No.: HY-Y0892

4-Hydroxybenzyl alcohol is a phenolic compoundwidely distributed in various kinds of plants.Anti-inflammatory, anti-oxidant, anti-nociceptiveactivity. Neuroprotective effect. Inhibitor oftumor angiogenesis and growth.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-Hydroxybenzyl cyanideCat. No.: HY-W015823

4-Hydroxybenzyl cyanide is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

4-HydroxybenzylamineCat. No.: HY-W004078

4-Hydroxybenzylamine is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

4-HydroxycoumarinCat. No.: HY-N6856

4-Hydroxycoumarin, a coumarin derivative, is oneof the most versatile heterocyclic scaffolds andis frequently applied in the synthesis of variousorganic compounds. 4-Hydroxycoumarin possessesboth electrophilic and nucleophilic properties.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg

4-Hydroxycyclohexanecarboxylic acidCat. No.: HY-W015675

4-Hydroxycyclohexanecarboxylic acid belongs to theclass of organic compounds known as cyclohexanols.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

4-HydroxymethylpyrazoleCat. No.: HY-33914

4-Hydroxymethylpyrazole is the primary metaboliteof Fomepizole (HY-B0876). Fomepizole is acompetitive inhibitor of the enzyme alcoholdehydrogenase.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 33

 

4-Hydroxynonenal (4-HNE) Cat. No.: HY-113466

4-Hydroxynonenal (4-HNE) is an α,β unsaturatedhydroxyalkenal and an oxidative/nitrosative stressbiomarker. 4-Hydroxynonenal is a substrate and aninhibitor of .acetaldehyde dehydrogenase 2 (ALDH2)

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg

4-Hydroxyphenylacetic acidCat. No.: HY-N1902

4-hydroxyphenylacetic acid, a majormicrobiota-derived metabolite of polyphenols, isinvolved in the antioxidative action.4-hydroxyphenylacetic acid induces expression of

.Nrf2

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-MethoxybenzaldehydeCat. No.: HY-Y0740

4-Methoxybenzaldehyde is a naturally occurringfragrant phenolic compound that is soluble inacetone. 4-Methoxybenzaldehyde has been found inmany plant species including horseradish, anise,star anise.

Purity: 99.67%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-Methoxycinnamic acidCat. No.: HY-N1387

4-Methoxycinnamic acid is detected as naturalphenylpropanoid in .A. preissii

Purity: 96.56%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 1 g

4-Methyl-1-phenyl-2-pentanoneCat. No.: HY-W041470

4-Methyl-1-phenyl-2-pentanone is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

4-Methyl-2-oxopentanoic acidCat. No.: HY-W012722

4-Methyl-2-oxopentanoic acid, an abnormalmetabolite, is both a neurotoxin and ametabotoxin.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-Methylbiphenyl (4-Phenyltoluene) Cat. No.: HY-W017077

4-Methylbiphenyl is an endogenous metabolite.

Purity: 98.75%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

4-MethylcatecholCat. No.: HY-W012814

4-Methylcatechol, a metabolite of -toluate, is apsubstrate as well as a suicide inhibitor of

.Catechol 2,3-Dioxygenase

Purity: 99.17%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

4-Pentenoic acidCat. No.: HY-Y0624

4-Pentenoic acid is an endogenous metabolite.

Purity: 98.95%Clinical Data: No Development ReportedSize: 500 mg

4-Pyridoxic acidCat. No.: HY-113493

4-Pyridoxic acid is a catabolic product of vitaminB6 which is excreted in the urine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

34 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

4-VinylphenolCat. No.: HY-W005288

4-Vinylphenol is found in the medicinal herb, wild rice and is alsoHedyotis diffusa Willd

the metabolite of p-coumaric and ferulic acid bylactic acid bacteria in wine.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

4-Hydroxyphenylpyruvic acidCat. No.: HY-W010040

4-Hydroxyphenylpyruvic acid is an intermediate inthe metabolism of the amino acid phenylalanine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5'-DeoxyadenosineCat. No.: HY-113291

5'-Deoxyadenosine is an oxidized nucleoside foundin the urine of normal subjects.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

5'-Guanylic acid (5'-GMP; 5'-guanosine monophosphate) Cat. No.: HY-N5134

5'-Guanylic acid (5'-GMP) is involved in severalmetabolic disorders, including theAICA-ribosiduria pathway, adenosine deaminasedeficiency, adenine phosphoribosyltransferasedeficiency (aprt), and the 2-hydroxyglutricaciduria pathway.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5'-Guanylic acid disodium salt (5'-GMP disodium salt;

5'-guanosine monophosphate disodium salt) Cat. No.: HY-W010970

5'-Guanylic acid disodium salt (5'-GMP disodiumsalt) is composed of guanine, ribose, andphosphate moieties and it is a nucleotide monomerin messenger RNA.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

5'-Methylthioadenosine (5'-(Methylthio)-5'-deoxyadenosine;

5'-Deoxy-5'-(methylthio)adenosine; …) Cat. No.: HY-16938

5'-Methylthioadenosine is produced fromS-adenosylmethionine and behaves as a powfulinhibitory product.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg

5,6-Dihydro-5-methyluracil (Dihydrothymine) Cat. No.: HY-N6787

5,6-Dihydro-5-methyluracil (Dihydrothymine), anintermediate breakdown product of thymine, comesfrom animal or plants. 5,6-Dihydro-5-methyluracil(Dihydrothymine) can be toxic when present atabnormally high levels.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5,6-DihydrouridineCat. No.: HY-113047

5,6-Dihydrouridine is a modified base found inconserved positions in the D-loop of tRNA inBacteria, Eukaryota, and some Archaea.

Purity: 99.87%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

5,6-DihydroxyindoleCat. No.: HY-W018025

5,6-Dihydroxyindole, a melanin precursor, has abroad-spectrum , , ,antibacterial antifungal antiviral

activity. 5,6-Dihydroxyindole hasantiparasiticcytotoxic effects and is strongly toxic againstvarious pathogens.

Purity: 95.94%Clinical Data: No Development ReportedSize: 100 mg

5,6-Dimethyl-1H-benzo[d]imidazoleCat. No.: HY-W017511

5,6-Dimethyl-1H-benzo[d]imidazole is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 35

 

5-ALA benzyl ester hydrochloride (Benzyl-ALA hydrochloride) Cat. No.: HY-133100

5-ALA benzyl ester hydrochloride (Benzyl-ALAhydrochloride) is a protoporphyrin precursor usedas a photodetection agent. 5-ALA benzyl esterhydrochloride induces protoporphyrin IX (PPIX)accumulation in colon carcinoma cell lines.

Purity: 99.76%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg

5-Amino-3H-imidazole-4-Carboxamide (5-Aminoimidazole-4-carboxamide; AICA) Cat. No.: HY-41461

5-Amino-3H-imidazole-4-Carboxamide (AICA) is animportant precursor for the synthesis of purinesin general and of the nucleobases adenine andguanine in particular.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

5-Aminolevulinic acid (5-ALA; δ-Aminolevulinic acid;

5-Amino-4-oxopentanoic acid) Cat. No.: HY-W000450

5-Aminolevulinic acid (5-ALA) is a non-proteinamino acid that plays a rate-limiting role in hemebiosynthesis.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride;

δ-Aminolevulinic acid hydrochloride; …) Cat. No.: HY-N0305

5-Aminolevulinic acid hydrochloride (5-ALAhydrochloride) is an intermediate in hemebiosynthesis in the body and the universalprecursor of tetrapyrroles.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g, 5 g, 10 g

5-Aminosalicylic Acid (Mesalamine; 5-ASA; Mesalazine) Cat. No.: HY-15027

5-Aminosalicylic acid (Mesalamine) acts as aspecific agonist and also inhibitsPPARγp21-activated kinase 1 ( ) and .PAK1 NF-κB

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

5-Aminovaleric acidCat. No.: HY-W015878

5-Aminovaleric acid is believed to act as amethylene homologue of gamma-aminobutyric acid(GABA) and functions as a weak agonist.GABA

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

5-Fluorouracil (5-FU) Cat. No.: HY-90006

5-Fluorouracil (5-FU) is an analogue of uracil anda potent antitumor agent. 5-Fluorouracil affects

by inhibiting thymidylatepyrimidine synthesissynthetase thus depleting intracellular dTTPpools. 5-Fluorouracil induces and can beapoptosisused as a chemical sensitizer.

Purity: 99.86%Clinical Data: LaunchedSize: 10 mM × 1 mL, 200 mg, 1 g, 5 g

5-Hydroxy-2'-deoxyuridine (5-OHdU) Cat. No.: HY-130801

5-Hydroxy-2'-deoxyuridine (5-OHdU) is a majorstable oxidation product of 2'-Deoxycytidine.5-Hydroxy-2'-deoxyuridine can be incorporated intoDNA in vitro by DNA polymerase.

Purity: 98.02%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

5-Hydroxydopamine hydrochlorideCat. No.: HY-113523

5-Hydroxydopamine is a naturally occurring aminein human urine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5-Hydroxyindole-3-acetic acidCat. No.: HY-W008253

5-Hydroxyindole-3-acetic acid is the mainmetabolite of serotonin or metanephrines, whichcan be used as a biomarker of neuroendocrinetumors.

Purity: 98.28%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

36 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

5-Hydroxymethyl-2-furancarboxylic acidCat. No.: HY-W005241

5-Hydroxymethyl-2-furancarboxylic acid is the mainmetabolite of 5-hydroxymethyl-2-furfural (HMF) inthe body and eliminated renally.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

5-HydroxymethyluracilCat. No.: HY-W004924

5-Hydroxymethyluracil is a product of oxidativeDNA damage. 5-Hydroxymethyluracil can be used as apotential epigenetic mark enhancing or inhibitingtranscription with bacterial RNA polymerase.

Purity: 99.60%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

5-Hydroxytryptamine creatinine sulfate monohydrateCat. No.: HY-W010973

5-Hydroxytryptamine creatinine sulfate monohydrateis an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5-Hydroxytryptophan (5-HTP; DL-5-Hydroxytryptophan) Cat. No.: HY-N0122

5-Hydroxytryptophan, a tryptophan metabolite, is adirect 5-hydroxytryptamine (5-HT) precursor and anL-aromatic amino acid decarboxylase substrate.

Purity: 99.91%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

5-HydroxytryptopholCat. No.: HY-W041019

5-Hydroxytryptophol is a mammalian serotoninmetabolite, acting as a marker of acute alcoholconsumption.

Purity: 98.31%Clinical Data:Size: 10 mM × 1 mL, 10 mg, 50 mg

5-Methoxy-5-oxopentanoic acidCat. No.: HY-W017523

5-Methoxy-5-oxopentanoic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5-Methoxy-DL-tryptophanCat. No.: HY-128731

5-Methoxy-DL-tryptophan is an endogenousmetabolite.

Purity: 99.10%Clinical Data: No Development ReportedSize: 2 mg, 10 mg, 50 mg, 100 mg

5-Methoxyindole-3-acetic acidCat. No.: HY-W007566

5-Methoxyindole-3-acetic acid, isolated frompineal tissue, is a metabolite of Melatonin.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

5-MethoxytryptopholCat. No.: HY-113440

5-Methoxytryptophol is a natural indole present inthe pineal gland.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5-Methyl-2'-deoxycytidine (5-Methyldeoxycytidine) Cat. No.: HY-W012078

5-Methyl-2'-deoxycytidine in single-stranded DNAcan act in cis to signal DNA methylation.de novo

Purity: 98.15%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 37

 

5-MethylcytidineCat. No.: HY-113135

5-Methylcytidine is a pyrimidine nucleosidedetected in multiple biofluids.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

5-MethylcytosineCat. No.: HY-W008091

5-Methylcytosine is a well-characterized DNAmodification, and is also predominantly inabundant non-coding RNAs in both prokaryotes andeukaryotes.

Purity: 99.82%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

5-Methyltetrahydrofolic acid (5-Methyl THF) Cat. No.: HY-113046

5-Methyltetrahydrofolic acid (5-Methyl THF) is abiologically active form of folic acid.5-Methyltetrahydrofolic acid is a methylatedderivate of tetrahydrofolate.

Purity: 98.92%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

5-MethyluridineCat. No.: HY-W009444

5-Methyluridine is a is an endogenous methylatednucleoside found in human fluids.

Purity: 98.82%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

5-Phenylvaleric acid (5-Phenylpentanoic acid) Cat. No.: HY-W032915

5-Phenylvaleric acid (5-Phenylpentanoic acid) is apentanoic acid of bacterial origin, occasionallyfound in human biofluids.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

5a-Pregnane-3,20-dioneCat. No.: HY-W006492

5a-Pregnane-3,20-dione is the endogenousprogesterone metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg, 1 g, 5 g

5α-Cholestan-3-one (5α-Cholestanone) Cat. No.: HY-107826

5α-Cholestan-3-one is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 250 mg, 500 mg

5α-Cholestan-3β-ol (Dihydrocholesterol; 5α-Cholestanol; NSC 18188) Cat. No.: HY-107819

5α-Cholestan-3β-ol is a derivitized steroidcompound, which is isolated from the testes ofWhite Carneau pigeons.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

6-Biopterin (L-Biopterin) Cat. No.: HY-102015

6-Biopterin (L-Biopterin), a pterin derivative, isa cofactor.NO synthase

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

6-HydroxymelatoninCat. No.: HY-W011956

6-Hydroxymelatonin is a primary metabolic of, which is metabolized by cytochromeMelatonin

P450 (CYP) 1A2.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

38 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

6-Hydroxynicotinic acidCat. No.: HY-W001996

6-Hydroxynicotinic acid is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

6-Hydroxypyridin-2(1H)-one hydrochlorideCat. No.: HY-W036553

6-Hydroxypyridin-2(1H)-one hydrochloride is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

6-Mercaptopurine (Mercaptopurine; 6-MP) Cat. No.: HY-13677

6-Mercaptopurine is a purine analogue which actsas an antagonist of the and hasendogenous purinesbeen widely used as antileukemic agent andimmunosuppressive drug.

Purity: 99.16%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg

6-Phosphogluconic acidCat. No.: HY-113514

6-Phosphogluconic acid is a potent and competitive inhibitor with s ofphosphoglucose isomerase (PGI) Ki

48 μM for glucose 6-phosphate and 42 μM forfructose 6-phosphate. 6-Phosphogluconic acid is an

.endogenous metabolite

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

6-Thioguanine (Thioguanine; 2-Amino-6-purinethiol) Cat. No.: HY-13765

6-Thioguanine (Thioguanine; 2-Amino-6-purinethiol)is an anti-leukemia and immunosuppressant agent,acts as an inhibitor of SARS and MERS coronaviruspapain-like proteases ( ) and also potentlyPLprosinhibits activity, with s of 25 μM andUSP2 IC50

40 μM for Plpros and recombinant human…

Purity: >99.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

7,8-Dihydro-L-biopterinCat. No.: HY-W008646

7,8-Dihydro-L-biopterin is an oxidation product oftetrahydrobiopterin.

Purity: 98.29%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

7,8-DihydroneopterinCat. No.: HY-136341

7,8-Dihydroneopterin, an inflammation marker,induces cellular in astrocytes andapoptosisneurons via enhancement of nitric oxide synthase( ) expression. 7,8-Dihydroneopterin can be usediNOSin the research of neurodegenerative diseases.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

7-DehydrocholesterolCat. No.: HY-113279

7-Dehydrocholesterol is biosynthetic precursor ofcholesterol and vitamin D .3

Purity: 99.06%Clinical Data: No Development ReportedSize: 100 mg

7-Ketolithocholic acid (3α-Hydroxy-7-oxo-5β-cholanic acid) Cat. No.: HY-W018512

7-Ketolithocholic acid(3α-Hydroxy-7-oxo-5β-cholanic acid), a bile acid,can be absorbed and suppresses endogenous bileacid production and biliary cholesterol secretion.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

7-MethylguanineCat. No.: HY-113352

7-Methylguanine is a metabolite of DNAmethylation. It can be generated by methylatingagents, and used as a probe of protein–DNAinteractions and a key component of DNA sequencingmethod.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 39

 

7-MethylguanosineCat. No.: HY-122524

7-Methylguanosine is a novel cNIIIB nucleotidaseinhibitor with IC value of 87.8 ± 7.5 µM.50

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

7-MethylxanthineCat. No.: HY-W017163

7-Methylxanthine, a methyl derivative of xanthine,is one of the purine components in urinarycalculi.

Purity: >99.0%Clinical Data: Phase 2Size: 10 mg, 50 mg

7α,25-Dihydroxycholesterol (7α,25-OHC) Cat. No.: HY-113962

7α, 25-dihydroxycholesterol (7α,25-OHC) is apotent and selective agonist and endogenous ligandof the orphan GPCR receptor . 7α,EBI2 (GPR183)25-dihydroxycholesterol is highly potent atactivating EBI2 ( =140 pM; =450 pM).EC50 Kd

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg

7α-Hydroxy-4-cholesten-3-oneCat. No.: HY-113259

7α-Hydroxy-4-cholesten-3-one is an intermediate insynthesis of bile acids from cholesterol.7α-Hydroxy-4-cholesten-3-one is a pregnane X

agonist.receptor (PXR)

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

8-AzaguanineCat. No.: HY-B1468

8-Azaguanine is a purine analogue that showsantineoplastic activity. 8-Azaguanine functions asan antimetabolite and easily incorporates intoribonucleic acids, interfering with normalbiosynthetic pathways, thus inhibiting cellulargrowth.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

8-DehydrocholesterolCat. No.: HY-113435

8-Dehydrocholesterol elevated concentration is oneof the diagnostic biochemical hallmarks ofclassical Smith-Lemli-Opitz syndrome (SLOS).

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg

8-Hydroxy-2'-deoxyguanosineCat. No.: HY-W011540

8-Hydroxy-2'-deoxyguanosine is a criticalbiomarker of oxidative stress and carcinogenesis.

Purity: 95.62%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg

8-HydroxyguanineCat. No.: HY-113338

8-Hydroxyguanine is a major pre-mutagenic lesiongenerated from reactive oxygen species. It causesG-T and A-C substitutions.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg

8-HydroxyguanosineCat. No.: HY-113262

8-Hydroxyguanosine is a systematic marker ofoxidative stress and a marker of hydroxyl radicaldamage to RNA.

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

8-Isoprostaglandin F2αCat. No.: HY-113209

8-Isoprostaglandin F2α is an isoprostane producedby the non-enzymatic peroxidation of arachidonicacid in membrane phospholipids. 8-IsoprostaglandinF2α is present in human plasma in two distinctforms - esterified in phospholipids and as thefree acid.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg

40 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

9-cis-RetinalCat. No.: HY-W009310

9-cis-Retinal is a natural retinoid. Dietary9-cis-β-carotene generates 9-cis-retinoids viacleavage into 9-cis-retinal. 9-cis Retinal bindsto cellular retinol-binding protein-I (CRBP-I) andCRBP-II with s of 8 nM and 5 nM, respectively.Kd

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg

9-cis-Vitamin A palmitate (9-cis-Retinyl palmitate) Cat. No.: HY-N8356A

9-cis-Vitamin A palmitate (9-cis-Retinylpalmitate) is a 9-cis isomer formed by vitamin Apalmitate in corn flakes. 9-cis-Vitamin Apalmitate has a biological activity of 26% ofall-trans-vitamin A palmitate, the mostbiologically ac-tive form of vitamin A.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

9-EthyladenineCat. No.: HY-119413

9-Ethyladenine is a partially effective inhibitorof .APRT (adenine phosphoribosyltransferase)

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Ac-Ala-OHCat. No.: HY-W004066

Ac-Ala-OH is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Ac-Arg-OHCat. No.: HY-W014130

Ac-Arg-OH is one of the guanidino compounds foundelevated in the serum of an hemodialyzed renalinsufficient (uremic) pediatric population.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Ac-DL-Trp-OHCat. No.: HY-W011982

Ac-DL-Trp-OH is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Aceglutamide (α-N-Acetyl-L-glutamine; N2-Acetylglutamine) Cat. No.: HY-B1065

Aceglutamide (α-N-Acetyl-L-glutamine) is apsychostimulant and nootropic, used to improvememory and concentration.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

Acetaminophen (Paracetamol; 4-Acetamidophenol; 4'-Hydroxyacetanilide) Cat. No.: HY-66005

Acetaminophen (Paracetamol) is a selectivecyclooxygenase-2 ( ) inhibitor with an COX-2 IC50

of 25.8 μM; is a widely used antipyretic andanalgesic agent. Acetaminophen is a potent hepatic

inhibitor.N-acetyltransferase 2 (NAT2)

Purity: 99.96%Clinical Data: LaunchedSize: 500 mg, 5 g, 10 g

Acetoacetic acid lithium saltCat. No.: HY-112540A

Acetoacetic acid lithium salt is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Acetyl Coenzyme A trisodium (Acetyl-CoA trisodium) Cat. No.: HY-113596

Acetyl Coenzyme A trisodium (Acetyl-CoA trisodium)is a central metabolic intermediate.

Purity: >95.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

www.MedChemExpress.com 41

 

Acetyl phosphate(lithium potassium)Cat. No.: HY-128730

Acetyl phosphate(lithium potassium) is anendogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 5 mg

Acetyl-L-carnitine hydrochloride (O-Acetyl-L-carnitine (hydrochloride)) Cat. No.: HY-B0762

Acetyl-L-carnitine hydrochloride is a blood-brainpermeable acetyl ester of the amino acidL-carnitine found in the body. Acetyl-L-carnitinehydrochloride is often used as a dietarysupplement, and exibits anti-stress-relatedpsychiatric disorders.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 500 mg

Acetyl-L-lysineCat. No.: HY-W048838

Acetyl-L-lysine is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Acetylcholine chloride (ACh chloride) Cat. No.: HY-B0282

Acetylcholine chloride (ACh chloride), aneurotransmitter, is a potent agonist.cholinergicAcetylcholine chloride is a modulator of theactivity of dopaminergic (DAergic) neurons throughthe stimulation of nicotinic acetylcholinereceptors (nAChRs).

Purity: 99.68%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Acetylcysteine (N-Acetylcysteine; N-Acetyl-L-cysteine; NAC) Cat. No.: HY-B0215

Acetylcysteine (N-Acetylcysteine) is a which reduces the thickness ofmucolytic agent

the mucus. Acetylcysteine is a inhibitor.ROS

Purity: >98.0%Clinical Data: LaunchedSize: 500 mg, 5 g, 10 g

AcetylvalineCat. No.: HY-W015466

Acetylvaline is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Adenine (6-Aminopurine; Vitamin B4) Cat. No.: HY-B0152

Adenine (6-Aminopurine), a purine, is one of thefour nucleobases in the nucleic acid of DNA, withthe other three being cytosine (C), guanine (G),and thymine (T). Adenine plays an important rolein biochemistry, including cellular respirationand protein synethesis .

Purity: 98.76%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Adenine hemisulfate (6-Aminopurine hemisulfate; Vitamin B4 hemisulfate) Cat. No.: HY-B0152B

Adenine hemisulfate (6-Aminopurine hemisulfate) isa purine derivative with a variety of roles inbiochemistry, including cellular respiration, inthe form of both the energy-rich adenosinetriphosphate (ATP) and the cofactors nicotinamideadenine dinucleotide (NAD) and flavin…

Purity: >95.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

Adenine hydrochloride (6-Aminopurine hydrochloride; Vitamin B4 hydrochloride) Cat. No.: HY-B0152A

Adenine hydrochloride (6-Aminopurinehydrochloride) is a purine derivative with avariety of roles in biochemistry, includingcellular respiration, in the form of both theenergy-rich adenosine triphosphate (ATP) and thecofactors nicotinamide adenine dinucleotide…

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Adenine monohydrochloride hemihydrateCat. No.: HY-W015213

Adenine monohydrochloride hemihydrate is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

42 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Adenosine (Adenine riboside; D-Adenosine) Cat. No.: HY-B0228

Adenosine (Adenine riboside), a ubiquitousendogenous autacoid, acts through the enrollmentof four G protein-coupled receptors: A1, A2A, A2B,and A3.

Purity: 99.92%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Adenosine 2',5'-diphosphate sodiumCat. No.: HY-N7740

Adenosine 2',5'-diphosphate sodium is acompetitive antagonist. AdenosineP2Y12',5'-diphosphate sodium exhibits non-selectiveantagonism at recombinant and human platelet P2X1receptors.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Adenosine 5'-diphosphate (Adenosine diphosphate; ADP) Cat. No.: HY-W010918

Adenosine 5'-diphosphate (Adenosine diphosphate)is a nucleoside diphosphate. Adenosine5'-diphosphate is the product of ATPdephosphorylation by ATPases.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Adenosine 5'-diphosphate sodium saltCat. No.: HY-W010791

Adenosine 5'-diphosphate (ADP) sodium salt is anucleoside diphosphate, which is the product ofATP dephosphorylation by ATPases. Adenosine5'-diphosphate sodium salt induces human plateletaggregation and inhibits stimulated adenylatecyclase by an action at P -purinoceptors.2T

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Adenosine monophosphate (AMP) Cat. No.: HY-A0181

Adenosine monophosphate is a key cellularmetabolite regulating energy homeostasis andsignal transduction.

Purity: >98.0%Clinical Data: Phase 4Size: 10 mM × 1 mL, 500 mg, 1 g

Adenosine-2'-monophosphate (2'-AMP; Adenosine 2'-phosphate; AMP 2'-phosphate) Cat. No.: HY-124151

Adenosine-2'-monophosphate (2'-AMP) is convertedby extracellular 2’,3'-CAMP.Adenosine-2'-monophosphate is further metabolizedto extracellular adenosine (a mechanism called theextracellular 2’,3’-cAMP-adenosine pathway).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Adenosylcobalamin (Coenzyme B12; Cobamamide; AdoCbl) Cat. No.: HY-112790

Adenosylcobalamin (Coenzyme B12;Cobamamide;AdoCbl)is an active form of Vitamin B which is a12

cofactor for methylmalonyl CoA mutase.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Adipic acidCat. No.: HY-W017522

Adipic acid is found to be associated with HMG-CoAlyase deficiency, carnitine-acylcarnitinetranslocase deficiency, malonyl-Coa decarboxylasedeficiency, and medium Chain acyl-CoAdehydrogenase deficiency, which are inborn errorsof metabolism.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Adrenic Acid (cis-7,10,13,16-Docosatetraenoic acid) Cat. No.: HY-W013215

Adrenic Acid (cis-7,10,13,16-Docosatetraenoicacid) is a naturally polyunsaturated fatty acid inthe adrenal gland, brain, kidney, and vasculature.Adrenic Acid can regulate the vascular tone inarteries of the adrenal cortex.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mg (300 mM * 100 μL in Ethanol),

Adrenosterone ((+)-Adrenosterone) Cat. No.: HY-17462

Adrenosterone ((+)-Adrenosterone) is a steroidhormone with weak androgenic effect. Adrenosteroneis a dietary supplement that can decrease fat andincrease muscle mass.

Purity: 98.54%Clinical Data: No Development ReportedSize: 100 mg, 500 mg

www.MedChemExpress.com 43

 

Aflatoxin B1Cat. No.: HY-N6615

Aflatoxin B1 (AFB1) is a Class 1A carcinogen,which is a secondary metabolite of Aspergillus

and . Aflatoxin B1 (AFB1) mainlyflavus A. parasiticusinduces the transversion of G-->T in the thirdposition of codon 249 of the p53 tumor suppressorgene, resulting in mutation.

Purity: 99.94%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg

Agmatine sulfateCat. No.: HY-101238

Agmatine sulfate exerts modulatory action atmultiple molecular targets, such asneurotransmitter systems, ion channels and nitricoxide synthesis. It is an endogenous agonist at

and a imidazoline receptor NO synthaseinhibitor.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg, 1 g

AKBA (Acetyl-11-keto-β-boswellic acid) Cat. No.: HY-N0892

AKBA (Acetyl-11-keto-β-boswellic acid) is anactive triterpenoid compound from the extract ofBoswellia serrate and a novel Nrf2 activator.

Purity: 99.71%Clinical Data: Phase 2Size: 10 mM × 1 mL, 5 mg, 10 mg

Alanylphenylalanine (L-Alanyl-L-phenylalanine; H-Ala-Phe-OH) Cat. No.: HY-W012161

Alanylphenylalanine is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

AldosteroneCat. No.: HY-113313

Aldosterone is the primary mineralocorticoid.Aldosterone is a steroid hormone, and it issynthesized and secreted in response torenin-angiotensin system activation (RAS) or highdietary potassium by the zona glomerulosa (ZG) ofthe adrenal cortex.

Purity: >99.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 1 mg, 5 mg

all-trans-4-Oxoretinoic acid (all-trans 4-Keto Retinoic Acid) Cat. No.: HY-107494A

all-trans-4-Oxoretinoic acid, an active metaboliteof vitamin A, induces gene transcription viabinding to nuclear retinoic acid receptors (RARs).

Purity: >94.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 2 mg, 5 mg, 10 mg

all-trans-Anhydro Retinol (Anhydrovitamin A) Cat. No.: HY-N7495

all-trans-Anhydro Retinol (Anhydrovitamin A) is ametabolite of Vitamin A. all-trans-Anhydro Retinolis used in synthetic multivitamin preparations.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

All-trans-retinalCat. No.: HY-W004500

All-trans-retinal is a one of the major vitamin Ametabolites in the retina. In physiologicalconditions, all-trans-RAL is regenerated to thevisual chromophore, 11-cis-retinal.

Purity: 98.39%Clinical Data: No Development ReportedSize: 100 mg

Allantoic acidCat. No.: HY-B1514

Allantoic acid is a degradative product of uricacid and associated with purine metabolism.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Allantoin (5-Ureidohydantoin) Cat. No.: HY-N0543

Allantoin is a skin conditioning agent thatpromotes healthy skin, stimulates new and healthytissue growth.

Purity: 99.85%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

44 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

AlloepipregnanoloneCat. No.: HY-113307

Alloepipregnanolone, a pregnane with hypnotic, andsedative properties, interferes with thedevelopment of rapid tolerance to the anxiolyticeffect of ethanol.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Allopurinol ribosideCat. No.: HY-101397

Allopurinol riboside, a metabolite of allopurinol,shows potent activities against parasites.

Purity: 99.04%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Allotetrahydrocortisol (5a-Tetrahydrocortisol) Cat. No.: HY-113215

Allotetrahydrocortisol (5a-Tetrahydrocortisol) isa metabolite of Cortisol. Cortisol is the mainglucocorticoid in human. It is produced in adrenalcortex and plays a crucial role in manyphysiological processes.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg

Allyl methyl sulfideCat. No.: HY-128447

Allyl methyl sulfide is a bioactive organosulfurcompound found in garlic. Allyl methyl sulfideexhibits antibacterial, antioxidant and anticancerproperties.

Purity: 98.45%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

alpha-Cyperone (α-Cyperone; (+)-α-Cyperone) Cat. No.: HY-N0710

alpha-Cyperone (α-Cyperone) is associated with thedown-regulation of COX-2, IL-6, Nck-2, Cdc42 andRac1, resulting in reduction of inflammation,which would be highly beneficial for treatment ofinflammatory diseases such as AD.

Purity: 99.12%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg

alpha-D-glucoseCat. No.: HY-128417

alpha-D-glucose is an endogenous metabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Alpha-Estradiol (Alfatradiol; Epiestradiol; Epiestrol) Cat. No.: HY-B0141A

Alpha-Estradiol is a weak estrogen and a inhibitor which is used as a topical5α-reductase

medication in the treatment of androgenicalopecia.

Purity: 99.77%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Aminoadipic acidCat. No.: HY-113328

Aminoadipic acid is an intermediate in themetabolism of lysine and saccharopine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Aminomalonic acidCat. No.: HY-112052

Aminomalonic acid is an amino endogenousmetabolite, acts as a strong inhibitor of

from Leukemia 5178Y/ARL-asparagine synthetase( = 0.0023 M) and mouse pancreas ( = 0.0015 M)Ki Ki

in vitro.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

AnandamideCat. No.: HY-10863

Anandamide is an immune modulator in the centralnervous system acts via not only cannabinoid

( and ) but also other targetsreceptors CB1 CB2(e.g., / ).GPR18 GPR55

Purity: >99.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg

www.MedChemExpress.com 45

 

Androsterone (5α-Androstan-3α-ol-17-one) Cat. No.: HY-N0933

Androsterone is a metabolic product oftestosterone and can activate Farnesoid X Receptor( ).FXR

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 250 mg

Angiotensin IIICat. No.: HY-113035

Angiotensin III is an and angiotensin 1 (AT1) AT2receptor agonist.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Angiotensin III TFACat. No.: HY-113035A

Angiotensin III (TFA) is an angiotensin 1 (AT1)and receptor agonist.AT2

Purity: 99.76%Clinical Data: LaunchedSize: 5 mg, 10 mg, 25 mg

Angiotensinogen (1-14), humanCat. No.: HY-P1486

Angiotensinogen (1-14), human is a fragment of therenin substrate angiotensinogen. Angiotensinogenis naturally occurring substrate for renin and aprecursor for all angiotensin peptides.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg

AnserineCat. No.: HY-113354

Anserine, a methylated form of Carnosine, is anorally active, natural Histidine-containingdipeptide found in skeletal muscle of vertebrates.Anserine is not cleaved by serum carnosinase andact as biochemical buffers, chelators,antioxidants, and anti-glycation agents.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

Antineoplaston A10Cat. No.: HY-128553

Antineoplaston A10, a naturally occurringsubstance in human body, is a inhibitorRaspotentially for the treatment of glioma, lymphoma,astrocytoma and breast cancer.

Purity: 98.58%Clinical Data: Phase 2Size: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

Arabinose ((±)-Arabinose; DL-Arabinose; dl-Arabinose) Cat. No.: HY-N2353

Arabinose is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Arachidic acid (Icosanoic acid) Cat. No.: HY-W004260

Arachidonic acid (Icosanoic acid), a long-chainfatty acid, is present in all mammalian cells,typically esterified to membrane phospholipids,and is one of the most abundant polyunsaturatedfatty acids present in human tissue.

Purity: >97.0%Clinical Data: Phase 4Size: 10 mM × 1 mL, 100 mg

Arachidonic acid (Immunocytophyt; Immunocytophyte; Vevodar) Cat. No.: HY-109590

Arachidonic acid is an essential fatty acid and amajor constituent of biomembranes.

Purity: 98.01%Clinical Data: Phase 4Size: 10 mM × 1 mL, 5 mg, 10 mg

Argininic acidCat. No.: HY-113079

Argininic acid is an α-amino acid that is used inthe biosynthesis of proteins.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

46 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Ascorbyl palmitate (L-Ascorbic acid 6-hexadecanoate;

6-O-Palmitoyl-L-ascorbic acid) Cat. No.: HY-B0987

Ascorbyl palmitate is an ester formed fromascorbic acid and palmitic acid creating afat-soluble form of vitamin C, it is also used asan antioxidant food additive.

Purity: 99.61%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 200 mg, 500 mg

AsiaticosideCat. No.: HY-N0439

Asiaticoside, a trisaccaride triterpene from, suppresses Centella asiatica TGF-β/Smad

signaling through inducing Smad7 and inhibitingTGF-βRI and TGF-βRII in keloid fibroblasts;Asiaticoside shows antioxidant, anti-inflammatory,and anti-ulcer properties.

Purity: 99.84%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Asymmetric dimethylarginineCat. No.: HY-113216

Asymmetric dimethylarginine is an endogenousinhibitor of , andnitric oxide synthase (NOS)functions as a marker of endothelial dysfunctionin a number of pathological states.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg

ATP (Adenosine 5'-triphosphate) Cat. No.: HY-B2176

ATP (Adenosine 5'-triphosphate) is a centralcomponent of energy storage and metabolism invivo, provides the metabolic energy to drivemetabolic pumps and serves as a coenzyme in cells.ATP is an important endogenous signaling moleculein immunity and inflammation.

Purity: 98.34%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

ATP dipotassium (Adenosine 5'-triphosphate dipotassium) Cat. No.: HY-B2176C

ATP dipotassium (Adenosine 5'-triphosphatedipotassium) is a central component of energystorage and metabolism in vivo, provides themetabolic energy to drive metabolic pumps andserves as a coenzyme in cells.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

ATP disodium salt (Adenosine 5'-triphosphate disodium salt;

Disodium adenosine triphosphate) Cat. No.: HY-B0345A

ATP disodium salt (Adenosine 5'-triphosphatedisodium salt) is a central component of energystorage and metabolism in vivo, provides themetabolic energy to drive metabolic pumps andserves as a coenzyme in cells.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 500 mg, 1 g, 5 g

ATP disodium salt hydrate (Adenosine 5'-triphosphate disodium salt hydrate) Cat. No.: HY-W010735

ATP disodium salt hydrate (Adenosine5'-triphosphatedisodium salt hydrate) is a centralcomponent of energy storage and metabolism invivo, provides the metabolic energy to drivemetabolic pumps and serves as a coenzyme in cells.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

ATP disodium trihydrate (Adenosine-5'-triphosphate disodium trihydrate) Cat. No.: HY-B2176A

ATP disodium trihydrate (Adenosine 5'-triphosphatedisodium trihydrate) is a central component ofenergy storage and metabolism in vivo, providesthe metabolic energy to drive metabolic pumps andserves as a coenzyme in cells.

Purity: 98.34%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

AtranorinCat. No.: HY-N2907

Atranorin is a lichen secondary metabolite.Atranorin inhibits lung cancer cell motility andtumorigenesis by affecting AP-1, Wnt, and STATsignaling and suppressing activity.RhoGTPase

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Atrial natriuretic factor (1-28) (human, porcine) (Atrial natriuretic peptide (1-28)) Cat. No.: HY-P2281

Atrial natriuretic factor (1-28) (human, porcine)(Atrial natriuretic peptide (1-28)) is anendogenous peptide produced by the heart, involvedin blood pressure regulation. Atrial natriureticfactor (1-28) (human, porcine) producesnatriuresis, diuresis and vasorelaxation in vivo.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 47

 

Atropine (Tropine tropate; DL-Hyoscyamine) Cat. No.: HY-B1205

Atropine (Tropine tropate) is a competitivemuscarinic acetylcholine receptor (mAChR)antagonist, with anti-myopia effect. Atropineblocks the inhibitory effect of ACh on heart rateand contractility, potentially also leading totachyarrhythmias.

Purity: 99.55%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Azelaic acid (Nonanedioic acid) Cat. No.: HY-B0704

Azelaic acid is an organic compound produced bythe ozonolysis of oleic acid; component of anumber of hair and skin conditioners.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

BatilolCat. No.: HY-W011175

3-(Octadecyloxy)propane-1,2-diol is an endogenousmetabolite.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Benzamide (NSC-3114; Benzenecarboxamide; Phenylamide) Cat. No.: HY-Z0283

Benzamide inhibits poly(ADP-ribose) polymerase.(PARP)

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Benzoic acidCat. No.: HY-N0216

Benzoic acid is an aromatic alcohol existingnaturally in many plants and is a common additiveto food, drinks, cosmetics and other products. Itacts as preservatives through inhibiting both

and .bacteria fungi

Purity: 98.96%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

BenzophenoneCat. No.: HY-Y0546

Benzophenone is an endogenous metabolite.

Purity: 99.96%Clinical Data: No Development ReportedSize: 500 mg

Benzylideneacetone (Benzalacetone) Cat. No.: HY-W012595

Benzylideneacetone is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Berberine (Natural Yellow 18) Cat. No.: HY-N0716

Berberine (Natural Yellow 18) is an alkaloidisolated from the Chinese herbal medicineHuanglian, as an . Berberine (NaturalantibioticYellow 18) induces reactive oxygen species ( )ROSgeneration and inhibits .DNA topoisomerase

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Beta-CortolCat. No.: HY-113418

Beta-Cortol is an androgen metabolite present inadults.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Beta-Sitosterol (purity>80%) (β-Sitosterol (purity>80%);

22,23-Dihydrostigmasterol (purity>80%)) Cat. No.: HY-N0171

Beta-Sitosterol (purity>80%) includesβ-sitosterol (≥80%), stigmasterol, campesterol andbrassicasterol mainly. Beta-Sitosterol is a plantsterol.

Purity: >80.0%Clinical Data: No Development ReportedSize: 100 mg, 1 g, 5 g

48 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Betulin (Trochol) Cat. No.: HY-N0083

Betulin (Trochol), is a sterol regulatoryelement-binding protein ( ) inhibitor with anSREBP

of 14.5 μM in K562 cell line.IC50

Purity: >98.0%Clinical Data: No Development ReportedSize: 50 mg, 100 mg, 200 mg

Betulinic acid (Lupatic acid; Betulic acid) Cat. No.: HY-10529

Betulinic acid is a natural pentacyclictriterpenoid, acts as a eukaryotic

inhibitor, with an of 5 μM,topoisomerase I IC50

and possesses anti-HIV, anti-malarial,anti-inflammatory and anti-tumor properties.Betulinic acid acts as a new activator of .NF-kB

Purity: >98.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 100 mg, 200 mg, 500 mg

BilirubinCat. No.: HY-N0323

Bilirubin is a yellow breakdown product of hemecatabolism. Bilirubin exhibits antioxidant andantimutagenic effects.

Purity: 98.71%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

Bilobalide ((-)-Bilobalide) Cat. No.: HY-N0076

Bilobalide is a biologically active terpenictrilactone present in Ginkgo biloba. An increasingnumber of studies have demonstrated itsneuroprotective effects.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Biocytin ((+)-Biocytin) Cat. No.: HY-101884

Biocytin is a conjugate of -biotin and -lysine,D L

where the carboxylate of -biotin is coupled withD

the ϵ-amine of -lysine via a secondary amide bond.L

Biocytin is a classical neuroanatomical tracercommonly used to map brain connectivity.

Purity: 98.50%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg

Biotin sulfoneCat. No.: HY-113268

Biotin sulfone is first isolated as a naturalmetabolite of biotin.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Bis(2-ethylhexyl) phthalate (Diplast O; ESBO-D 82; Ergoplast

FDO; Ergoplast FDO-S; Etalon) Cat. No.: HY-B1945

Bis(2-ethylhexyl) phthalate is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Bisphenol ACat. No.: HY-18260

Bisphenol A is a phenolic, organic syntheticcompound widely used in the production ofpolycarbonate plastics and epoxy resins. BisphenolA is a reproductive, developmental, and systemictoxicant, often classified as anendocrine-disrupting compound (EDC).

Purity: 99.90%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Boldenone Undecylenate (Ba 29038) Cat. No.: HY-17434

Boldenone Undecylenate (Ba 29038) is a syntheticsteroid which has a similar effect as the naturalsteroid testosterone; it is frequently used inveterinary medicine, though it is also used inhumans.

Purity: >96.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

Bovinic acidCat. No.: HY-113162

Bovinic acid is a conjugated linoleic acid withanticarcinogenic and anti-atherogenic activities.

Purity: >99.0%Clinical Data: No Development ReportedSize: 356 mM × 100μL, 356 mM × 50μL

www.MedChemExpress.com 49

 

BradykininCat. No.: HY-P0206

Bradykinin is an active peptide that is generatedby the kallikrein-kinin system. It is ainflammatory mediator and also recognized as aneuromediator and regulator of several vascularand renal functions.

Purity: 99.86%Clinical Data: Phase 4Size: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Butylparaben (Butyl parahydroxybenzoate; Butyl paraben; Butyl

4-hydroxybenzoate) Cat. No.: HY-B1431

Butylparaben is an organic compound, has proven tobe a highly successful antimicrobial preservativein cosmetics, also used in medication suspensions,and as a flavoring additive in food.

Purity: 99.10%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

ButyrylcarnitineCat. No.: HY-113168

Butyrylcarnitine is a metabolite in plasma, actsas a biomarker to improve the diagnosis andprognosis of heart failure, and is indicative ofanomalous lipid and energy metabolism.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg

c-di-AMP (Cyclic diadenylate; Cyclic-di-AMP) Cat. No.: HY-12326

c-di-AMP (Cyclic diadenylate) is a agonist,STINGwhich binds to the transmembrane protein STINGthereby activating the TBK3-IRF3 signalingpathway, subsequently triggering the production oftype I IFN and TNF.

Purity: 99.29%Clinical Data: No Development ReportedSize: 500 μg, 1 mg

c-di-AMP sodium (Cyclic diadenylate sodium; Cyclic-di-AMP sodium) Cat. No.: HY-12326A

c-di-AMP (Cyclic diadenylate) sodium is a STINGagonist, which binds to the transmembrane proteinSTING thereby activating the TBK3-IRF3 signalingpathway, subsequently triggering the production oftype I IFN and TNF.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

C16-PAF (PAF (C16)) Cat. No.: HY-108635

C16-PAF (PAF (C16)), a phospholipid mediator, is aplatelet-activating factor and ligand for PAFG-protein-coupled receptor ( ). C16-PAFPAFRexhibits anti-apoptotic effect and inhibitscaspase-dependent death by activating the PAFR.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Caffeic acidCat. No.: HY-N0172

Caffeic acid is an inhibitor of both ionTRPV1channel and ( ).5-Lipoxygenase 5-LO

Purity: 98.71%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 5 g

Calcifediol (25-hydroxy Vitamin D3) Cat. No.: HY-32351

Calcifediol (25-hydroxy Vitamin D3), a majorcirculating metabolite of vitamin D3, is a potent

inhibitor.VDR

Purity: 99.94%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 100 mg

Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate) Cat. No.: HY-32351A

Calcifediol monohydrate (25-hydroxy Vitamin D3monohydrate), a major circulating metabolite ofvitamin D3, is a potent inhibitor.VDR

Purity: 99.89%Clinical Data: LaunchedSize: 5 mg, 100 mg

Calcitriol (1,25-Dihydroxyvitamin D3) Cat. No.: HY-10002

Calcitriol is the most active metabolite ofvitamin D and also a ( )vitamin D receptor VDRagonist.

Purity: 99.81%Clinical Data: LaunchedSize: 2 mg, 5 mg, 10 mg, 50 mg, 100 mg

50 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Calcium 2-hydroxy-4-(methylthio)butanoateCat. No.: HY-W011195

Calcium 2-hydroxy-4-(methylthio)butanoate is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Calcium 2-oxoglutarateCat. No.: HY-W013636B

Calcium 2-oxoglutarate is an intermediate in theproduction of ATP or GTP in the Krebs cycle.Calcium 2-oxoglutarate also acts as the majorcarbon skeleton for nitrogen-assimilatoryreactions. Calcium 2-oxoglutarate is a reversibleinhibitor of ( =15 mM).tyrosinase IC50

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Calcium L-ThreonateCat. No.: HY-W009208

Calcium L-Threonate is an anti-osteoporosis agent,and widely used as a calcium supplement. CalciumL-Threonate also stimulates the uptake of ascorbicacid.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Calenduloside ECat. No.: HY-N6850

Calenduloside E (CE) is a natural pentacyclictriterpenoid saponin extracted from .Aralia elataCalenduloside E (CE) has potent byanti-apoptotictargeting heat shock protein 90 ( ).Hsp90

Purity: 98.47%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Campesterol ((24R)-5-Ergosten-3β-ol) Cat. No.: HY-N1459

Campesterol is a plant sterol with cholesterollowering and anticarcinogenic effects.

Purity: >98.0%Clinical Data: No Development ReportedSize: 2 mg, 5 mg, 10 mg, 25 mg

Canrenone (Aldadiene; SC9376; SC14266) Cat. No.: HY-B1438

Canrenone (Aldadiene; SC9376; SC14266) is an antagonist extensively used as aaldosterone

diuretic agent.

Purity: 99.16%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg

CarvacrolCat. No.: HY-N0711

Carvacrol is a monoterpenoid phenol isolated fromLamiaceae family plants, with antioxidant,anti-inflammatory and anticancer properties.Carvacrol causes cell cycle arrest in G0/G1,downregulates , and Jagged-1, and inducesNotch-1

.apoptosis

Purity: 99.99%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

CarveolCat. No.: HY-W017370

Carveol is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Caryophyllene oxide ((-)-Caryophyllene oxide) Cat. No.: HY-N3544

Caryophyllene oxide, isolated from from Annona. bark., possesses analgesic andsquamosa L

anti-inflammatory activity.

Purity: 99.43%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Catechin ((+)-Catechin; Cianidanol; Catechuic acid) Cat. No.: HY-N0898

Catechin ((+)-Catechin) inhibits cyclooxygenase-1( ) with an of 1.4 μM.COX-1 IC50

Purity: 99.23%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

www.MedChemExpress.com 51

 

CE(20:5(5Z,8Z,11Z,14Z,17Z)Cat. No.: HY-113463

CE(20:5(5Z,8Z,11Z,14Z,17Z) is an endogenousmetabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg (15 mM * 100 μL in Chloroform),

Cecropin P1, porcineCat. No.: HY-P2317

Cecropin P1, porcine is an peptideantibacterialoriginally identified in moths (Hyalophoracecropia) and later in pig intestine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

cGAMP disodium (Cyclic GMP-AMP disodium; 3',3'-cGAMP disodium) Cat. No.: HY-110385

cGAMP disodium (Cyclic GMP-AMP disodium) is thethird cyclic dinucleotide (CDN) to be discoveredin bacteria.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Chenodeoxycholic Acid (CDCA) Cat. No.: HY-76847

Chenodeoxycholic Acid is a hydrophobic primarybile acid that activates nuclear receptors ( )FXRinvolved in cholesterol metabolism.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Chlorogenic acid (3-O-Caffeoylquinic acid; Heriguard; NSC-407296) Cat. No.: HY-N0055

Chlorogenic acid is a major phenolic compound incoffee and tea.

Purity: 99.43%Clinical Data: Phase 3Size: 10 mM × 1 mL, 500 mg

Cholestenone (4-Cholesten-3-one) Cat. No.: HY-113365

Cholestenone (4-Cholesten-3-one), the intermediateoxidation product of cholesterol, is metabolizedprimarily in the liver. Cholestenone is highlymobile in membranes and influences cholesterolflip-flop and efflux. Cholestenone may causelong-term functional defects in cells.

Purity: >98.0%Clinical Data: No Development ReportedSize: 250 mg, 500 mg

CholesterolCat. No.: HY-N0322

Cholesterol is the major sterol in mammals and ismakes up 20-25% of structural component of theplasma membrane. Plasma membranes are highlypermeable to water but relatively impermeable toions and protons.

Purity: >98.0%Clinical Data: LaunchedSize: 500 mg

Cholesterol glucuronideCat. No.: HY-N7390

Cholesterol glucuronide is an endogenous of lipid generated in the liver bymetabolite

UDP glucuonyltransferase.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Cholesterol myristate (Cholesteryl myristate; Cholesteryl tetradecanoate) Cat. No.: HY-N2338

Cholesterol myristate is a natural steroid presentin traditional Chinese medicine. Cholesterolmyristate binds to several ion channels such asthe , nicotinic acetylcholine receptor GABAA

, and the inward-rectifier receptor potassium.ion channel

Purity: >98.0%Clinical Data: No Development ReportedSize: 250 mg

Cholesteryl arachidonateCat. No.: HY-113369

Cholesteryl arachidonate is an endogenousmetabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg

52 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Cholesteryl behenate (Cholesteryl docosanoate; Cholesterol behenate) Cat. No.: HY-N2339

Cholesteryl behenate is a cholesterol esterassociated with the neutral core of low densitylipoprotein Receptor-LDL complexes are taken up bylysosomes and hydrolyzed to release cholesterolfrom the esters.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Cholesteryl linoleateCat. No.: HY-W010697

Cholesteryl linoleate is shown to be the majorcholesteryl ester contained in LDL andatherosclerotic lesions.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Cholesteryl LinolenateCat. No.: HY-125910

Cholesteryl Linolenate is an endogenousmetabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Cholesteryl oleateCat. No.: HY-113217

Cholesteryl oleate is an esterified form ofCholesterol. Cholesteryl oleate can be used in thegeneration of solid lipid nanoparticle (SLN, ananoparticle-based method for gene therapy).

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg, 500 mg

Cholesteryl palmitateCat. No.: HY-W010708

Cholesteryl palmitate is a useful prognosticbiomarker for chronic interstitial pneumonia(CIP).

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Cholesteryl sulfate sodiumCat. No.: HY-111355B

Cholesteryl sulfate sodium is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Cholic acidCat. No.: HY-N0324

Cholic acid is a major primary bile acid producedin the liver and usually conjugated with glycineor taurine. It facilitates fat absorption andcholesterol excretion.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 100 mg, 1 g

Cholic acid sodiumCat. No.: HY-N0324A

Cholic acid sodium is a major primary bile acidproduced in the liver and usually conjugated withglycine or taurine. It facilitates fat absorptionand cholesterol excretion.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Chondroitin sulfate (Chondroitin polysulfate) Cat. No.: HY-B2162

Chondroitin sulfate, one of five classes ofglycosaminoglycans, has been widely used in thetreatment of osteoarthritis. Chondroitin sulfatereduces inflammation mediators and the apoptoticprocess and is able to reduce protein productionof inflammatory cytokines, and .iNOS MMPs

Purity: >95.0%Clinical Data: LaunchedSize: 250 mg, 1 g

Cinnamic acid (3-Phenylacrylic acid; β-Phenylacrylic acid) Cat. No.: HY-N0610A

Cinnamic acid has potential use in cancerintervention, with of 1-4.5 mM inIC s50

glioblastoma, melanoma, prostate and lungcarcinoma cells.

Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 53

 

CinnamoylglycineCat. No.: HY-77641

Cinnamoylglycine is a glycine conjugate ofcinnamic acid and a urinary inmetabolitehuman. Cinnamoylglycine is used as a potentialurinary biomarker indicating intact or disruptedcolonization resistance during and afterantibiotic treatment.

Purity: 95.83%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 250 mg

cis-9,10-Epoxystearic acid (cis-9,10-Epoxyoctadecanoic acid) Cat. No.: HY-129554

cis-9,10-Epoxystearic acid(cis-9,10-Epoxyoctadecanoic acid) is an endogenousconstituent in human blood and urine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg

Citicoline (Cytidine diphosphate-choline; CDP-Choline;

Cytidine 5'-diphosphocholine) Cat. No.: HY-B0739

Citicoline (Cytidine diphosphate-choline) is anintermediate in the synthesis ofphosphatidylcholine, a component of cellmembranes. Citicoline exerts neuroprotectiveeffects.

Purity: 99.51%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Citicoline sodium (Cytidine diphosphate-choline sodium;

CDP-Choline sodium; Cytidine 5'-diphosphocholine sodium) Cat. No.: HY-B0739A

Citicoline sodium salt is an intermediate in thesynthesis of phosphatidylcholine which is acomponent of cell membranes and also exertsneuroprotective effects.

Purity: 99.89%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Citraconic acidCat. No.: HY-113298

Citraconic acid belongs to the class of organiccompounds known as methyl-branched fatty acids.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Citric acidCat. No.: HY-N1428

Citric acid is a weak organic tricarboxylic acidfound in citrus fruits. Citric acid is a naturalpreservative and food tartness enhancer.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Coenzyme ACat. No.: HY-128851

Coenzyme A is is an obligatory cofactor in allliving cells synthesised from pantothenate(Vitamin B5), adenosine triphosphate (ATP) andcysteine.

Purity: >97.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 5 mg, 10 mg

Coenzyme FOCat. No.: HY-136497

Coenzyme FO, a deazaflavin chromophore, acts as animportant hydride acceptor/donor in the centralmethanogenic pathway.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Coenzyme Q10 (CoQ10; Ubiquinone-10) Cat. No.: HY-N0111

Coenzyme Q10 is an essential cofactor of theelectron transport chain and a potent antioxidantagent.

Purity: >98.0%Clinical Data: LaunchedSize: 100 mg, 200 mg, 500 mg, 1 g, 5 g

Coenzyme Q9 (Ubiquinone Q9; CoQ9; Ubiquinone 9) Cat. No.: HY-101415

Coenzyme Q9 (Ubiquinone Q9), the major form ofubiquinone in rodents, is an amphipathic molecularcomponent of the electron transport chain thatfunctions as an endogenous antioxidant. CoenzymeQ9 attenuates the diabetes-induced decreases inantioxidant defense mechanisms.

Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg

54 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Coniferyl alcoholCat. No.: HY-N4283

Coniferyl alcohol is an intermediate inbiosynthesis of eugenol and of stilbenoids andcoumarin. Coniferyl alcohol specifically inhibitsfungal growth.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mg

Copper tripeptide (GHK-Cu) Cat. No.: HY-P0063

Copper tripeptide (GHK-Cu), a naturally occurringtripeptide, is first isolated from human plasma,but can be found in saliva and urine.

Purity: 99.40%Clinical Data: No Development ReportedSize: 100 mg, 250 mg, 500 mg

Coproporphyrin III (Zincphyrin) Cat. No.: HY-101398

Coproporphyrin III (Zincphyrin) is a naturallyoccurring porphyrin derivative that is mainlyfound in urine.

Purity: 99.49%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Corticosterone (17-Deoxycortisol;

11β,21-Dihydroxyprogesterone; Kendall's compound B) Cat. No.: HY-B1618

Corticosterone is an adrenocortical steroid thathas modest but significant activities as amineralocorticoid and a glucocorticoid.

Purity: 99.70%Clinical Data: Phase 3Size: 10 mM × 1 mL, 50 mg

Cortisone (17-Hydroxy-11-dehydrocorticosterone; Kendall's

compound E) Cat. No.: HY-17461

Cortisone (17-Hydroxy-11-dehydrocorticosterone),an oxidized metabolite of Cortisol (aGlucocorticoid). Cortisone acts as animmunosuppressant and anti-inflammatory agent.

Purity: 99.90%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Cortisone acetate (Cortisone 21-acetate) Cat. No.: HY-17461A

Cortisone acetate (Cortisone 21-acetate), anoxidized metabolite of Cortisol (aGlucocorticoid). Cortisone acetate acts as animmunosuppressant and anti-inflammatory agent.

Purity: 99.68%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Cortodoxone (11-Deoxycortisol; cortexolone; Reichstein's substance S) Cat. No.: HY-77839

Cortodoxone is a glucocorticoid steroid hormonethat can be oxygenated to cortisol(Hydrocortisone).

Purity: 98.74%Clinical Data: No Development ReportedSize: 100 mg

Costunolide ((+)-Costunolide; Costus lactone) Cat. No.: HY-N0036

Costunolide ((+)-Costunolide; Costus lactone) is abioactive sesquiterpene lactone, withantioxidative, anti-inflammatory, antiallergic,bone remodeling, neuroprotective, hair growthpromoting, anticancer, and antidiabeticproperties.

Purity: 99.84%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Cotinine ((-)-Cotinine; (S)-Cotinine; NIH-10498) Cat. No.: HY-B1178

Cotinine is an alkaloid found in tobacco and isalso the predominant metabolite of nicotine, usedas a biomarker for exposure to tobacco smoke.

Purity: 99.42%Clinical Data: Phase 4Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Coumaran (2,3-Dihydrobenzofuran) Cat. No.: HY-75247

Coumaran (2,3-Dihydrobenzofuran) is an inhibitor isolatedacetylcholinesterase (AChE)

from leaves of . Coumaran can be usedL. camaraas a biopesticide.

Purity: 99.69%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

www.MedChemExpress.com 55

 

CreatineCat. No.: HY-W010388

Creatine, an endogenous amino acid derivative,plays an important role in cellular energy,especially in muscle and brain.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

Creatine monohydrateCat. No.: HY-W017462

Creatine monohydrate, an endogenous amino acidderivative, plays an important role in cellularenergy, especially in muscle and brain.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Creatine ribosideCat. No.: HY-117821

Creatine riboside is a urinary metabolite and is adiagnostic and prognostic biomarker of lungcancer.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Creatinine (NSC13123) Cat. No.: HY-B0504

Creatinine(NSC13123) is a break-down product ofcreatine phosphate in muscle, and is usuallyproduced at a fairly constant rate by the body.

Purity: 99.87%Clinical Data: Phase 4Size: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Creatinine-D3 (NSC13123-D3) Cat. No.: HY-B0504S

Creatinine-D3 (NSC13123-D3) is a deuterium labeledCreatinine. Creatinine is a break-down product ofcreatine phosphate in muscle.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg

Creosol (2-Methoxy-4-methylphenol) Cat. No.: HY-W040971

Creosol is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Crustecdysone (20-Hydroxyecdysone) Cat. No.: HY-N6979

Crustecdysone (20-Hydroxyecdysone) is a naturallyoccurring ecdysteroid hormone isolated from

which controls theCyanotis arachnoides C.B.Clarkeecdysis (moulting) and metamorphosis ofarthropods, it inhibits activity andcaspaseinduces via the 20E nuclear…autophagy

Purity: 99.64%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

Cryptochlorogenic acid (4-Caffeoylquinic acid; 4-O-Caffeoylquinic acid) Cat. No.: HY-N0787

Cryptochlorogenic acid is a natural product.

Purity: 99.88%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

CS-722 Free baseCat. No.: HY-106888

CS-722 Free base is a synthesized centrally actingmuscle relaxant, and has a muscle relaxantactivity and depressant effectson the spinalreflex.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Cucurbitacin BCat. No.: HY-N0416

Cucurbitacin B belongs to a class of highlyoxidized tetracyclic triterpenoids; could represscancer cell progression.

Purity: 99.92%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg

56 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

CuminaldehydeCat. No.: HY-Y0790

Cuminaldehyde is the major component of Cuminum, a natural aldehyde with inhibitorycyminum

effect on alpha-synuclein fibrillation andcytotoxicity. Cuminaldehyde shows anticanceractivity.

Purity: 96.35%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Cyclic ADP-ribose (cADPR) Cat. No.: HY-N7395

Cyclic ADP-ribose (cADPR) is a potent secondmessenger for that iscalcium mobilizationsynthesized from NAD by an ADP-ribosyl cyclase.+

Purity: >98%Clinical Data: No Development ReportedSize: 500 μg

Cyclic AMP (Cyclic adenosine monophosphate; Adenosine cyclic

3', 5'-monophosphate; cAMP) Cat. No.: HY-B1511

Cyclic AMP (cAMP) is a mitogenic messenger andpromotes the G to S phase transition in the cell1

cycle.

Purity: >98.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 500 mg, 1 g

Cyclic N-Acetyl-D-mannosamine (Cyclic ManNAc) Cat. No.: HY-W040154

Cyclic N-Acetyl-D-mannosamine (Cyclic ManNAc) isan endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Cyclic-di-GMP (c-di-GMP; cyclic diguanylate; 5GP-5GP) Cat. No.: HY-107780

Cyclic-di-GMP (c-di-GMP) is a activator and aSTINGubiquitous second messenger that regulates biofilmformation, motility, and virulence in diversebacterial species.

Purity: 99.26%Clinical Data: No Development ReportedSize: 1 mg

Cyclic-di-GMP sodium (c-di-GMP sodium; cyclic diguanylate

sodium; 5GP-5GP sodium) Cat. No.: HY-107780A

Cyclic di-GMP sodium (c-di-GMP sodium) is a STINGactivator and a global bacterial second messenger,which regulates biofilm formation, motility, andvirulence in diverse bacterial species.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Cyclo(Ala-Gly)Cat. No.: HY-75564

Cyclo(Ala-Gly), a metabolite of a mangroveendophytic fungus, ,Penicillium thomiexhibits cytotoxicity against A549, HepG2 and HT29cells. The IC values range from 9.5 to 18.1 μM.50

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 250 mg

Cyclo(his-pro) (Cyclo(histidyl-proline); Histidylproline

diketopiperazine) Cat. No.: HY-101402

Cyclo(his-pro) (Cyclo(histidyl-proline)) is anorally active cyclic dipeptide structurallyrelated to tyreotropin-releasing hormone.Cyclo(his-pro) could inhibit nuclearNF-κBaccumulation.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Cyclo(his-pro) TFA (Cyclo(histidyl-proline) TFA;

Histidylproline diketopiperazine TFA) Cat. No.: HY-101402A

Cyclo(his-pro) TFA (Cyclo(histidyl-proline) TFA)is an orally active cyclic dipeptide structurallyrelated to tyreotropin-releasing hormone.Cyclo(his-pro) TFA could inhibit nuclearNF-κBaccumulation.

Purity: 99.35%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Cyclohexaneacetic acidCat. No.: HY-W018653

Cyclohexaneacetic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

www.MedChemExpress.com 57

 

Cyclohexanecarboxylic acidCat. No.: HY-Y1373

Cyclohexanecarboxylic acid is a Valproatestructural analogue with anticonvulsant action.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

Cyclopamine (11-Deoxojervine) Cat. No.: HY-17024

Cyclopamine is a ( ) pathwayHedgehog Hhantagonist with an of 46 nM in the Hh cellIC50

assay. Cyclopamine is also a selective Smoinhibitor.

Purity: 99.97%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mg

Cyromazine (Cyromazin; CGA-72662) Cat. No.: HY-B1331

Cyromazine is a triazine insect growth regulatorused as an insecticide and an acaricide. It is acyclopropyl derivative of melamine. Cyromazineworks by affecting the nervous system of theimmature larval stages of certain insects.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Cysteamine (β-Mercaptoethylamine; 2-Aminoethanethiol;

2-Mercaptoethylamine) Cat. No.: HY-77591A

Cysteamine (β-Mercaptoethylamine) is an orallyactive agent for the treatment of nephropathiccystinosis and an antioxidant.

Purity: >95.0%Clinical Data: LaunchedSize: 500 mg

Cysteamine hydrochloride (β-Mercaptoethylamine Hydrochloride;

2-Aminoethanethiol Hydrochloride; …) Cat. No.: HY-77591

Cysteamine hydrochloride (β-MercaptoethylamineHydrochloride) is an orally active agent for thetreatment of nephropathic cystinosis and anantioxidant.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

CysteinylglycineCat. No.: HY-113110

Cysteinylglycine is an endogenous metabolite andused in disease diagnosis.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Cytarabine (Cytosine β-D-arabinofuranoside; Cytosine

Arabinoside; Ara-C) Cat. No.: HY-13605

Cytarabine, a nucleoside analog, causes S phasecell cycle arrest and inhibits .DNA polymeraseCytarabine inhibits with an ofDNA synthesis IC50

16 nM. Cytarabine has antiviral effects against.HSV

Purity: 99.99%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg, 1 g

Cytidine (Cytosine β-D-riboside; Cytosine-1-β-D-ribofuranoside) Cat. No.: HY-B0158

Cytidine is a pyrimidine nucleoside and acts as acomponent of RNA. Cytidine is a precursor ofuridine. Cytidine controls neuronal-glialglutamate cycling, affecting cerebral phospholipidmetabolism, catecholamine synthesis, andmitochondrial function.

Purity: 98.78%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Cytidine 5'-monophosphate (5'-Cytidylic acid; 5'-CMP) Cat. No.: HY-W009162

Cytidine 5'-monophosphate (5'-Cytidylic acid) is anucleotide which is used as a monomer in RNA.Cytidine 5'-monophosphate consists of thenucleobase cytosine, the pentose sugar ribose, andthe phosphate group.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Cytidine-5'-triphosphate disodiumCat. No.: HY-W013100

Cytidine-5'-triphosphate disodium is an endogenousmetabolite.

Purity: 98.12%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

58 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

CytosineCat. No.: HY-I0626

Cytosine is one of the four main bases found inDNA and RNA. Cytosine modifications exhibitcircadian oscillations that are involved inepigenetic diversity and aging.

Purity: 99.52%Clinical Data: Phase 4Size: 10 mM × 1 mL, 500 mg, 5 g

D(+)-Raffinose pentahydrate (D-Raffinose pentahydrate) Cat. No.: HY-N1938

D(+)-Raffinose pentahydrate (D-Raffinosepentahydrate) is a trisaccharide composed ofgalactose, glucose, and fructose that occursnaturally in a variety of vegetables and grains.D(+)-Raffinose pentahydrate is a functionaloligosaccharide.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D(-)-2-Aminobutyric acidCat. No.: HY-Y0127

D(-)-2-Aminobutyric acid is a substrate of D-aminoacid oxidase.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-(+)-CellobioseCat. No.: HY-N2325

D-(+)-Cellobiose is an endogenous metabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 100 mg

D-(+)-Glucono-1,5-lactone (Gluconic acid lactone) Cat. No.: HY-I0301

D-(+)-Glucono-1,5-lactone is a polyhydroxy (PHA)that is capable of metal chelating, moisturizingand antioxidant activity.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

D-(+)-Trehalose (D-Trehalose; α,α-Trehalose) Cat. No.: HY-N1132

D-(+)-Trehalose, isolated from Saccharomyces, can be used as a food ingredient andcerevisiae

pharmaceutical excipient.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-(-)-Lactic acid ((R)-2-Hydroxypropionic acid) Cat. No.: HY-111095

D-(-)-Lactic acid is a normal intermediate in thefermentation (oxidation, metabolism) of sugar.D-(-)-Lactic acid is identified to be acompetitive inhibitor of ProDH (prolinedehydrogenase) in plants.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg, 500 mg

D-(-)-Quinic acidCat. No.: HY-N0464

D-(-)-Quinic acid is a cyclohexanecarboxylic acidand is implicated in the perceived acidity ofcoffee.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-Alanine ((R)-Alanine; Ba 2776; D-α-Alanine) Cat. No.: HY-41700

D-Alanine is a weak (inhibitory glycineGlyRreceptor) and agonist, with an of 9PMBA EC50

mM for GlyR.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

D-AlloseCat. No.: HY-128741

D-Allose is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 59

 

D-AllothreonineCat. No.: HY-W001959

D-Allothreonine is the D type stereoisomer ofAllothreonine. D-Allothreonine is a peptido-lipidderived from bacteria. D-Allothreonine,amide-linked to the D-galacturonic acid, is also aconstituent in the polysaccharide.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg

D-arabinoseCat. No.: HY-N0059

D-arabinose is an endogenous metabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

D-ArabitolCat. No.: HY-N3686

D-Arabitol is a polyol and its accumulation maycause a neurotoxic effect in human.

Purity: >97.0%Clinical Data:Size: 10 mM × 1 mL, 100 mg, 1 g

D-Asparagine (H-D-Asn-OH) Cat. No.: HY-W010378

D-Asparagine (H-D-Asn-OH) is a competitiveinhibitor of with a valueL-Asparagine hydrolysis Ki

of 0.24 mM. D-Asparagine is a source of nitrogenfor yeast strains. D-Asparagine is a goodsubstrate for the external yeast asparaginase butis a poor substrate for the internal enzyme.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Carnitine hydrochloride ((S)-Carnitine hydrochloride) Cat. No.: HY-B2246A

D-Carnitine hydrochloride ((S)-CarnitineHydrochloride) has been used to study sulfurfactor transporter SLC22A4 and carnitinetransporter SLC22A5 in ergot. D-Carnitinehydrochloride is also used to get palmitic acidinto mitochondria.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

D-chiro-InositolCat. No.: HY-N3021

D-chiro-Inositol is an epimer of -inositolmyofound in certain mammalianglycosylphosphatidylinositol protein anchors andinositol phosphoglycans possessing insulin-likebioactivity.

Purity: >98.0%Clinical Data: Phase 4Size: 10 mM × 1 mL, 10 mg

D-CysteineCat. No.: HY-W018555

D-Cysteine is the D-isomer of cysteine and apowerful inhibitor of growth.Escherichia coliD-cysteine is mediated by D-amino acid oxidase toproduce H S and is a neuroprotectant against2

cerebellar ataxias.

Purity: >97.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 25 mg

D-DesthiobiotinCat. No.: HY-128699

D-Desthiobiotin is a biotin derivative used inaffinity chromatography and proteinchromatography, also can be used for protein andcell labeling, detection and isolation.

Purity: 98.19%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

D-Erythro-dihydrosphingosineCat. No.: HY-W019838

D-Erythro-dihydrosphingosin directly inhibitscytosolic phospholipase A α ( ) activity.2 cPLA α2

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg

D-erythro-Sphingosine (Erythrosphingosine;

erythro-C18-Sphingosine; trans-4-Sphingenine) Cat. No.: HY-101047

D-erythro-Sphingosine (Erythrosphingosine) is avery potent activator of with an p32-kinase EC50

of 8 μM, and inhibits .protein kinase C (PKC)D-erythro-Sphingosine (Erythrosphingosine) is alsoa activator.PP2A

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg

60 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

D-Fructose-6-phosphate disodium saltCat. No.: HY-113407A

D-Fructose-6-phosphate disodium salt is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Galactose (D-(+)-Galactose) Cat. No.: HY-N0210

D-Galactose is a natural aldohexose and C-4 epimerof glucose.

Purity: >98.0%Clinical Data: Phase 2Size: 500 mg, 5 g

D-Galacturonic acid hydrateCat. No.: HY-B1827

D-Galacturonic acid hydrate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

D-Glucaric acid potassiumCat. No.: HY-128749

D-Glucaric acid potassium is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Gluconic acidCat. No.: HY-Y0569

D-Gluconic acid is the carboxylic acid by theoxidation with antiseptic and chelatingproperties.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 g, 50 g, 100 g

D-Glucose (Glucose; D-(+)-Glucose; Dextrose) Cat. No.: HY-B0389

D-Glucose (Glucose), a monosaccharide, is animportant carbohydrate in biology.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

D-Glucose 6-phosphateCat. No.: HY-112537

D-Glucose 6-phosphate is a glucose sugarphosphorylated at the hydroxy group on carbon 6.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

D-Glucose 6-phosphate disodium saltCat. No.: HY-128374

D-Glucose-6-phosphate disodium salt is a glucosesugar phosphorylated at the hydroxy group oncarbon 6.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-Glucose 6-phosphate sodiumCat. No.: HY-112537B

D-Glucose 6-phosphate sodium is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Glucose-13C6 (Glucose-13C6; D-(+)-Glucose-13C6; Dextrose-13C6) Cat. No.: HY-B0389A

D-Glucose-13C6 (Glucose-13C6) is a tracer used totrace glucose-related synthetic catabolism, is alow-cost alternative with the significantadvantage that the sixth isotope of naturalglucose has virtually zero natural abundance,which facilitates isotopomer analysis with…

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 61

 

D-Glucuronic acidCat. No.: HY-N6612

D-Glucuronic acid is an important intermediateisolated from many gums. D-Glucuronic acid and itsderivative glucuronolactone are as a liverantidote in the prophylaxis of human health.D-Glucuronic acid has an anti-inflammatory effectfor the skin.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-Glucuronic acid lactone (D-Glucurono-6,3-lactone;

D-Glucurono-γ-lactone; D-Glucuronolactone; Dicurone; …) Cat. No.: HY-41982

D-Glucuronic acid lactone is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-Glucuronic acid sodium salt monohydrateCat. No.: HY-N6612A

D-Glucuronic acid sodium salt monohydrate is anendogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

D-Glutamic acid ((R)-Glutamic acid) Cat. No.: HY-100805

D-glutamic acid, an enantiomer of L- glutamicacid, is widely used in pharmaceuticals and foods.

Purity: >99.0%Clinical Data: No Development ReportedSize: 500 mg

D-GlutamineCat. No.: HY-100587

D-Glutamine is a cell-permeable D typestereoisomer of Glutamine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

D-KynurenineCat. No.: HY-W014502

D-kynurenine, a metabolite of D-tryptophan, canserve as the bioprecursor of kynurenic acid (KYNA)and 3-hydroxykynurenine. D-Kynurenine is anagonist for G protein-coupled receptor, .GPR109BD-Kynurenine is a substrate in a fluorometricassay of D-amino acid oxidase.

Purity: 98.84%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg, 50 mg, 100 mg

D-Leucine ((R)-Leucine) Cat. No.: HY-Y0378

D-Leucine is a more potent anti-seizure agent thanL-leucine. D-leucine potently terminates seizureseven after the onset of seizure activity.D-leucine, but not L-leucine, reduces long-termpotentiation but had no effect on basal synaptictransmission in vitro.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

D-LyxoseCat. No.: HY-128753

D-Lyxose is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Mannitol (Mannitol; Mannite) Cat. No.: HY-N0378

D-Mannitol is an osmotic diuretic agent and a weakrenal vasodilator. Target: Others D(-)Mannitol isa sugar alcohol that can be used as an inertosmotic control substance.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g, 10 g

D-MannoseCat. No.: HY-N0379

D-Mannose is a carbohydrate, which plays animportant role in human metabolism, especially inthe glycosylation of specific proteins.

Purity: >97.0%Clinical Data: Phase 4Size: 10 mM × 1 mL, 100 mg

62 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

D-MelibioseCat. No.: HY-107824

D-Melibiose is a disaccharide which is composed ofone galactose and one glucose moiety in an alpha(1-6) glycosidic linkage.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-Methionine sulfoxideCat. No.: HY-129770

D-methionine sulfoxide is the D-isomer ofMethionine sulfoxide. Methionine sulfoxide is anoxidation product of methionine. Methionine is thelimiting amino acid in milk or leguminous proteins, which is easily oxidized during the course ofstorage or processing.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-N-AcetylgalactosamineCat. No.: HY-33212

D-N-Acetylgalactosamine is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-Panthenol (Dexpanthenol) Cat. No.: HY-B1391

D-Panthenol is the biologically-active alcohol ofpantothenic acid, which leads to an elevation inthe amount of coenzyme A in the cell.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

D-Pantothenic acid hemicalcium salt (Calcium pantothenate;

Calcium D-pantothenate; Vitamin B5 calcium salt) Cat. No.: HY-N0681

D-Pantothenic acid hemicalcium salt (Vitamin B5calcium salt), a vitamin, can reduce the patulincontent of the apple juice.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

D-PhenylalanineCat. No.: HY-Y0079

D-Phenylalanine is the synthetic dextro isomer ofphenylalanine. D-Phenylalanine inhibits biofilmdevelopment of SC2014.Pseudoalteromonas sp.

Purity: 99.74%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

D-Pipecolinic acidCat. No.: HY-Y0181

D-Pipecolinic acid is a normal human metabolitefound in human biofluids.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

D-RibonolactoneCat. No.: HY-76691

D-Ribonolactone is sugar lactone and an inhibitorof of with a ofβ-galactosidase Escherichia coli Ki

26 mM.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

D-Ribose 5-phosphateCat. No.: HY-W009371A

D-Ribose 5-phosphate is an intermediate of theoxidative branch of the pentose phosphate pathway(PPP) and an end product of the nonoxidativebranch of the PPP. D-Ribose 5-phosphate is used inthe synthesis of nucleotides and nucleic acids.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Ribose(mixture of isomers)Cat. No.: HY-W018772

D-Ribose(mixture of isomers) is an energyenhancer, and acts as a sugar moiety of ATP, andwidely used as a metabolic therapy supplement forchronic fatigue syndrome or cardiac energymetabolism.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 63

 

D-Sedoheptulose 7-phosphateCat. No.: HY-113206

D-Sedoheptulose 7-phosphate is a common precursorfor the heptoses of septacidin (group III) andhygromycin B (group IV). D-Sedoheptulose7-phosphate can be converted to NDP-heptosesthrough similar biosynthetic pathways in thosecompounds .

Purity: >97.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Sorbitol (Sorbitol; D-Glucitol) Cat. No.: HY-B0400

D-Sorbitol (Sorbitol) is a six-carbon sugaralcohol and can used as a sugar substitute.D-Sorbitol can be used as a stabilizing excipientand/or isotonicity agent, sweetener, humectant,thickener and dietary supplement.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

D-ThreitolCat. No.: HY-W012846

D-threitol serves as a antifreeze agent in theAlaskan beetle Upis .ceramboides

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-Threonine (H-D-Thr-OH) Cat. No.: HY-W012874

D-Threonine (H-D-Thr-OH) is an enantiomer ofL-threonine. D-Threonine is a metabolite of

.Saccharomyces cerevisiae

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

D-ValineCat. No.: HY-N0717A

D-Valine is the of L-Valineenantiomer(HY-N0717). L-Valine is one of 20 proteinogenicamino acids. L-Valine is an essential amino acid.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

D-XyluloseCat. No.: HY-W010256

D-xylulose is a precursor of the pentiolD-arabitol.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

D-α-Hydroxyglutaric acid ((R)-2-Hydroxypentanedioic acid) Cat. No.: HY-113038

D-α-Hydroxyglutaric acid((R)-2-Hydroxypentanedioic acid) is the principalmetabolite accumulating in neurometabolic diseaseD-2-hydroxyglutaric aciduria.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg

D-α-Hydroxyglutaric acid disodium (Disodium (R)-2-hydroxyglutarate) Cat. No.: HY-100542

D-α-Hydroxyglutaric acid disodium (Disodium(R)-2-hydroxyglutarate) is the principalmetabolite accumulating in neurometabolic diseaseD-2-hydroxyglutaric aciduria.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg

D-α-Tocopherol acetate (D-Vitamin E acetate) Cat. No.: HY-B1278

D-α-Tocopherol acetate (D-Vitamin E acetate) canbe hydrolyzed to d-alpha-tocopherol (VE) andabsorbed in the small intestine.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 250 mg

D-(+)-Phenyllactic acid (D-3-Phenyllactic acid) Cat. No.: HY-30219

D-(+)-Phenyllactic acid is an anti-bacterialagent, excreted by ,Geotrichum candiduminhibits a range of Gram-positive from humans andfoodstuffs and Gram-negative bacteria found inhumans.

Purity: 99.54%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

64 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

D-Glucosamic acidCat. No.: HY-128745

D-Glucosamic acid is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Dacisteine (N,S-Diacetyl-L-cysteine) Cat. No.: HY-121765

Dacisteine (N,S-Diacetyl-L-cysteine) is a cysteinederivative and displays a less New Delhi

inhibitor withmetallo-beta-lactamase-1 (NDM-1)an IC value of 1000 μM.50

Purity: 99.40%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

DaidzeinCat. No.: HY-N0019

Daidzein is a soy isoflavone, which acts as a activator.PPAR

Purity: 99.89%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g, 10 g

Decanedioic acidCat. No.: HY-W014787

Decanedioic acid, a normal urinary acid, is foundto be associated with carnitine-acylcarnitinetranslocase deficiency and medium chain acyl-CoAdehydrogenase deficiency.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Decyl aldehydeCat. No.: HY-W012570

Decyl aldehyde is a simple ten-carbon aldehyde.Decyl aldehyde is a bacterial luciferasesubstrate.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Defensin HNP-1 humanCat. No.: HY-P2310

Defensin HNP-1 human is a Human neutrophilpeptides (HNPs), involved in endothelial celldysfunction at the time of early atheroscleroticdevelopment.Defensin HNP-1 human can regulate thegrowth of atherosclerosis.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Defensin HNP-2 humanCat. No.: HY-P2311

Defensin HNP-2 human is an endogenous antibioticpeptide and monocyte chemotactic peptide producedby human neutrophils.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Dehydrocholate sodium (Sodium dehydrocholate) Cat. No.: HY-B0998

Dehydrocholic sodium is a hydrocholeretic,increasing bile output to clear increased bileacid load.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Dehydroepiandrosterone sulfate sodium salt (Sodium prasterone sulfate) Cat. No.: HY-B0765

Dehydroepiandrosterone sulfate sodium salt (DHEAS)is the most abundant circulating steroid in human.Dehydroepiandrosterone sulfate sodium salt (DHEAS)affects steroid hormone biosynthesis on amolecular level resulting in an increasedformation of pregnenolone.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Delta-TocopherolCat. No.: HY-113026

Delta-Tocopherol is an isomer of Vitamin E.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 50 mg

www.MedChemExpress.com 65

 

delta-ValerobetaineCat. No.: HY-114202

delta-Valerobetaine is a precursor oftrimethylamine N-oxide (TMAO).

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

DeltoninCat. No.: HY-N2283

Deltonin, a steroidal saponin, isolated from, with antitumorDioscorea zingiberensis Wright

activity; Deltonin inhibits and ERK1/2 AKTactivation.

Purity: 99.93%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Deoxycholic acid (Cholanoic Acid; Desoxycholic acid) Cat. No.: HY-N0593

Deoxycholic acid is specifically responsible foractivating the G protein-coupled bile acidreceptor that stimulates brown adiposeTGR5tissue (BAT) thermogenic activity.

Purity: 99.89%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Deoxycholic acid sodium salt (Sodium deoxycholate) Cat. No.: HY-N0593A

Deoxycholic acid sodium salt is specificallyresponsible for activating the G protein-coupledbile acid receptor that stimulates brownTGR5adipose tissue (BAT) thermogenic activity.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

DeoxycorticosteroneCat. No.: HY-113414

Deoxycorticosterone is a steroid hormone producedby the adrenal gland that possessesmineralocorticoid activity and acts as analdosterone precursor.

Purity: 99.57%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Deoxycorticosterone acetate (11-Deoxycorticosterone acetate;

DOC acetate; Cortexone acetate) Cat. No.: HY-B1472

Deoxycorticosterone acetate is a steroid hormoneproduced by the adrenal gland that possessesmineralocorticoid activity and acts as a precursorto aldosterone.

Purity: 98.45%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Deoxycytidine triphosphate (dCTP) Cat. No.: HY-101400

Deoxycytidine triphosphate (dCTP), a nucleosidetriphosphate, is a raw material in DNA synthesis.Deoxycytidine triphosphate has many applications,such as real-time PCR, cDNA synthesis, and DNAsequencing.

Purity: 98.15%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid) Cat. No.: HY-W015346

Desaminotyrosine is a microbially associatedmetabolite protecting from throughinfluenzaaugmentation of signaling.type I interferon

Purity: 99.32%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Desloratadine (Sch34117) Cat. No.: HY-B0539

Desloratadine(Sch34117) is a potent antagonist forhuman histamine H1 receptor used to treatallergies. Target: Histamine H1 ReceptorDesloratadine binds to the human H1 receptor withKi value of 0.87 nM in displacing tritiatedmepyramine.

Purity: 99.98%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg, 1 g

DHEA (Prasterone; Dehydroisoandrosterone;

Dehydroepiandrosterone) Cat. No.: HY-14650

DHEA (Prasterone) is one of the most abundantsteroid hormones. DHEA (Prasterone) mediates itsaction via multiple signaling pathways involvingspecific membrane receptors and via transformationinto androgen and estrogen derivatives (e.g.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

66 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Diadenosine pentaphosphate pentaammoniumCat. No.: HY-113273B

Diadenosine pentaphosphate pentaammonium is anendogenous vasoactive purine dinucleotide whichhas been isolated from thrombocytes.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Diadenosine pentaphosphate pentalithiumCat. No.: HY-113273C

Diadenosine pentaphosphate pentalithium is anendogenous vasoactive purine dinucleotide whichhas been isolated from thrombocytes.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Diadenosine pentaphosphate pentasodiumCat. No.: HY-113273A

Diadenosine pentaphosphate pentasodium is anendogenous vasoactive purine dinucleotide whichhas been isolated from thrombocytes.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Dibenzyl disulfideCat. No.: HY-W009516

Dibenzyl disulfide is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Dichlorisone acetateCat. No.: HY-B1383

Dichlorisone acetate is a synthetic glucocorticoidcorticosteroid used as an anti-inflammatory agent.

Purity: 99.77%Clinical Data: LaunchedSize: 10 mg, 50 mg

DichloroiodomethaneCat. No.: HY-133642

Dichloroiodomethane is a natural compound in humanbeings.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Diethyl oxalpropionateCat. No.: HY-128720

Diethyl oxalpropionate is an intermediate forpoly((R,S)-3,3-dimethylmalic acid) (PDMMLA)derivative synthesis. PDMMLA derivative can beused in synthesis of nanoparticles and study ofwarfarin encapsulation and controlled release.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Diethyl phosphate (Diethyl phosphoric acid) Cat. No.: HY-101417

Diethylphosphate (DEP) is product of metabolismand of environmental degradation of a commonlyused insecticide Chlorpyrifos.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 200 mg, 500 mg

Dihomo-γ-linolenic acid (all-cis-8,11,14-Eicosatrienoic acid) Cat. No.: HY-A0143

Dihomo-γ-linolenic acid(all-cis-8,11,14-Eicosatrienoic acid) is a20-carbon ω-6 fatty acid, with anti-inflammatoryand anti-proliferative activities.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL,

Dihydrocaffeic acid (3,4-Dihydroxy-benzenepropanoic acid) Cat. No.: HY-N2406

Dihydrocaffeic acid is a phenolic acid found in, reduces phosphorylation of Gynura bicolor MAPK

and prevent UVB-induced skin damage.p38Antioxidant potential and anti-inflammatoryactivity.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

www.MedChemExpress.com 67

 

Dihydrodaidzein ((±)-Dihydrodaidzein) Cat. No.: HY-N1461

Dihydrodaidzein is one of the most prominentdietary phytoestrogens.

Purity: 99.87%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Dihydrofolic acidCat. No.: HY-113267

Dihydrofolic acid is a folic acid derivative actedupon by dihydrofolate reductase to producetetrahydrofolic acid.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Dihydrouracil (5,6-Dihydrouracil) Cat. No.: HY-W012926

Dihydrouracil (5,6-Dihydrouracil), a metabolite ofUracil, can be used as a marker for identificationof dihydropyrimidine dehydrogenase(DPD)-deficient.

Purity: 98.07%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Dihydroxyacetone phosphateCat. No.: HY-113131

Dihydroxyacetone phosphate is an importantintermediate in lipid biosynthesis and inglycolysis. It is a biochemical compound involvedin many metabolic pathways, including the Calvincycle in plants and glycolysis.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Dihydroxyfumaric acid hydrateCat. No.: HY-128734

Dihydroxyfumaric acid hydrate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Dimethyl fumarate (DMF) Cat. No.: HY-17363

Dimethyl fumarate is a nuclear factor(erythroid-derived)-like 2 ( ) pathwayNrf2activator and induces upregulation of antioxidantgene expression.

Purity: >98.0%Clinical Data: LaunchedSize: 500 mg, 5 g

Dimethyl sulfoneCat. No.: HY-Y1314

Dimethyl sulfone is an endogenous metabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 g

Dimethyl trisulfideCat. No.: HY-128454

Dimethyl trisulfide is an organic chemicalcompound and the simplest organic trisulfide foundin garlic, onion, broccoli, and similar plants.Dimethyl trisulfide is a cyanide antidote.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Dimethylmalonic acidCat. No.: HY-W007894

Dimethylmalonic acid is a short-chain dicarboxylicacid in human serum. Dimethylmalonic acid is alsoa volatile organic compound detected in alveolarbreath.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Dinoprost (Prostaglandin F2α; PGF2α) Cat. No.: HY-12956

Dinoprost (Prostaglandin F2α) is an orally active,potent prostaglandin F (PGF) receptor (FP

agonist. Dinoprost is a luteolyticreceptor)hormone produced locally in the endometrialluminal epithelium and corpus luteum (CL).

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

68 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Dinoprost tromethamine salt (Prostaglandin F2α tromethamine

salt; PGF2α THAM; Prostaglandin F2α THAM) Cat. No.: HY-12956A

Dinoprost tromethamine salt (Prostaglandin F2αtromethamine salt) is an orally active, potentprostaglandin F (PGF) receptor (FP receptor)agonist.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Diphenyl disulfideCat. No.: HY-Y1177

Diphenyl disulfide is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

DL-3-Phenyllactic acidCat. No.: HY-W017162

DL-3-Phenyllactic acid is a broad-spectrumantimicrobial compound.

Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

DL-5-Hydroxylysine hydrochlorideCat. No.: HY-W014930

DL-5-Hydroxylysine hydrochloride is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

DL-DopaCat. No.: HY-113404

DL-Dopa is a beta-hydroxylated derivative ofphenylalanine.

Purity: >97.0%Clinical Data:Size: 1 mg, 5 mg

DL-Epinephrine hydrochloride ((±)-Epinephrine hydrochloride;

(±)-Adrenaline hydrochloride; DL-Adrenalin hydrochloride) Cat. No.: HY-B0447C

DL-Epinephrine hydrochloride is an endogenousmetabolite.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

DL-Glutamine ((±)-Glutamine; DL-Gl) Cat. No.: HY-B1346

DL-Glutamine is used for biochemical research anddrug synthesis.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

DL-Glyceraldehyde 3-phosphateCat. No.: HY-113054

DL-Glyceraldehyde 3-phosphate is an intermediatein several metabolic pathways, includingglycolysis and gluconeogenesis. DL-Glyceraldehyde3-phosphate is a potent inhibitor of the growth of

. DL-Glyceraldehyde 3-phosphate is aE. colicompetitive inhibitor of the .acyltransferase

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

DL-Glyceric Acid (Glyceric Acid (20% in Water,ca.2 mol/L)) Cat. No.: HY-W018035

DL-Glyceric Acid is a compound that is secretedexcessively in the urine by patients sufferingfrom D-glyceric aciduria.

Purity: >97.0%Clinical Data: No Development ReportedSize: 5 mL

DL-HomocysteineCat. No.: HY-W040821

DL-Homocysteine is a weak neurotoxin, and canaffect the production of kynurenic acid in thebrain.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 69

 

DL-Homocysteine thiolactone hydrochlorideCat. No.: HY-101404

DL-Homocysteine thiolactone hydrochloride is acyclic amino acid derivative that exhibitsroot-growth inhibitory activity.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg, 1 g

DL-HomocystineCat. No.: HY-W009390

DL-Homocystine is the double-bonded form ofhomocysteine and homocysteine is recognized as animportant substance in the pathogenesis andpathophysiology of schizophrenia.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg, 5 g

DL-Isocitric acid trisodium saltCat. No.: HY-W009362

DL-Isocitric acid trisodium salt is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 50 mg

DL-Mevalonolactone ((±)-Mevalonolactone; Mevalolactone) Cat. No.: HY-107855

DL-Mevalonolactone((±)-Mevalonolactone;Mevalolactone) is theδ-lactone form of mevalonic acid, a precursor inthe mevalonate pathway.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

DL-Norvaline (2-Aminopentanoic acid) Cat. No.: HY-W010510

DL-Norvaline, a derivative of ,L-norvalineL-norvaline is a non-competitive inhibitor ofarginase.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

DL-O-PhosphoserineCat. No.: HY-15130

DL-O-Phosphoserine, a normal metabolite in humanbiofluid, is an ester of serine and phosphoricacid.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg

DL-Tryptophan ((±)-Tryptophan) Cat. No.: HY-W012480

DL-Tryptophan is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

DL-α-Tocopherol acetate (Vitamin E acetate) Cat. No.: HY-B1278A

DL-α-Tocopherol acetate is a vitamin E derivativewhich is often included in the formulations ofenteral nutrition.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Docetaxel (RP-56976) Cat. No.: HY-B0011

Docetaxel (RP-56976) is a inhibitor,microtubule depolymerization

with an of 0.2 μM. Docetaxel attenuates theIC50

effects of  and gene expression.bcl-2 bcl-xLDocetaxel arrests the cell cycle at G2/M and leadsto cell .apoptosis

Purity: 99.96%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 200 mg

Docosahexaenoic Acid (DHA; Cervonic Acid) Cat. No.: HY-B2167

Docosahexaenoic Acid (DHA) is an omega-3 fattyacid abundantly present brain and retina. It canbe obtained directly from fish oil and maternalmilk.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 200 mg, 500 mg

70 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Docosanoic acidCat. No.: HY-W013049

Docosanoic acid is poorly absorbed, and acholesterol-raising saturated fatty acid inhumans.

Purity: >97.0%Clinical Data: No Development ReportedSize: 100 mg

Docosapentaenoic acid 22n-3Cat. No.: HY-113159

Docosapentaenoic acid (22n-3) is a component ofphospholipids found in all animal cell membranes.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Docosatrienoic Acid (cis-13,16,19-docosatrienoic acid;

(13Z,16Z,19Z)-13,16,19-Docosatrienoic acid) Cat. No.: HY-101408

Docosatrienoic acid is a rare ω-3 fatty acid;inhibits LTB4 binding to pig neutrophil membraneswith an of 5 μM.Ki

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mg (149 mM * 200 μL in Ethanol)

Dodecanedioic acidCat. No.: HY-W012241

Dodecanedioic acid (C12) is a dicarboxylic acidwhich is a water-soluble substance with ametabolic pathway intermediate to those of lipidsand carbohydrates.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

DodecanoylcarnitineCat. No.: HY-113166

Dodecanoylcarnitine is present in fatty acidoxidation disorders such as long-chain acyl CoAdehydrogenase deficiency, carnitinepalmitoyltransferase I/II deficiency, and is alsoassociated with celiac disease.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

DPPC (129Y83) Cat. No.: HY-109506

DPPC (129Y83) is a zwitterionic phosphoglyceridethat can be used for the preparation of liposomalmonolayers. DPPC-liposome serves effectively as adelivery vehicle for inducing immune responsesagainst GSL antigen in mice.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mg, 50 mg

Dulcite (Dulcitol; Melampyrit; NSC 1944) Cat. No.: HY-Y0418

Dulcite is a sugar alcohol with a slightly sweettaste which is a metabolic breakdown product ofgalactose.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Ecdysone (α-Ecdysone) Cat. No.: HY-N0179

Ecdysone (α-Ecdysone), a major steroid hormone ininsects and herbs, triggers mineralocorticoid

activation and induces cellularreceptor (MR).apoptosis

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Eicosadienoic acidCat. No.: HY-113130

Eicosadienoic acid is a rare, naturally occurringn-6 polyunsaturated fatty acid found mainly inanimal tissues.

Purity: >99.0%Clinical Data: No Development ReportedSize: 5 mg (81 mM * 200 μL in Ethanol),

Eicosapentaenoic Acid (EPA; Timnodonic acid) Cat. No.: HY-B0660

Eicosapentaenoic Acid (EPA; Timnodonic acid) is anomega-3 fatty acid.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg

www.MedChemExpress.com 71

 

Eicosapentaenoic acid ethyl ester (EPA ethyl ester; Ethyl eicosapentaenoate) Cat. No.: HY-B0747

Eicosapentaenoic acid ethyl ester is an omega-3fatty acid agent.

Purity: 99.92%Clinical Data: Phase 4Size: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg

Elaidic acidCat. No.: HY-113016

Elaidic acid is the major trans fat found inhydrogenated vegetable oils and can be used as apharmaceutical solvent.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 100 mg

Ellagic acidCat. No.: HY-B0183

Ellagic acid is a natural antioxidant, and acts asa potent and ATP-competitive inhibitor, withCK2an of 40 nM and a of 20 nM.IC50 Ki

Purity: 99.92%Clinical Data: Phase 2Size: 500 mg, 1 g, 5 g

Enterostatin(human,mouse,rat)Cat. No.: HY-P1067

Enterostatin, human, mouse, rat is a pentapeptidethat reduces fat intake.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Enterostatin(human,mouse,rat) TFACat. No.: HY-P1067A

Enterostatin (human,mouse,rat) TFA is a mainly formed in the intestine by thepentapeptide

cleavage of secreted pancreatic procolipase.Enterostatin  selectively reduces fat intake,bodyweight, and body fat .in vivo

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Epiandrosterone (3β-Androsterone; trans-Androsterone; iso-Androsterone) Cat. No.: HY-I0352

Epiandrosterone is a steroid hormone with weakandrogenic activity. Epiandrosterone is naturallyproduced by the enzyme 5α-reductase from theadrenal hormone DHEA.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

EpipregnanoloneCat. No.: HY-113036

Epipregnanolone is an endogenous neurosteroid thathas hypnotic, and sedative properties.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg

Ercalcidiol (25-hydroxy Vitamin D2) Cat. No.: HY-32349

Ercalcidiol is a metabolite of , isvitamin D2

regarded as an indicator of vitamin D nutritionalstatus.

Purity: 99.04%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 25 mg

Ercalcitriol (1α,25-Dihydroxy Vitamin D2) Cat. No.: HY-32350

Ercalcitriol (1α,25-Dihydroxy Vitamin D2) is anactive metabolite of vitamin D2.

Purity: 98.17%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 25 mg

Ergosterol (Ergosterin; Provitamin D; Provitamin D2) Cat. No.: HY-N0181

Ergosterol is the primary sterol found in fungi,with antioxidative, anti-proliferative, andanti-inflammatory effects.

Purity: >97.0%Clinical Data: No Development ReportedSize: 100 mg

72 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Ergothioneine (L-(+)-Ergothioneine) Cat. No.: HY-N1914

Ergothioneine, an imidazole-2-thione derivative ofhistidine betaine, is synthesized by certainbacteria and fungi. Ergothioneine is generallyconsidered an antioxidant.

Purity: 98.99%Clinical Data: Phase 3Size: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg

Eriodictyol (Huazhongilexone) Cat. No.: HY-N0637

Eriodictyol is a flavonoid isolated from theChinese herb, with antioxidant andanti-inflammatory activity. Eriodictyol induces

signaling pathway. Eriodictyol is also aNrf2potent influenza RNA-dependent RNA polymeraseinhibitor with an of 18 nM.IC50

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Erucic acidCat. No.: HY-N7109

Erucic acid, a monounsaturated fatty acid (MUFA),is isolated from the seed of .Raphanus sativus LErucic acid can readily cross the blood-brainbarrier (BBB), it has been reported to normalizethe accumulation of very long-chain fatty acids inthe brain.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

ErythrodiolCat. No.: HY-N2419

Erythrodiol is an olive oil component. Erythrodiolpromotes Cholesterol efflux (ChE) by selectivelyinhibiting the degradation of protein.ABCA1Erythrodiol is a good candidate to be furtherexplored for therapeutic or preventive applicationin the context of atherosclerosis.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

EstetrolCat. No.: HY-15731

Estetrol, a natural estrogen synthesizedexclusively during pregnancy by the human fetalliver, is a selective nuclear estrogen receptormodulator. Estetrol exerts estrogenic actions onthe endometrium or the central nervous system butpresents antagonistic effects on the breast.

Purity: 95.46%Clinical Data: No Development ReportedSize: 1 mg

Estradiol (β-Estradiol; E2; 17β-Estradiol; 17β-Oestradiol) Cat. No.: HY-B0141

Estradiol is a steroid sex hormone vital to themaintenance of fertility and secondary sexualcharacteristics in females. Estradiol upregulatesIL-6 expression through the estrogen receptor β(ERβ) pathway.

Purity: 99.99%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

Estriol (Oestriol) Cat. No.: HY-B0412

Estriol is an antagonist of the G-protein coupledestrogen receptor in estrogen receptor-negativebreast cancer cells.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Estrone (E1; Oestrone) Cat. No.: HY-B0234

Estrone (E1) is a natural estrogenic hormone.Estrone is the main representative of theendogenous estrogens and is produced by severaltissues, especially adipose tissue. Estrone is theresult of the process of aromatization ofandrostenedione that occurs in fat cells.

Purity: 99.86%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g, 10 g

Estrone sulfate potassiumCat. No.: HY-113293A

Estrone sulfate potassium is a natural endogenoussteroid and is an estrogen ester and conjugate.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Ethoxyacetic acidCat. No.: HY-W027555

Ethoxyacetic acid is an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

www.MedChemExpress.com 73

 

Ethyl glucuronideCat. No.: HY-113093

Ethyl glucuronide is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Ethyl nonanoateCat. No.: HY-129623

Ethyl nonanoate is a rich ester in spirits and itspresence is commonly related to the pleasantfruity bouquet of alcoholic beverages. Ethylnonanoate is an .endogenous metabolite

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Ethylmalonic acidCat. No.: HY-34740

Ethylmalonic acid is non-carcinogenic potentiallytoxic and associated with anorexia nervosa andmalonyl-CoA decarboxylase deficiency.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 500 mg, 1 g

Ethynyl Estradiol (17α-Ethynylestradiol; Ethynylestradiol) Cat. No.: HY-B0216

Ethynyl Estradiol(17α-Ethynylestradiol;Ethynylestradiol) is anorally bio-active estrogen used in almost allmodern formulations of combined oral contraceptivepills.

Purity: 99.87%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

EupholCat. No.: HY-N0313

Euphol is a tetracyclic triterpene alcoholisolated from the sap of withEuphorbia tirucallianti-mutagenic, anti-inflammatory andimmunomodulatory effects, orally active.

Purity: 98.82%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

FAPy-adenineCat. No.: HY-113303

FAPy-adenine is an oxidized DNA base. Fapy-adenineshows an increased trend levels in the Alzheimer'sdisease brain. Oxidized nucleosides arebiochemical markers for tumors, aging, andneurodegenerative diseases.

Purity: 99.93%Clinical Data: No Development ReportedSize: 10 mg, 25 mg, 50 mg, 100 mg

FarnesolCat. No.: HY-Y0248A

Farnesol is a sesquiterpene alcohol that modulatescell-to-cell communication in , andCandida albicanshas the activity in inhibiting bacteria.

Purity: 99.41%Clinical Data: No Development ReportedSize: 500 mg

Ferulic acid (Coniferic acid) Cat. No.: HY-N0060

Ferulic acid is a novel fibroblast growth factorreceptor 1 ( ) inhibitor with s of 3.78FGFR1 IC50

and 12.5 μM for and , respectively.FGFR1 FGFR2

Purity: 99.87%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Ferulic acid sodium (Coniferic acid sodium) Cat. No.: HY-N0060A

Ferulic acid sodium is a novel fibroblast growthfactor receptor 1 ( ) inhibitor with s ofFGFR1 IC50

3.78 and 12.5 μM for and ,FGFR1 FGFR2respectively.

Purity: 99.74%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g, 5 g

Flavin adenine dinucleotide (FAD) Cat. No.: HY-B1654

Flavin adenine dinucleotide (FAD) is a redoxcofactor, more specifically a prosthetic group ofa protein, involved in several important enzymaticreactions in metabolism.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

74 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Flavin adenine dinucleotide disodium salt (FAD disodium salt; FAD-Na2) Cat. No.: HY-B1654A

Flavin adenine dinucleotide (FAD) disodium salt isa redox cofactor, more specifically a prostheticgroup of a protein, involved in several importantenzymatic reactions in metabolism.

Purity: 99.84%Clinical Data: LaunchedSize: 10 mM × 1 mL, 25 mg

Flavone (2-Phenyl-4-chromone) Cat. No.: HY-N2424

Flavone is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

FlavonolCat. No.: HY-107825

Flavonol is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Fluticasone (propionate)Cat. No.: HY-B0154

Fluticasone propionate, a potent topicalanti-inflammatory corticosteroid, is a selective

agonist, with an absoluteglucocorticoid receptoraffinity ( ) of 0.5 nM. Fluticasone propionateKD

shows little or no activity at other steroidreceptors. Anti-viral activity.

Purity: 99.97%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg

Folic acid (Vitamin B9; Vitamin M) Cat. No.: HY-16637

Folic acid(Vitamin M; Vitamin B9) is a B vitamin;is necessary for the production and maintenance ofnew cells, for DNA synthesis and RNA synthesis.

Purity: 99.56%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g, 10 g

Folinic acid (leucovorin) Cat. No.: HY-17556

Folinic acid (Leucovorin) is a biological folicacid and is generally administered along withmethotrexate (MTX) as a rescue agent to decreaseMTX-induced toxicity.

Purity: 99.90%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

Folinic acid calcium (Leucovorin calcium; Calcium folinate) Cat. No.: HY-13664

Folinic acid calcium (Leucovorin calcium) is abiological folic acid and is generallyadministered along with methotrexate (MTX) as arescue agent to decrease MTX-induced toxicity.

Purity: 99.52%Clinical Data: LaunchedSize: 100 mg, 500 mg

For-Met-OHCat. No.: HY-W016647

For-Met-OH is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Formamide (Methanamide; Formimidic acid) Cat. No.: HY-Y0842

Formamide is an amide derived from formic acid andhas been used as solvent for many ionic compounds.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 g

Formic acid ammonium saltCat. No.: HY-Y0488A

Formic acid ammonium salt is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 75

 

Fosfructose (Diphosphofructose; Esafosfan; FDP) Cat. No.: HY-106950

Fosfructose (Diphosphofructose;Esafosfan;FDP) is acytoprotective natural sugar phosphate for thepotential treatment of cardiovascular ischemia,sickle cell anemia and asthma. It acts bystimulating anaerobic glycolysis which generatesadenosine triphosphate under ischemic conditions.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Fosfructose trisodium (Diphosphofructose trisodium; Esafosfan

trisodium; FDP trisodium) Cat. No.: HY-106950A

Fosfructose trisodium (Diphosphofructosetrisodium;Esafosfan trisodium;FDP trisodium) is acytoprotective natural sugar phosphate for thepotential treatment of cardiovascular ischemia,sickle cell anemia and asthma.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Fructosyl-lysine (Fructoselysine) Cat. No.: HY-129380

Fructosyl-lysine (Fructoselysine) is an amadori product from the reaction of glucose andglycation

lysine by the Maillard reaction. Fructosyl-lysineis the to glucosepane, aprecursorlysine–arginine protein cross-link that can be anindicator in diabetes detection.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Fructosyl-lysine dihydrochloride (Fructoselysine dihydrochloride) Cat. No.: HY-129380A

Fructosyl-lysine (Fructoselysine) dihydrochlorideis an product from theamadori glycationreaction of glucose and lysine by the Maillardreaction.

Purity: >95.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

FucosterolCat. No.: HY-N4103

Fucosterol is isolated from withE. stoloniferaanti-adipogenic, anti-diabetic and anti-canceractivities. Fucosterol regulates adipogenesis viamodulation of and expression.PPARα C/EBPα

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mg

Fumaric acidCat. No.: HY-W015883

Fumaric acid, associated with fumarase deficiency,is identified as an oncometabolite or anendogenous, cancer causing metabolite.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Galactose 1-phosphateCat. No.: HY-113143

Galactose 1-phosphate is an intermediate in thegalactose metabolism and nucleotide sugars.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Galactose 1-phosphate Potassium saltCat. No.: HY-113143A

Galactose 1-phosphate Potassium salt is is anintermediate in the galactose metabolism andnucleotide sugars.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Gallic acid (3,4,5-Trihydroxybenzoic acid) Cat. No.: HY-N0523

Gallic acid is an antioxidant which can inhibitboth .COX-2

Purity: 99.85%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Gamma-Linolenic acid (γ-Linolenic acid) Cat. No.: HY-N7140

Gamma-linolenic acid (γ-Linolenic acid) is anomega-6 (n-6), 18 carbon (18C-) polyunsaturatedfatty acid (PUFA) extracted from human milk andseveral botanical seed oils. Gamma-linolenic acidsupplements could restore needed PUFAs andmitigate the disease.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mg, 50 mg

76 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Ganoderic acid ACat. No.: HY-N1447

Ganoderic acid A can inhibit of the JAK-STAT3signaling pathway, also inhibit proliferation,viability, ROS.

Purity: 99.84%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg, 25 mg

GarcinolCat. No.: HY-107569

Garcinol, a polyisoprenylated benzophenoneharvested from , exertsGarcinia indicaanti-cholinesterase properties towards acetyl

and cholinesterase (AChE) butyrylcholinesterase with s of 0.66 µM and 7.39 µM,(BChE) IC50

respectively.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg

GDP-α-D-mannose disodiumCat. No.: HY-N7389B

GDP-α-D-mannose disodium is the donor substratefor mannosyltransferases and the precursor ofGDP-β-L-fucose. GDP-α-D-mannose disodium gives acompetitive inhibition with respect to GTP (K 14.7i

μM) and an uncompetitive inhibition with respectto mannose-1-P (K 115 μM).i

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Geniposidic acidCat. No.: HY-N0010

Geniposidic acid is an effective anticancer andradioprotection agent. Target: Others Mice weregiven an intraperitoneal injection of Geniposidicacid (GA) (12.5, 25, 50 mg/kg) 1 h beforereceiving GA against d-galactosamine (GalN) (800mg/kg)/LPS (40 μg/kg).

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

Genistein (NPI 031L) Cat. No.: HY-14596

Genistein, a soy isoflavone, is a multiple tyrosine (e.g., ) inhibitor which acts as akinases EGFR

chemotherapeutic agent against different types ofcancer, mainly by altering , the cellapoptosiscycle, and angiogenesis and inhibiting metastasis.

Purity: 99.68%Clinical Data: Phase 4Size: 10 mM × 1 mL, 100 mg, 500 mg

GeraniolCat. No.: HY-N6952

Geraniol, an olefinic terpene, was found toinhibit growth of andCandida albicans

strains.Saccharomyces cerevisiae

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Ginkgolide A (BN-52020) Cat. No.: HY-B0355

Ginkgolide A (BN-52020) is an extract from inGinkgo biloba and a g-aminobutyric acid (GABA)antagonist.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Ginkgolide B (BN-52021) Cat. No.: HY-N0784

Ginkgolide B (BN-52021), an important activeterpenoid from Ginkgo biloba leaves, is reportedto increase cell viability and decrease cellapoptosis.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Ginkgolide C (BN-52022; Ginkgolide-C) Cat. No.: HY-N0785

Ginkgolide C is a flavone isolated from Ginkgo leaves, possessing multiple biologicalbiloba

functions, such as decreasing platelet aggregationand ameliorating Alzheimer disease.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Ginsenoside F1 (20(S)-Ginsenoside F1) Cat. No.: HY-N0598

Ginsenoside F1, an enzymatically modifiedderivative of Ginsenoside Rg1, demonstratescompetitive inhibition of activity andCYP3A4weaker inhibition of CYP2D6 activity.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg

www.MedChemExpress.com 77

 

Ginsenoside F2Cat. No.: HY-125848

Ginsenoside F2, a metabolite from Ginsenoside Rb1,induces apoptosis accompanied by protectiveautophagy in breast cancer stem cells.

Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 20 mg

Ginsenoside Rb2 (Ginsenoside C) Cat. No.: HY-N0040

Ginsenoside Rb2 is one of the main bioactivecomponents of ginseng extracts. Rb2 can upregulate

gene expression. Ginsenoside Rb2 hasGPR120antiviral effects.

Purity: 98.26%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Ginsenoside Rd (Gypenoside VIII) Cat. No.: HY-N0043

Ginsenoside Rd inhibits TNFα-induced NF-κBtranscriptional activity with an ofIC50

12.05±0.82 μM in HepG2 cells. Ginsenoside Rdinhibits expression of and mRNA.COX-2 iNOSGinsenoside Rd also inhibits influx.Ca2+

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Ginsenoside Re (Ginsenoside B2; Panaxoside Re; Sanchinoside Re) Cat. No.: HY-N0044

Ginsenoside Re (Ginsenoside B2) is an extract from. Ginsenoside Re decreases thePanax notoginseng

protein ( ). Ginsenoside Re plays aβ-amyloid Aβrole in antiinflammation through inhibition of

and .JNK NF-κB

Purity: 98.04%Clinical Data: Phase 1Size: 10 mM × 1 mL, 5 mg, 10 mg

Ginsenoside Rf (Panaxoside Rf) Cat. No.: HY-N0601

Ginsenoside Rf is a trace component of ginsengroot. Ginsenoside Rf inhibits N-type Ca2+

.channel

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Ginsenoside Rh1 (Prosapogenin A2; Sanchinoside B2; Sanchinoside Rh1) Cat. No.: HY-N0604

Ginsenoside Rh1 (Prosapogenin A2; Sanchinoside B2;Sanchinoside Rh1) is isolated from the root of

. Ginsenoside Rh1 inhibits thePanax Ginsengexpression of , , , and .PPAR-γ TNF-α IL-6 IL-1β

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Ginsenoside Rh2 (20(S)-Ginsenoside Rh2; 20(S)-Rh2; Ginsenoside-Rh2) Cat. No.: HY-N0605

Ginsenoside Rh2 is isolated from the root of. Ginsenoside Rh2 induces the activation ofGinseng

and . Ginsenoside Rh2 inducescaspase-8 caspase-9cancer cell in a multi-path manner.apoptosis

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Glucagon-Like Peptide (GLP) II, humanCat. No.: HY-P1841

Glucagon-Like Peptide (GLP) II, human is a33-amino acid peptide derived from the C-terminalof proglucagon and mainly produced by theintestinal L cells. Glucagon-Like Peptide (GLP)II, human stimulates intestinal mucosal growth anddecreases apoptosis of enterocytes .

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Gluconate sodium (D-Gluconic acid sodium salt; Sodium

D-gluconate; D-Gluconate sodium salt) Cat. No.: HY-B1092A

Gluconate sodium (D-Gluconic acid sodium salt) isa corrosion and scale inhibitor of ordinary steelin simulated cooling water.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Glucosamine (D-Glucosamine; Chitosamine) Cat. No.: HY-B1125

Glucosamine (D-Glucosamine) is an amino sugar anda prominent precursor in the biochemical synthesisof glycosylated proteins and lipids, is used as adietary supplement.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

78 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Glucosamine hydrochloride (D-(+)-Glucosamine hydrochloride;

Chitosamine hydrochloride) Cat. No.: HY-N0733

Glucosamine hydrochloride (D-Glucosaminehydrochloride) is an amino sugar and a prominentprecursor in the biochemical synthesis ofglycosylated proteins and lipids, is used as adietary supplement.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

Glucosamine sulfate (D-Glucosamine sulfate) Cat. No.: HY-N0487

Glucosamine sulfate (D-Glucosamine sulfate) is anamino sugar and a prominent precursor in thebiochemical synthesis of glycosylated proteins andlipids, is used as a dietary supplement.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Glutaric acidCat. No.: HY-W008820

Glutaric acid, C5 dicarboxylic acid, is anintermediate during the catabolic pathways oflysine and tryptophan. Glutaric acid affectspericyte contractility and migration. Glutaricacid is an indicator of glutaric aciduria type I.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

GlutarylcarnitineCat. No.: HY-113005

Glutarylcarnitine is the diagnostic metabolite formalonic aciduria and glutaric aciduria type Imonitored in most tandem mass spectrometry newbornscreening programmes.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Glutathione oxidized (L-Glutathione oxidized; GSSG) Cat. No.: HY-D0844

Glutathione oxidized is produced by the oxidationof glutathione which is a major intracellularantioxidant and detoxifying agent.

Purity: 98.34%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Glycerol (Glycerin) Cat. No.: HY-B1659

Glycerol is a clear, colourless, viscous,sweet-tasting liquid. Glycerol is used in samplepreparation and gel formation for polyacrylamidegel electrophoresis.

Purity: >99.0%Clinical Data: LaunchedSize: 100 mL

Glycerophosphoric acid disodium salt hydrateCat. No.: HY-126304

Glycerophosphoric acid disodium salt hydrate is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

GlycineCat. No.: HY-Y0966

Glycine is an inhibitory neurotransmitter in theCNS and also acts as a co-agonist along withglutamate, facilitating an excitatory potential atthe glutaminergic N-methyl-D-aspartic acid

receptors.(NMDA)

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

Glycochenodeoxycholic acid (Chenodeoxycholylglycine) Cat. No.: HY-N2334

Glycochenodeoxycholic acid(Chenodeoxycholylglycine) is a bile acid formed inthe liver from chenodeoxycholate and glycine. Itacts as a detergent to solubilize fats forabsorption and is itself absorbed.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

Glycochenodeoxycholic acid sodium salt(Chenodeoxycholylglycine sodium salt; …) Cat. No.: HY-N2334A

Glycochenodeoxycholic acid sodium salt(Chenodeoxycholylglycine sodium salt) is a bileacid formed in the liver from chenodeoxycholateand glycine. It acts as a detergent to solubilizefats for absorption and is itself absorbed.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 79

 

Glycocholic acidCat. No.: HY-N1423

Glycocholic acid is a bile acid with anticanceractivity, targeting against pumpresistance-related and non-pump resistance-relatedpathways.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 50 mg

Glycocyamine (Guanidinoacetic acid) Cat. No.: HY-W021448

Glycocyamine (Guanidinoacetic acid), a precursorof creatine, is a replacement of dietary arginineand could support overall energy homeostasis ofthe bird.

Purity: >97.0%Clinical Data: No Development ReportedSize: 100 mg

Glycodeoxycholate Sodium (Sodium glycyldeoxycholate) Cat. No.: HY-N1427

Glycodeoxycholate Sodium is a bile salt.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Glycodeoxycholic AcidCat. No.: HY-125731

Glycodeoxycholic Acid is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

GlycogenCat. No.: HY-113511

Glycogen is a glycolytic intermediates andhigh-energy phosphates that can serve as a form ofenergy storage in humans, animals, fungi, andbacteria.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

Glycohyodeoxycholic acidCat. No.: HY-126995

Glycohyodeoxycholic acid is a major metabolite ofHyodeoxycholic acid in humans. Glycohyodeoxycholicacid has preventative effects on gallstoneformation.

Purity: 98.06%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Glycolic acidCat. No.: HY-W015967

Glycolic acid is an inhibitor of ,tyrosinasesuppressing melanin formation and lead to alightening of skin colour.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Glycoursodeoxycholic acid (Ursodeoxycholylglycine) Cat. No.: HY-N1424

Glycoursodeoxycholic acid, a acyl glycine and abile acid-glycine conjugate, is a metabolite ofursodeoxycholic acid.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Glycyl-L-valineCat. No.: HY-W016785

Glycyl-L-valine is a dipeptide that containsglycine and valine.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

GlycylglycineCat. No.: HY-D0889

Glycylglycine is the simplest of all peptides andcould function as a gamma-glutamyl acceptor.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

80 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Glyoxalic acid (NSC 27785; Formylformic acid; Oxalaldehydic acid) Cat. No.: HY-79494

Glyoxalic acid (NSC 27785) is an organic compoundthat is both an aldehyde and a carboxylic acid.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg, 1 g

Guaiacol (2-Methoxyphenol) Cat. No.: HY-N1380

Guaiacol, a phenolic compound isolated from Guaiacresin, inhibits LPS-stimulated expressionCOX-2and activation. Anti-inflammatory activity.NF-κB

Purity: 99.70%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

GuaiazuleneCat. No.: HY-N6951

Guaiazulene is present in several essential oilsof medicinal and aromatic plants, with antioxidantactivity. Guaiazulene has in vitro cytotoxicactivity against neuron and N2a neuroblastom(N2a-NB) cells.

Purity: >98.0%Clinical Data: LaunchedSize: 5 mg

Guanidine hydrochloride (Guanidinium chloride; Aminoformamidine hydrochloride) Cat. No.: HY-B0178A

Guanidine hydrochloride (Guanidinium chloride) astrong chaotrope, is also a strong denaturant ofproteins.

Purity: >99.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 10 g, 50 g

Guanidinosuccinic acidCat. No.: HY-113373

Guanidinosuccinic acid is a nitrogenous metaboliteisolated in excess from serum and urine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

GuanineCat. No.: HY-Y1055

Guanine is one of the fundamental components ofnucleic acids ( and ). Guanine is a purineDNA RNAderivative, consisting of a fusedpyrimidine-imidazole ring system with conjugateddouble bonds.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

Guanosine (DL-Guanosine; Vernine) Cat. No.: HY-N0097

Guanosine (DL-Guanosine) is a purine nucleosidecomprising guanine attached to a ribose(ribofuranose) ring via a β-N9-glycosidic bond.Guanosine possesses anti- activity.HSV

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Guanosine 5'-diphosphateCat. No.: HY-113066

Guanosine 5'-diphosphate is a nucleosidediphosphate. Guanosine 5'-diphosphate is apotential iron mobilizer, which prevents thehepcidin-ferroportin interaction and modulatingthe interleukin-6 (IL-6)/stat-3 pathway.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Guanosine 5'-diphosphate disodium saltCat. No.: HY-113066A

Guanosine 5'-diphosphate disodium salt is anucleoside diphosphate. Guanosine 5'-diphosphateis a potential iron mobilizer, which prevents thehepcidin-ferroportin interaction and modulatingthe interleukin-6 (IL-6)/stat-3 pathway.

Purity: >90.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Guanosine 5'-triphosphate trisodium salt (5'-GTP trisodium salt) Cat. No.: HY-12695

Guanosine 5'-triphosphate trisodium salt (5'-GTPtrisodium salt) is an activator of the signaltransducing which are involved inG proteinsvarious cellular processes includingproliferation, differentiation, and activation ofseveral intracellular kinase cascades.

Purity: 99.27%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg, 200 mg, 500 mg, 1 g

www.MedChemExpress.com 81

 

Guanosine-5'-triphosphate disodium salt (5'-GTP disodium salt) Cat. No.: HY-W010737

Guanosine-5'-triphosphate disodium salt (5'-GTPtrisodium salt) is an activator of the signaltransducing G proteins and also serves as anenergy-rich precursor of mononucleotide units inthe enzymatic biosynthesis of DNA and RNA.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Guanylin(human)Cat. No.: HY-P1179

Guanylin(human), a 15-amino acid peptide, is anendogenous activator.intestinal guanylate cyclase

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Guanylin(human) TFACat. No.: HY-P1179A

Guanylin(human) TFA, a 15-amino acid peptide, isan endogenous intestinal guanylate cyclaseactivator.

Purity: 97.45%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Gynostemma Extract (Ginsenoside C-Mx1; Gynosaponin I; Gypenoside IX) Cat. No.: HY-N0167

Gynostemma Extract (Ginsenoside C-Mx1) is anatural product.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

Gypenoside XVII (Gynosaponin S) Cat. No.: HY-N0553

Gypenoside XVII, a novel phytoestrogen belongingto the gypenosides, can activate estrogen

.receptors

Purity: 99.63%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

H-Abu-OHCat. No.: HY-W010589

H-Abu-OH, one of the three isomers of aminobutyricacid, is elevated in the plasma of children withwith Reye's syndrome, tyrosinemia, homocystinuria,nonketotic hyperglycinemia, and ornithinetranscarbamylase deficiency.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

H-Arg-Lys-OHCat. No.: HY-126487

H-Arg-Lys-OH is a dipeptide formed from L-arginyland L-lysine residues.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

H-Arg-Lys-OH TFACat. No.: HY-126487A

H-Arg-Lys-OH TFA is a dipeptide formed fromL-arginyl and L-lysine residues.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

H-D-cis-Hyp-OHCat. No.: HY-W008129

cis-4-Hydroxy-D-proline is a precursor ofconformationally restricted PNA adenine monomer.cis-4-Hydroxy-D-proline can be used to study thespecificity and kinetics of D-alaninedehydrogenase.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

H-D-Trp-OHCat. No.: HY-W012479

H-D-Trp-OH is a D-stereoisomer of tryptophan andoccasionally found in naturally produced peptidessuch as the marine venom peptide.

Purity: 99.69%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

82 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

H-Gly-Pro-OHCat. No.: HY-W016887

H-Gly-Pro-OH is an end product of collagenmetabolism that is further cleaved by prolidase.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

H-His-OH.HCl.H2OCat. No.: HY-W014423

H-His-OH.HCl.H2O is an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

H-HoArg-OHCat. No.: HY-W008385

H-HoArg-OH, a homologue arginine, is a stronginhibitor of human bone and liver alkaline

.phosphatase

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

H-HomoArg-OH.HClCat. No.: HY-W012340

H-HomoArg-OH.HCl is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 250 mg

H-HoPro-OHCat. No.: HY-W012734

H-HoPro-OH is a breakdown product of lysine,accumulates in body fluids of infants withgeneralized genetic peroxisomal disorders, such asZellweger syndrome, neonatal adrenoleukodystrophy.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

H-Phe-Phe-OHCat. No.: HY-W007970

H-Phe-Phe-OH is a peptide made of twophenylalanine molecules; Phenylalanine is anessential amino acid and the precursor for theamino acid tyrosine.

Purity: 97.79%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

H-Ser-His-OHCat. No.: HY-126488

H-Ser-His-OH is a short peptide with hydrolysiscleavage activity, an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

H-Trp-NH2.HClCat. No.: HY-W008766

H-Trp-NH2.HCl is an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

H-Tyr(3-I)-OHCat. No.: HY-W008452

H-Tyr(3-I)-OH is a potent and effective tyrosine inhibitor. H-Tyr(3-I)-OH is anhydroxylase

intermediate in the production of thyroid hormonesand has a role as a human or mouse metabolite.

Purity: 99.75%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

H-Val-Ala-OH (Valyl-alanine) Cat. No.: HY-W007035

H-Val-Ala-OH (Valyl-alanine) is a dipeptide formedfrom L-Valine and L-Alanine residues. H-Val-Ala-OHhas a role as a metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

www.MedChemExpress.com 83

 

H-Val-Tyr-OH (Valyl-tyrosine) Cat. No.: HY-W009338

H-Val-Tyr-OH is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

Hematoporphyrin (Hematoporphyrin IX) Cat. No.: HY-B0754

Hematoporphyrin (Hematoporphyrin IX) is asubstrate for affinity chromatography ofheme-binding proteins.

Purity: >98.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg

Heneicosanoic acidCat. No.: HY-121447

Heneicosanoic acid is a long-chain saturated fattyacid which is found in plants and animals.

Purity: >95.0%Clinical Data: No Development ReportedSize: 500 mg

Heparan SulfateCat. No.: HY-101916

Heparan sulfate, a complex and linearpolysaccharide, exists as part of glycoproteinsnamed heparan sulfate proteoglycans, which areexpressed abundantly on the cell surface and inthe extracellular matrix.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg

HeparinCat. No.: HY-17567

Heparin is a highly sulfatedglycosaminoglycan,that is widely used as aninjectable anticoagulant, and has the highestnegative charge density of any known biologicalmolecule. Heparin significantly inhibitsexosome-cell interactions.

Purity: >98%Clinical Data: LaunchedSize: 10 mg(10 mg × mL in Water)

Heptadecanoic acidCat. No.: HY-W004284

Heptadecanoic acid is an odd chain saturated fattyacid (OCS-FA). Heptadecanoic acid is associatedwith several diseases, including the incidence ofcoronary heart disease, prediabetes and type 2diabetes as well as multiple sclerosis.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Hesperidin (Hesperetin 7-rutinoside) Cat. No.: HY-15337

Hesperidin (Hesperetin 7-rutinoside), a flavanoneglycoside, is isolated from citrus fruits.Hesperidin has numerous biological properties,such as decreasing inflammatory mediators andexerting significant antioxidant effects.

Purity: 97.00%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g

Hexacosanoic acidCat. No.: HY-113301

Hexacosanoic acid is a long-chain fatty acidrelated to various diseases such asadrenoleukodystrophy (ALD), adrenomyeloneuropathy(AMN) and atherosclerosis.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg, 250 mg

Hexadecanal (Palmitaldehyde) Cat. No.: HY-W004305

Hexadecanal (Palmitaldehyde) is a free fattyaldehyde present in animals.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

Hexadecanedioic acidCat. No.: HY-W018161

Hexadecanedioic acid is covalently linked toSepharose 4B, shows better performance in terms ofspecificity than dye-based resins and could beused for depletion of SA from plasma samples.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

84 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Hippuric acid (2-Benzamidoacetic acid) Cat. No.: HY-W016562

Hippuric Acid (2-Benzamidoacetic acid), an acylglycine produced by the conjugation of benzoicacid and glycine, is a normal component in urineas a metabolite of aromatic compounds from food.

Purity: 99.21%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

HispidinCat. No.: HY-100618

Hispidin, a inhibitor and a phenolic compoundPKCfrom , has been shown to possessPhellinus linteusstrong anti-oxidant, anti-cancer, anti-diabetic,and anti-dementia properties.

Purity: 99.57%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Histamine (Ergamine) Cat. No.: HY-B1204

Histamine is an organic nitrogenous compoundinvolved in local immune responses as well asregulating physiological function in the gut andacting as a neurotransmitter.

Purity: 99.96%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Histamine dihydrochlorideCat. No.: HY-B0722

Histamine dihydrochloride is an endogenousmetabolite.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

Homogentisic acidCat. No.: HY-113283

Homogentisic acid is a specific metabolite inurine and serum, which is used for diagnosis ofalkaptonuria.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Homovanillic acid (Vanilacetic acid) Cat. No.: HY-N0384

Homovanillic acid is a dopamine metabolite foundto be associated with aromatic L-amino aciddecarboxylase deficiency, celiac disease, growthhormone deficiency, and sepiapterin reductasedeficiency.

Purity: 98.29%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Hyaluronic acid (Hyaluronate) Cat. No.: HY-B0633A

Hyaluronic acid (corn fermented) is a biopolymercomposed of repeating units of disaccharides withvarious applications.

Purity: >98%Clinical Data: LaunchedSize: 50 mg, 100 mg, 200 mg, 500 mg, 1 g

Hydrocinnamic acid (3-Phenylpropionic acid; 3-Phenylpropanoic

acid; 3-Phenyl-n-propionic acid) Cat. No.: HY-Y1088

Hydrocinnamic acid is the major rhizosphericcompound with known growth regulatory activities.

Purity: 99.97%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Hydrocortisone (Cortisol) Cat. No.: HY-N0583

Hydrocortisone (Cortisol) is a steroid hormone orglucocorticoid secreted by the adrenal cortex.

Purity: 99.90%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Hydrocortisone acetate (Hydrocortisone 21-acetate; Cortisol 21-acetate) Cat. No.: HY-B1183

Hydrocortisone acetate is a corticosteroid, usedto decrease swelling, itching, and pain that iscaused by minor skin irritations or byhemorrhoids.

Purity: 99.23%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 85

 

Hydroxy bosentan (Ro 48-5033) Cat. No.: HY-121385

Hydroxy bosentan (Ro 48-5033) is a primarymetabolite of Bosentan (BOS) metabolized by thecytochrome P450 system in the liver. Ro 48-5033assists BOS pharmacologically, retaining 10%-20%activities.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Hydroxy-α-sanshoolCat. No.: HY-N6825

Hydroxy-α-sanshool is an alkylamide isolatedfrom , acts as a covalent and pepper TRPA1 TRPV1non-covalent agonist, with s of 69 and 1.1EC50

µM, respectively.

Purity: 99.13%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

HydroxyacetoneCat. No.: HY-Y1366

Hydroxyacetone is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

HydroxycotinineCat. No.: HY-113239

Hydroxycotinine is the main nicotine metabolitedetected in smokers urine.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 1 mg

HydroxyphenylacetylglycineCat. No.: HY-113210

Hydroxyphenylacetylglycine is an acyl glycine, andan endogenous human metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Hydroxyphenyllactic acidCat. No.: HY-113219

Hydroxyphenyllactic acid is an antifungalmetabolite.

Purity: 99.19%Clinical Data:Size: 1 mg, 5 mg

Hydroxypyruvic acid (β-Hydroxypyruvic acid; 3-Hydroxypyruvic acid) Cat. No.: HY-113013

Hydroxypyruvic acid (β-Hydroxypyruvic acid) is an in the metabolism of glycine,intermediate

serine and threonine. Hydroxypyruvic acid is a for serine-pyruvate aminotransferasesubstrate

and glyoxylate reductase/hydroxypyruvatereductase.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Hydroxypyruvic acid lithium hydrate (β-Hydroxypyruvic acid

lithium hydrate; 3-Hydroxypyruvic acid lithium hydrate) Cat. No.: HY-113013A

Hydroxypyruvic acid lithium hydrate(β-Hydroxypyruvic acid lithium hydrate) is an

in the metabolism of glycine,intermediateserine and threonine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Hydroxytyrosol (DOPET; 3,4-Dihydroxyphenethyl alcohol; 3-Hydroxytyrosol) Cat. No.: HY-N0570

Hydroxytyrosol (DOPET) is a phenolic compounddrawn from the olive tree and its leaves withanti-oxidant, anti-atherogenic, anti-thrombotic,antimicrobial, anti-inflammatory and anti-tumoureffects.

Purity: 99.82%Clinical Data: Phase 4Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Hyodeoxycholic acid (HDCA) Cat. No.: HY-N0169

Hyodeoxycholic acid is a secondary bile acidformed in the small intestine by the gut flora,and acts as a agonist, with anTGR5 (GPCR19)

of 31.6 µM in CHO cells.EC50

Purity: >99.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

86 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Hypotaurine (2-Aminoethanesulfinic acid) Cat. No.: HY-100803

Hypotaurine (2-aminoethanesulfinic acid), anintermediate in taurine biosynthesis from cysteinein astrocytes, is an endogenous inhibitory aminoacid of the .glycine receptor

Purity: 99.69%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

Hypoxanthine (Purin-6-ol; Sarcine) Cat. No.: HY-N0091

Hypoxanthine, a purine derivative, is a potentialfree radical generator and could be used as anindicator of hypoxia.

Purity: 99.94%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

i-Inositol (myo-Inositol; meso-Inositol) Cat. No.: HY-B1411

i-Inositol is a chemical compound, associatedlipids are found in many foods, in particularfruit, especially cantaloupe and oranges.

Purity: >99.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

Iberin (NSC 321801) Cat. No.: HY-101413

Iberin, a sulfoxide analogue of sulforaphane, is anaturally occurring member of isothiocyanatefamily. It inhibits cell survival with an ofIC50

2.3 μM in HL60 cell.

Purity: 98.00%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Imidazol-1-yl-acetic acidCat. No.: HY-W010448

Imidazol-1-yl-acetic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Imidazoleacetic acid (Imidazolyl-4-acetic acid) Cat. No.: HY-113413

Imidazoleacetic acid is an endogenous ligand thatstimulates .imidazole receptors

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Imidazoleacetic acid hydrochloride (Imidazolyl-4-acetic acid hydrochloride) Cat. No.: HY-W007686

2-(1H-Imidazol-5-yl)acetic acid hydrochloride isan endogenous metabolite.

Purity: 99.65%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Impulsin (AM 3112; Loramine P 256; Mackpeart DR 14V) Cat. No.: HY-20685

Impulsin (AM 3112) is an active endogenouscompound which can used for preventing virusinfection of the respiratory tract.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

IndoleCat. No.: HY-W001132

Indole is an endogenous metabolite.

Purity: 99.67%Clinical Data: Phase 2Size: 10 mM × 1 mL, 100 mg

Indole-2-carboxylic acidCat. No.: HY-I0096

Indole-2-carboxylic acid is a strong inhibitor of. Indole-2-carboxylic acid (I2CA)lipid peroxidation

specifically and competitively inhibits thepotentiation by glycine of -gated current.NMDA

Purity: 99.85%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

www.MedChemExpress.com 87

 

Indole-3-acetamideCat. No.: HY-W016784

Indole-3-acetamide is a biosynthesis intermediateof indole-3-acetic acid (HY-18569).Indole-3-acetic acid is the most common naturalplant growth hormone of the auxin class.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

Indole-3-butyric acid (3-indolebutyric acid) Cat. No.: HY-N0186

Indole-3-butyric acid (3-indolebutyric acid; IBA)is a plant growth auxin and a good rooting agent.It can promote herbs and woody ornamental plantrooting and used for improving fruit rate.

Purity: 99.39%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g, 10 g

Indole-3-carbinol (I3C; 3-Indolemethanol) Cat. No.: HY-N0170

Indole-3-carbinol (I3C) inhibits activityNF-κBand also is an ( )Aryl hydrocarbon receptor AhRagonist, and an inhibitor of (WWWWP1domain-containing ubiquitin E3 ligase 1).

Purity: >98.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 200 mg, 1 g

Indole-3-carboxylic acidCat. No.: HY-40161

Indole-3-carboxylic acid is a normal urinaryindolic tryptophan metabolite and has been foundelevated in patients with liver diseases.

Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Indole-3-methanamineCat. No.: HY-33893

Indole-3-methanamine is a potential biomarker forthe consumption of these foods such as barley,cereals, and cereal product.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

Indolelactic acidCat. No.: HY-113099

Indolelactic acid is a tryptophan (Trp) catabolitein cultures.Azotobacter vinelandii

Purity: 98.42%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

InosineCat. No.: HY-N0092

Inosine, an endogenous purine nucleoside, hasimmunomodulatory, neuroprotective, and analgesicproperties.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 10 g, 25 g, 100 g

Inosine 5'-monophosphate disodium salt hydrateCat. No.: HY-108213A

Inosine 5'-monophosphate disodium salt hydrate isan endogenous metabolite.

Purity: 99.87%Clinical Data: No Development ReportedSize: 100 mg

Inosine-5'-triphosphate trisodium saltCat. No.: HY-W013706

Inosine-5'-triphosphate trisodium salt is anucleoside triphosphate and functions as ansubstrate for ATPases and GTPases.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Inosinic acid (5'-IMP; IMP; Inosine 5'-dihydrogen phosphate) Cat. No.: HY-108213

Inosinic acid is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

88 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

IretolCat. No.: HY-13938

Iretol (2,4,6-trihydroxyanisole) is a adegradation product of a glucoside obtained fromIris Jorentina. Iretol is an intermediate in thesynthesis of natural isoflavones, such asTectorigenin, Irigenin and Caviunin.

Purity: 99.34%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg, 50 mg, 100 mg

Isethionic acid (2-Hydroxyethanesulfonic acid) Cat. No.: HY-Y0095

Isethionic acid (2-Hydroxyethanesulfonic acid) isan organosulfur compound. Isethionic acid iswidely distributed in animal species and in a fewred algal species. Isethionic acid can be used asan anionic detergent and has anti-settlementactivity against .Balanus amphitrite

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Isethionic acid sodium salt (Sodium

1-hydroxy-2-ethanesulfonate; …) Cat. No.: HY-Y1173

Isethionic acid sodium salt is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Isoalantolactone ((+)-Isoalantolactone; Isohelenin) Cat. No.: HY-N0780

Isoalantolactone is an inducer, whichapoptosisalso acts as an alkylating agent.

Purity: 99.99%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Isobutyryl-L-carnitineCat. No.: HY-113165

Isobutyryl-L-carnitine is a product of theacyl-CoA dehydrogenases.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Isobutyryl-L-carnitine chlorideCat. No.: HY-113165A

Isobutyryl-L-carnitine chloride is a product ofthe acyl-CoA dehydrogenases.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 100 mg

Isochlorogenic acid A (3,5-Dicaffeoylquinic acid; 3,5-CQA) Cat. No.: HY-N0056

Isochlorogenic acid A (3,5-Dicaffeoylquinic acid)is a natural phenolic acid with antioxidant andanti-inflammatory activities .

Purity: 99.53%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Isohomovanillic acid (3-Hydroxy-4-methoxyphenylacetic acid;

iso-HVA; Homoisovanillic acid) Cat. No.: HY-W002110

Isohomovanillic acid(3-Hydroxy-4-methoxyphenylacetic acid) isextracted from urine at pH 2 by ethyl acetate.Isohomovanillic acid is not found in appreciablevalues in many normal human urines.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Isomaltose (6-O-α-D-Glucopyranosyl-D-glucose; D-Isomaltose) Cat. No.: HY-N3018

Isomaltose is composed of two glucose units andsuitable as a non-cariogenic sucrose replacementand is favorable in products for diabetics andprediabetic dispositions.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Isonicotinic acidCat. No.: HY-I0736

Isonicotinic acid is a metabolite of Isoniazid.Isoniazid is converted to Isonicotinic acid byhydrazinolysis, with the Isoniazid to Isonicotinicacid biotransformation also to be catalyzed bycytochrome P450 (CYP) enzymes, e.g., CYP2C.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

www.MedChemExpress.com 89

 

Isoprenaline hydrochloride (Isoproterenol hydrochloride) Cat. No.: HY-B0468

Isoprenaline hydrochloride is a non-selective agonist with potentbeta-adrenergic receptor

peripheral vasodilator, bronchodilator, andcardiac stimulating activities.

Purity: >99.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 200 mg, 1 g

Isorhamnetin (3'-Methylquercetin) Cat. No.: HY-N0776

Isorhamnetin is a flavonoid compound extractedfrom the Chinese herb L..Hippophae rhamnoidesIsorhamnetin suppresses skin cancer through directinhibition of and .MEK1 PI3K

Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg

Isotretinoin (13-cis-Retinoic acid) Cat. No.: HY-15127

Isotretinoin(13-cis-Retinoic acid) is a medicationused for the treatment of severe acne. It wasfirst developed to be used as a chemotherapymedication for the treatment of brain cancer,pancreatic cancer and more.

Purity: 99.88%Clinical Data: LaunchedSize: 100 mg, 500 mg

IsovalerylcarnitineCat. No.: HY-113221

Isovalerylcarnitine is a product of the catabolismof L-leucine. It increases calpain activity.

Purity: >99.0%Clinical Data:Size: 5 mg

Itaconic acidCat. No.: HY-Y0520

Itaconic acid, a precursor of polymers, chemicals,and fuels, can be synthesized by many fungi.Itaconic acid also is a macrophage-specificmetabolite. Itaconic acid mediates crosstalkbetween macrophage metabolism and peritonealtumors.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

JBSNF-000088 (6-Methoxynicotinamide) Cat. No.: HY-112584

JBSNF-000088 (6-Methoxynicotinamide), a analog ofnicotinamide (NA), is a potent Nicotinamide

inhibitor with sN-methyltransferase (NNMT) IC50

of 1.8 µM, 2.8 µM, and 5.0µM for human NNMT,monkey NNMT and mouse NNMT, respectively.

Purity: 99.52%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Kaempferol (Kempferol; Robigenin) Cat. No.: HY-14590

Kaempferol (Kempferol), a flavonoid found in manyedible plants, inhibits estrogen receptor αexpression in breast cancer cells and inducesapoptosis in glioblastoma cells and lung cancercells by activation of MEK-MAPK. Kaempferol can beuesd for the research of breast cancer.

Purity: 99.62%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg, 200 mg, 500 mg

KSD 2405Cat. No.: HY-78446

KSD 2405 is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Kynurenic acid (Quinurenic acid) Cat. No.: HY-100806

Kynurenic acid, an endogenous tryptophanmetabolite, is a broad-spectrum antagonisttargeting <b >NMDA, glutamate, α7 nicotinicacetylcholine receptor. Kynurenic acid is also anagonist of .GPR35/CXCR8

Purity: 98.75%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg, 500 mg

L-(+)-ArabinoseCat. No.: HY-W015611

L-(+)-Arabinose selectively inhibits intestinalsucrase activity in a noncompetitive manner andsuppresses the plasma glucose increase due tosucrose ingestion.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

90 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

L-2-Hydroxyglutaric acid ((S)-2-Hydroxyglutaric acid) Cat. No.: HY-113039

L-2-Hydroxyglutaric acid is an epigenetic modifierand putative oncometabolite in renal cancer.L-2-Hydroxyglutaric acid can inhibit histone

and hence promote histonedemethylasesmethylation.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

L-5-Hydroxytryptophan (L-5-HTP; Oxitriptan) Cat. No.: HY-B1716

L-5-Hydroxytryptophan (L-5-HTP), a naturallyoccurring amino acid and a dietary supplement foruse as an antidepressant, appetite suppressant,and sleep aid, is the immediate precursor of theneurotransmitter serotonin and a reserpineantagonist.

Purity: 99.75%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

L-Alanine (L-2-Aminopropionic acid) Cat. No.: HY-N0229

L-Alanine is a non-essential amino acid, involvedin sugar and acid metabolism, increases immunity,and provides energy for muscle tissue, brain, andcentral nervous system.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 500 mg, 5 g

L-Alanyl-L-glutamineCat. No.: HY-W014102

L-Alanyl-L-glutamine, a glutamine dipeptide, isbenefit for the antioxidant system, attenuatinginflammation, and may modulate the heat shockprotein (HSP) response in catabolic situations.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

L-Alanyl-L-leucine (H-Ala-Leu-OH) Cat. No.: HY-W040088

L-Alanyl-L-leucine is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

L-Alloisoleucine ((3R)-LS-Isoleucine; L-Allo-isoleucine) Cat. No.: HY-I1060

L-Alloisoleucine is a branched chain amino acidand is a stereo-isomer of L-isoleucine.L-Alloisoleucine is a common constituent of humanplasma (albeit at low levels).

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg

L-Allothreonine (H-allo-Thr-OH) Cat. No.: HY-W008315

L-Allothreonine (H-allo-Thr-OH) is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

L-Anserine nitrateCat. No.: HY-W011393

L-Anserine nitrate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

L-ArabinitolCat. No.: HY-W040141

L-Arabinitol is a potential biomarker for thecomsuption of the food products such as sweetpotato, deerberry, moth bean, and is alsoassociated with Alzheimer's disease andribose-5-phosphate isomerase deficiency.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

L-Arginine ((S)-(+)-Arginine) Cat. No.: HY-N0455

L-Arginine ((S)-(+)-Arginine) is the substrate forthe endothelial nitric oxide synthase (eNOS) togenerate NO.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

www.MedChemExpress.com 91

 

L-Arginine hydrochloride ((S)-(+)-Arginine hydrochloride) Cat. No.: HY-N0455A

L-Arginine hydrochloride ((S)-(+)-Argininehydrochloride) is the nitrogen donor for synthesisof nitric oxide, a potent vasodilator that isdeficient during times of sickle cell crisis.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

L-Asparagine ((-)-Asparagine; Asn; Asparamide) Cat. No.: HY-N0667

L-Asparagine ((-)-Asparagine) is a non-essentialamino acid that is involved in the metaboliccontrol of cell functions in nerve and braintissue.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

L-Asparagine monohydrateCat. No.: HY-W017443

L-Asparagine monohydrate ((-)-Asparaginemonohydrate) is a non-essential amino acid that isinvolved in the metabolic control of cellfunctions in nerve and brain tissue.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

L-Aspartic acidCat. No.: HY-N0666

L-Aspartic acid is is an amino acid, shown to be asuitable prodrug for colon-specific drugdeliverly.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

L-Aspartic aicd sodium (Sodium L-aspartate) Cat. No.: HY-N0666C

L-Aspartic aicd sodium is is an amino acid, shownto be a suitable prodrug for colon-specific drugdeliverly.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

L-Azetidine-2-carboxylic acidCat. No.: HY-W050044

L-Azetidine-2-carboxylic acid is an endogenousmetabolite.

Purity: 99.78%Clinical Data: No Development ReportedSize: 500 mg

L-CanalineCat. No.: HY-129476

L-Canaline is a nonprotein amino acid stored inmany leguminous plants. L-Canaline is a cytotoxicmetabolite catalyzed by L-canavanine and itsarginase. L-Canaline is a potent and irreversibleinhibitor of .ornithine aminotransferase

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

L-Carnitine (Levocarnitine) Cat. No.: HY-B0399

L-Carnitine (Levocarnitine) is an endogenousmolecule involved in fatty acid metabolism,biosynthesized within the human body using aminoacids: L-lysine and L-methionine, as substrates.

Purity: >98.0%Clinical Data: LaunchedSize: 500 mg, 5 g, 10 g

L-Carnitine hydrochloride ((R)-Carnitine hydrochloride) Cat. No.: HY-B2246

L-Carnitine hydrochloride ((R)-Carnitinehydrochloride), a highly polar, small zwitterion,is an essential co-factor for the mitochondrialβ-oxidation pathway.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg

L-CarnosineCat. No.: HY-W013494

L-Carnosine is a dipeptide of the amino acidsbeta-alanine and histidine and has the potentialto suppress many of the biochemical changes thataccompany aging.

Purity: 99.81%Clinical Data: Phase 3Size: 10 mM × 1 mL, 100 mg

92 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

L-CitrullineCat. No.: HY-N0391

L-Citrulline is an amino acid derived fromornithine in the catabolism of proline orglutamine and glutamate, or from l-arginine viaarginine-citrulline pathway.

Purity: >97.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 500 mg, 1 g

L-CystathionineCat. No.: HY-W009749

L-Cystathionine is a nonprotein thioether and is akey amino acid associated with the metabolic stateof sulfur-containing amino acids. L-Cystathionineprotects against Homocysteine-inducedmitochondria-dependent apoptosis of vascularendothelial cells (HUVECs).

Purity: >99.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

L-Cysteic acid monohydrateCat. No.: HY-124009A

L-Cysteic acid monohydrate is an endogenousmetabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

L-CysteineCat. No.: HY-Y0337

L-Cysteine is a conditionally essential aminoacid, which acts as a precursor for biologicallyactive molecules such as hydrogen sulphide (H2S),glutathione and taurine. L-Cysteine suppressesghrelin and reduces appetite in rodents andhumans.

Purity: >97.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

L-Cysteine hydrochlorideCat. No.: HY-Y0337A

L-Cysteine hydrochloride is a conditionallyessential amino acid, which acts as a precursorfor biologically active molecules such as hydrogensulphide (H2S), glutathione and taurine.L-Cysteine hydrochloride suppresses ghrelin andreduces appetite in rodents and humans.

Purity: >97.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

L-Cysteine hydrochloride hydrateCat. No.: HY-W016715

L-Cysteine hydrochloride hydrate is aconditionally essential amino acid, which acts asa precursor for biologically active molecules suchas hydrogen sulphide (H2S), glutathione andtaurine.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

L-Cysteinesulfinic acidCat. No.: HY-100804

L-Cysteinesulfinic acid is a potent agonist atseveral rat metabotropic glutamate receptors( s) with pEC s of 3.92, 4.6, 3.9, 2.7,mGluR 50

4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4,mGluR6, and mGluR8, respectively.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

L-CystineCat. No.: HY-N0394

L-Cystine is an amino acid and intracellularthiol, which plays a critical role in theregulation of cellular processes.

Purity: >98.0%Clinical Data: LaunchedSize: 500 mg, 1 g

L-DABA (L-2,4-Diaminobutyric acid) Cat. No.: HY-101414

L-DABA (L-2,4-Diaminobutyric acid) is a week GABAtransaminase inhibitor with an of larger thanIC50

500 μM; exhibits antitumor activity and in vivo in.vitro

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

L-Dihydroorotic acidCat. No.: HY-W015495

L-Dihydroorotic acid can reversibly hydrolyze toyield the acyclic L-ureidosuccinic acid bydihydrowhey enzyme.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

www.MedChemExpress.com 93

 

L-DOPA (Levodopa; 3,4-Dihydroxyphenylalanine) Cat. No.: HY-N0304

L-DOPA (Levodopa) is an orally active metabolicprecursor of neurotransmitters dopamine. L-DOPAcan cross the blood-brain barrier and is convertedinto dopamine in the brain. L-DOPA hasanti-allodynic effects and the potential forParkinson's disease.

Purity: 99.97%Clinical Data: LaunchedSize: 200 mg, 1 g

L-Glutamine (L-Glutamic acid 5-amide) Cat. No.: HY-N0390

L-Glutamine (L-Glutamic acid 5-amide) is anon-essential amino acid present abundantlythroughout the body and involved in many metabolicprocesses. L-Glutamine provides a source ofcarbons for oxidation in some cells.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

L-Glutathione reduced (GSH; γ-L-Glutamyl-L-cysteinyl-glycine) Cat. No.: HY-D0187

L-Glutathione reduced (GSH;γ-L-Glutamyl-L-cysteinyl-glycine) is an endogenousantioxidant and is capable of scavengingoxygen-derived free radicals.

Purity: 99.83%Clinical Data: LaunchedSize: 500 mg, 1 g, 5 g

L-Glyceric acidCat. No.: HY-113377

L-Glyceric acid is a mainly urinary metaboliteaccumulating in rare inherited metabolic diseaseL-glyceric aciduria. L-Glyceric acid can be usedto diagnose primary hyperoxaluria type 2 (PH2).L-Glyceric acid excretion to distinguish PH1 fromPH2.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg

L-Glyceric acid sodiumCat. No.: HY-113377A

L-Glyceric acid sodium is a mainly urinarymetabolite accumulating in rare inheritedmetabolic disease L-glyceric aciduria. L-Glycericacid sodium can be used to diagnose primaryhyperoxaluria type 2 (PH2). L-Glyceric acid sodiumexcretion to distinguish PH1 from PH2.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

L-Gulono-1,4-lactoneCat. No.: HY-W016628

L-Gulono-1,4-lactone is a substrate ofL-gulono-1,4-lactone oxidoreductase, whichcatalyzes the last step of the biosynthesis ofL-ascorbic (Vatamin) C.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

L-HexanoylcarnitineCat. No.: HY-113144

L-Hexanoylcarnitine is an acylcarnitine and isfound to be associated with celiac disease.

Purity: >97.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

L-HistidineCat. No.: HY-N0832

L-Histidine is an essential amino acid forinfants. L-Histidine is an inhibitor of

.mitochondrial glutamine transport

Purity: 99.84%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

L-Histidinol dihydrochlorideCat. No.: HY-W014233

L-Histidinol dihydrochloride is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

L-HomocitrullineCat. No.: HY-W018004

L-Homocitrulline is metabolized to homoargininethrough homoargininosuccinate via the urea cyclepathway and its metabolic abnormality could leadto Lysinuric Protein Intolerance (LPI).

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

94 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

L-HomocysteineCat. No.: HY-W010347

L-Homocysteine, a homocysteine metabolite, is ahomocysteine that has L configuration.L-Homocysteine induces upregulation of cathepsin Vthat mediates vascular endothelial inflammation inhyperhomocysteinaemia.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg

L-HomocystineCat. No.: HY-W011690

L-Homocystine is the oxidized member of theL-homocysteine. Homocysteine is a pro-thromboticfactor, vasodilation impairing agent,pro-inflammatory factor and endoplasmaticreticulum-stress inducer used to studycardiovascular disease mechanisms.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

L-HomoserineCat. No.: HY-W002292

L-Homoserine is a non - protein amino acid, whichis an important biosynthetic intermediate ofthreonine, methionine and lysine.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

L-hydroxylysine dihydrochloride ((2S,5R)-5-Hydroxylysine dihydrochloride) Cat. No.: HY-113025A

L-hydroxylysine dihydrochloride((2S,5R)-5-Hydroxylysine dihydrochloride), anamino acid, is exclusive to collagen protein,which is formed by posttranslational hydroxylationof some lysine residues.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

L-HydroxyprolineCat. No.: HY-40135

L-Hydroxyproline, one of the hydroxyproline (Hyp)isomers, is a useful chiral building block in theproduction of many pharmaceuticals.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

L-IsoleucineCat. No.: HY-N0771

L-isoleucine is a nonpolar hydrophobic amino acid.L-Isoleucine is an essential amino acid.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

L-KynurenineCat. No.: HY-104026

L-Kynurenine is a metabolite of the amino acidL-tryptophan. L-Kynurenine is an aryl hydrocarbon

agonist.receptor

Purity: 99.85%Clinical Data: Phase 1Size: 10 mM × 1 mL, 50 mg

L-Lactic acid ((S)-2-Hydroxypropanoic acid) Cat. No.: HY-Y0479

L-Lactic acid is a buildiing block which can beused as a precursor for the production of thebioplastic polymer poly-lactic acid.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

L-LysineCat. No.: HY-N0469

L-lysine is an essential amino acid with importantroles in connective tissues and carnitinesynthesis, energy production, growth in children,and maintenance of immune functions.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

L-MethionineCat. No.: HY-N0326

L-Methionine is the L-isomer of Methionine, anessential amino acid for human development.Methionine acts as a hepatoprotectant.

Purity: 98.60%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

www.MedChemExpress.com 95

 

L-Methionine sulfoxide (H-Met(O)-OH) Cat. No.: HY-W010104

L-Methionine sulfoxide (H-Met(O)-OH), a metaboliteof Methionine, induces M1/classical macrophagepolarization, and modulates oxidative stress andpurinergic signaling parameters.

Purity: 99.57%Clinical Data: No Development ReportedSize: 500 mg

L-Norleucine ((S)-2-Aminohexanoic acid; (S)-Norleucine) Cat. No.: HY-Y0017

L-Norleucine ((S)-2-Aminohexanoic acid) is anisomer of leucine, specifically affects proteinsynthesis in skeletal muscle, and has antivirusactivity.

Purity: >98.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 500 mg, 1 g

L-NorvalineCat. No.: HY-Y0399

L-Norvaline is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

L-OctanoylcarnitineCat. No.: HY-113161

L-Octanoylcarnitine is the physiologically activeform of octanoylcarnitine.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

L-Ornithine ((S)-2,5-Diaminopentanoic acid) Cat. No.: HY-B1352

L-ornithine has an antifatigue effect inincreasing the efficiency of energy consumptionand promoting the excretion of ammonia.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

L-Ornithine hydrochlorideCat. No.: HY-W017018

L-Ornithine hydrochloride is a free amino acidthat plays a central role in the urea cycle and isalso important for the disposal of excessnitrogen.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

L-PalmitoylcarnitineCat. No.: HY-113147

L-Palmitoylcarnitine, a fatty acid metabolite,accumulates in the sarcolemma and deranges themembrane lipid environment during ischaemia.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mg, 50 mg

L-Phenylalanine ((S)-2-Amino-3-phenylpropionic acid) Cat. No.: HY-N0215

L-Phenylalanine ((S)-2-Amino-3-phenylpropionicacid) is an essential amino acid isolated from

. L-Phenylalanine is a Escherichia coli α2δ subunit antagonist withof voltage-dependent Ca channels+

a of 980 nM.Ki

Purity: 99.30%Clinical Data: LaunchedSize: 10 mM × 1 mL, 200 mg, 1 g

L-ProlineCat. No.: HY-Y0252

L-Proline is one of the twenty amino acids used inliving organisms as the building blocks ofproteins.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

L-ProlylglycineCat. No.: HY-WAA0142

L-Prolylglycine is an endogenous metabolite.

Purity: 99.01%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

96 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

L-Pyroglutamic acidCat. No.: HY-76082

L-Pyroglutamic acid is the levo-isomer ofPyroglutamic acid. L-Pyroglutamic acid is thebiologically active enantiomer in humans.Pyroglutamic acid is an intermediate inglutathione metabolism.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg, 1 g

L-SelenoMethionineCat. No.: HY-B1000A

L-SelenoMethionine is a major natural food-form ofselenium. Target The median lethal dose (LD50) ofL-SelenoMethionine in rats given anintraperitoneal injection was determined to 4.25mg Se/kg body and thus is comparable to that ofselenite or selenate.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

L-Sepiapterin (Sepiapterin) Cat. No.: HY-112234

L-Sepiapterin (Sepiapterin) is a precursor of theendothelial nitric oxide synthase (eNOS) cofactortetrahydrobiopterin (BH4). L-Sepiapterin improvesendothelial dysfunction in small mesentericarteries from db/db mice, and inducesangiogenesis.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg

L-Serine ((-)-Serine; (S)-Serine) Cat. No.: HY-N0650

L-Serine ((-)-Serine; (S)-Serine), one of theso-called non-essential amino acids, plays acentral role in cellular proliferation.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

L-Tartaric acid (L-(+)-Tartaric acid) Cat. No.: HY-Y0293

L-Tartaric acid (L-(+)-Tartaric acid) is anendogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

L-ThreonineCat. No.: HY-N0658

L-Threonine is a natural amino acid, can beproduced by microbial fermentation, and is used infood, medicine, or feed.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

L-Thyroxine (Levothyroxine; T4) Cat. No.: HY-18341

L-Thyroxine (Levothyroxine; T4) is a synthetichormone for the research of hypothyroidism. DIOenzymes convert biologically active thyroidhormone (Triiodothyronine,T3) from L-Thyroxine(T4).

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

L-Tryptophan (Tryptophan; Tryptophane) Cat. No.: HY-N0623

L-Tryptophan (Tryptophan) is an essential aminoacid that is the precursor of serotonin,melatonin, and vitamin B3.

Purity: 99.90%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

L-TyrosineCat. No.: HY-N0473

L-Tyrosine is a non-essential amino acid which caninhibit activity in the posteriorcitrate synthasecortex.

Purity: >98.0%Clinical Data: LaunchedSize: 200 mg, 500 mg

L-ValineCat. No.: HY-N0717

L-Valine is one of 20 proteinogenic amino acids.L-Valine is an essential amino acid.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 97

 

L-Valyl-L-phenylalanine (Valylphenylalanine; H-VAL-PHE-OH) Cat. No.: HY-107378

L-Valyl-L-phenylalanine (Valylphenylalanine;H-VAL-PHE-OH) has been reported as biocompatiblepolymer.

Purity: 98.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

L-Leucyl-L-alanineCat. No.: HY-128434

L-Leucyl-L-alanine is a simple dipeptide composedof L-leucine and L-alanine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

LactoseCat. No.: HY-B2123

Lactose, a major sugar in the milk of mostspecies, could regulate human’s intestinalmicroflora.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

LanosterolCat. No.: HY-W020033

Lanosterol is an intermediate of cholesterolsynthesis and use of lanosterol inducesubiquitination and degradation of arate-controlling enzyme of cholesterol synthesis,i.e., HMG CoA reductase.

Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg

Lapaquistat (T-91485) Cat. No.: HY-14925

Lapaquistat (T-91485), a cholesterol biosynthesisinhibitor, is the active metabolite of TAK-475.Lapaquistat can decrease statin-inducedmyotoxicity in lipid-lowering therapy.

Purity: 99.79%Clinical Data: Phase 3Size: 1 mg, 5 mg, 10 mg, 25 mg

LathosterolCat. No.: HY-113486

Lathosterol is a cholesterol-like molecule. SerumLathosterol concentration is an indicator ofwhole-body cholesterol synthesis.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Lauric acidCat. No.: HY-Y0366

Lauric acid is a middle chain-free fatty acid withstrong bactericidal properties. The EC s for 50 P.

, , , are 2, 6, 4acnes S.aureus S. epidermidisμg/mL, respectively.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

LecithinCat. No.: HY-B2235

Lecithin is regarded as a safe, conventionalphospholipid source. Phospholipids are reported toalter the fatty acid composition andmicrostructure of the membranes in animal cells.

Purity: >98.0%Clinical Data: LaunchedSize: 100 mg, 500 mg

Leucyl-phenylalanineCat. No.: HY-113278

Leucyl-phenylalanine belongs to the class oforganic compounds known as dipeptides.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

Leukotriene B4 (LTB4; 5(S),12(R)-DiHETE) Cat. No.: HY-107608

Leukotriene B4 (LTB4) is known as one of the mostpotent chemoattractants and activators ofleukocytes and is involved in inflammatorydiseases. Leukotriene B4 is also an alkylchain-based PROTAC linker that can be used in thesynthesis of PROTACs.

Purity: >98%Clinical Data: Phase 2Size: 25 μg

98 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Leukotriene C4Cat. No.: HY-113446

Leukotriene C4 is the parent cysteinyl leukotrieneproduced by the LTC4 synthase catalyzedconjugation of glutathione to LTA4. Leukotriene C4is produced by neutrophils, macrophages, mastcells, and by transcellular metabolism inplatelets.

Purity: >97.0%Clinical Data: No Development ReportedSize: 25 μg (159.8 µM * 250 μL in Ethanol)

Levomefolic acid (5-MTHF) Cat. No.: HY-14781

Levomefolic acid (5-MTHF) is the natural, activeform of folic acid used at the cellular level forDNA reproduction, the cysteine cycle and theregulation of homocysteine among other functions.

Purity: >98.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg

Levothyroxine acyl glucuronide (Thyroxine acyl-β-D-glucuronide) Cat. No.: HY-135955

Levothyroxine acyl glucuronide (ThyroxineAcyl-β-D-glucuronide), an endogenous metabolite,is the acyl glucuronide formation of thyroxine(T4).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Levulinic acid (4-Oxovaleric acid; Laevulinic acid; Levulic

acid; NSC 3716; β-Acetylpropionic acid; …) Cat. No.: HY-Y0839

Levulinic acid is a precursor for the synthesis ofbiofuels, such as ethyl levulinate.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Limonin (Limonoic acid 3,19:16,17 dilactone) Cat. No.: HY-17411

Limonin is a triterpenoid enriched in citrusfruits, which has antivirus and antitumor ability.IC50 Value: Target: HIV; anticancer Limonin is atriterpenoid aglycone that is a bitter principleof citrus fruits.

Purity: 99.78%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

LinaloolCat. No.: HY-N0368

Linalool is natural monoterpene in essential olisof coriander, acts as a competitive antagonist of

, withNmethyl d-aspartate (NMDA) receptoranti-tumor, anti-cardiotoxicity activity.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Linoleic acidCat. No.: HY-N0729

Linoleic acid is a common polyunsaturated (PUFA)is found in plant-based oils, nuts and seeds.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Liothyronine (Triiodothyronine; 3,3',5-Triiodo-L-thyronine; T3) Cat. No.: HY-A0070A

Liothyronine is an active form of thyroid hormone,which binds to β1 thyroid hormone receptor( ), and activates its activity.TRβ1

Purity: 99.28%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Lipoamide ((±)-α-Lipoamide; DL-Lipoamide; DL-6,8-Thioctamide) Cat. No.: HY-B1142

Lipoamide is a coenzyme, which transfer acetyl andhydrogen in Pyruvate deacylation oxidationProcess, used for pharmaceuticals.

Purity: 99.91%Clinical Data: No Development ReportedSize: 100 mg

Lipoic acid ((R)-(+)-α-Lipoic acid; R-(+)-Thioctic acid) Cat. No.: HY-18733

Lipoic acid ((R)-(+)-α-Lipoic acid) is anantioxidant, which is an essential cofactor of

enzyme complexes.mitochondrial(R)-(+)-α-Lipoic acid is more effective thanracemic Lipoic acid.

Purity: 99.59%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

www.MedChemExpress.com 99

 

Lithocholic acid (3α-Hydroxy-5β-cholanic acid) Cat. No.: HY-B0172

Lithocholic acid is a toxic secondary bile acid,causes intrahepatic cholestasis, hastumor-promoting activity. Target: OthersLithocholic acid has been used in a study toassess cholestasis and its action on severalorgans and tissues in rats.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Lobeline sulfate (α-Lobeline sulfate; L-Lobeline sulfate) Cat. No.: HY-128420

Lobeline sulfate (α-Lobeline sulfate; L-Lobelinesulfate) is a nonstimulant medication that canalter dopamine uptake in brain. Lobeline sulfate(α-Lobeline sulfate; L-Lobeline sulfate) inhibitsnicotine-induced hyperactivity and is effective insmoking cessation.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Lornoxicam (Chlortenoxicam; Ro 13-9297) Cat. No.: HY-B0367

Lornoxicam (Chlortenoxicam), a COX-1 and COX-2inhibitor, is a new nonsteroidal anti-inflammatorydrug (NSAID). Target: COX Lornoxicam showed abalanced inhibition of COX-1/-2 exhibiting thelowest IC50 (0.005 microM/0.008 microM) of thelarge panel of NSAIDs tested.

Purity: 98.31%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 200 mg, 500 mg

Lumisterol (9β,10α-Ergosterol) Cat. No.: HY-N0181A

Lumisterol (9β,10α-Ergosterol), a steroidcompound, is the (9β,10α)-stereoisomer ofErgosterol. Lumisterol is a photoprotective agentagainst UVB-induced DNA damage andanti-proliferative activities.

Purity: 99.41%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Lumisterol 3 (>90%) (9β,10α-Cholesta-5,7-dien-3β-ol;

Cholecalciferol EP Impurity A) Cat. No.: HY-112023

Lumisterol 3 (>90%)(9β,10α-Cholesta-5,7-dien-3β-ol) is a normal humansecosterooid metabolite from the class of vitaminD3 photoisomer derivatives. Lumisterol 3 (>90%)is used in the preparation of vitamin D.

Purity: 92.69%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg

Luteolin (Luteoline; Luteolol; Digitoflavone) Cat. No.: HY-N0162

Luteolin (Luteoline), a flavanoid compound, is apotent inhibitor.Nrf2

Purity: 98.15%Clinical Data: Phase 2Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 500 mg

LysoPC(14:0/0:0)Cat. No.: HY-113123

LysoPC(14:0/0:0) is a lysophospholipid (LyP). Itis a monoglycerophospholipid in which aphosphorylcholine moiety occupies a glycerolsubstitution site. LysoPC(14:0/0:0) has potentantispasmodic effect.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

m-AnisaldehydeCat. No.: HY-W007346

m-Anisaldehyde is an endogenous metabolite.

Purity: 99.28%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

m-Coumaric acidCat. No.: HY-113357

m-Coumaric acid is a polyphenol metabolite fromcaffeic acid, formed by the gut microflora and theamount in human biofluids is diet-dependant.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

m-TyramineCat. No.: HY-113356

m-Tyramine is an endogenous trace amineneuromodulator. m-Tyramine has effects on the

and receptor.adrenergic dopaminergic

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

100 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

m-Tyramine hydrobromideCat. No.: HY-128975

m-Tyramine hydrobromide is an endogenous traceamine neuromodulator. m-Tyramine hydrobromide haseffects on the and adrenergic dopaminergicreceptor.

Purity: 98.58%Clinical Data:Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Madecassoside (Asiaticoside A) Cat. No.: HY-N0568

Madecassoside is a pentacyclic triterpene isolatedfrom Centella asitica (L.), as ananti-inflammatory, anti-oxidative activities andanti-aging agent.

Purity: 99.86%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 200 mg

Maleic AcidCat. No.: HY-Y0367

Maleic Acid is a Glutamate Decarboxylase (GAD)inhibitor of and .E. coli L. monocytogenes

Purity: 99.86%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Malic acid (E 296; FDA 2018; Hydroxybutanedioic acid) Cat. No.: HY-Y1311

Malic acid is a dicarboxylic acid that isnaturally found in fruits such as apples andpears. It plays a role in many sour or tart foods.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Maltohexaose (Amylohexaose) Cat. No.: HY-N2559

Maltohexaose is a natural saccharide, and can beproduced from amylose, amylopectin and wholestarch.

Purity: 98.22%Clinical Data: No Development ReportedSize: 1 mg

MaltolCat. No.: HY-W012788

Maltol, a type of aromatic compound, exists inhigh concentrations in red ginseng. Maltol is apotent antioxidative agent and typically is usedto enhance flavor and preserve food.

Purity: >95.0%Clinical Data: Phase 4Size: 10 mM × 1 mL, 100 mg

Maltopentaose (Maltopentose) Cat. No.: HY-N1495

Maltopentaose is the shortest chainoligosaccharide that can be classified asmaltodextrin and is also used in a study toinvestigate glycation and phosphorylation ofα-lactalbumin.

Purity: 99.59%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

MaltoseCat. No.: HY-N2024

Maltose is a formed from two units ofdisaccharideglucose joined with an α(14) bond, a reducingsugar. Maltose monohydrate can be used as a energysource for bacteria.

Purity: >97.0%Clinical Data: Phase 3Size: 500 mg

Maltose monohydrateCat. No.: HY-N2024A

Maltose monohydrate is the energy source forbacteria.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 100 mg

Maltotetraose (Amylotetraose; Fujioligo 450; α-1,4-Tetraglucose) Cat. No.: HY-N2464

Maltotetraose can be used as a substrate for theenzyme-coupled determination of amylase activityin biological fluids.

Purity: 99.59%Clinical Data:Size: 10 mM × 1 mL, 5 mg, 10 mg

www.MedChemExpress.com 101

 

MaltotrioseCat. No.: HY-113011

Maltotriose, the second most abundant sugarpresent in brewing, is an inducer of the maltoseregulon of . Maltotriose can induceEscherichia colibeta-galactosidase synthesis.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

MeconineCat. No.: HY-W019151

Meconine is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

Medroxyprogesterone acetate (Medroxyprogesterone 17-acetate; MPA) Cat. No.: HY-B0469

Medroxyprogesterone acetate is a widely usedsynthetic steroid by its interaction with

, and progesterone androgen glucocorticoid.receptors

Purity: 99.82%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Meglutol (Dicrotalic acid; 3-Hydroxy-3-methylglutaric acid) Cat. No.: HY-B1189

Meglutol is an antilipemic agent which lowerscholesterol, triglycerides, serumbeta-lipoproteins and phospholipids, and inhibitsthe activity of hydroxymethylglutarryl CoAreductases, which is the rate limiting enzyme inthe biosynthesis of cholesterol.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

MelaninCat. No.: HY-113485

Melanin is a unique pigment with myriad functions.It is multifunctional, providing defense againstenvironmental stresses such as ultraviolet (UV)light, oxidizing agents and ionizing radiation.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

Melatonin (N-Acetyl-5-methoxytryptamine) Cat. No.: HY-B0075

Melatonin is a hormone made by the pineal glandthat can activates .melatonin receptorMelatonin plays a role in sleep and possessesimportant antioxidative and anti-inflammatoryproperties.

Purity: 99.47%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Meluadrine tartrateCat. No.: HY-50290A

Meluadrine tartrate is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Menadione (Vitamin K3) Cat. No.: HY-B0332

Menadione, a synthetic naphthoquinone, can beconverted to active vitamin K2 in vivo. Target:Others Menadione (Vitamin K3) is a syntheticanalogue of of 1,4-naphthoquinone with a methylgroup in the 2-position.

Purity: 98.07%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g

Menaquinone-4 (Vitamin K2(MK-4); Menaquinone K4) Cat. No.: HY-B2156

Menaquinone-4 is a vitamin K, used as a hemostaticagent, and also a adjunctive therapy for the painof osteoporosis.

Purity: 99.81%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 250 mg

Mesitaldehyde (2,4,6-Trimethylbenzaldehyde) Cat. No.: HY-W017469

Mesitaldehyde is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

102 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

meso-ErythritolCat. No.: HY-100551

meso-Erythritol is a sugar alcohol that occursnaturally in a variety of foods (e.g., pear,watermelon), is 60-80% as sweet as sucrose, and isan approved low-calorie sweetener food additive.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Mesoxalate sodium (monohydrate)Cat. No.: HY-128740

Mesoxalate sodium monohydrate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg, 500 mg

Methionine sulfoxideCat. No.: HY-W010104A

Methionine sulfoxide is an oxidation product ofmethionine with reactive oxygen species and can beregarded as a biomarker of oxidative stress invivo.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 500 mg

Methoxyacetic acidCat. No.: HY-Y1009

Methoxyacetic acid is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg

Methyl 2-(1H-indol-3-yl)acetateCat. No.: HY-W015224

Methyl 2-(1H-indol-3-yl)acetate is an endogenousmetabolite.

Purity: 97.61%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Methyl 2-(3-oxo-2-(pent-2-en-1-yl)cyclopentyl)acetateCat. No.: HY-W013507

Methyl2-(3-oxo-2-(pent-2-en-1-yl)cyclopentyl)acetate isan endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Methyl 2-furoate (Methyl furan-2-carboxylate) Cat. No.: HY-Y0949

Methyl 2-furoate (Methyl furan-2-carboxylate) is abuilding block in chemical synthesis. A flavoringagent in food. Found in cranberries, guava fruits,raisins and other fruits. Also present in bakedpotato, roasted filberts, roasted peanut,tomatoes, coffee, cocoa, okra, etc.

Purity: 99.75%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

Methyl 3-phenylpropanoateCat. No.: HY-W007828

Methyl 3-phenylpropanoate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Methyl acetylacetate (Acetoacetate methyl ester; Methyl

3-oxobutanoate; Methyl 3-oxobutyrate; …) Cat. No.: HY-Y1298

Methyl acetylacetate is an endogenous metabolite.

Purity: 98.94%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Methyl anisateCat. No.: HY-W015342

Methyl anisate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

www.MedChemExpress.com 103

 

Methyl p-tert-butylphenylacetateCat. No.: HY-W018501

Methyl p-tert-butylphenylacetate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Methyl Paraben (Methyl 4-hydroxybenzoate) Cat. No.: HY-N0349

Methyl Paraben, isolated from the barks of Tsuga the methyl ester of p-hydroxybenzoicdumosa

acid, is a standardized chemical allergen. MethylParaben is a stable, non-volatile compound used asan antimicrobial preservative in foods, drugs andcosmetics.

Purity: 99.71%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Methyl phenylacetateCat. No.: HY-76063

Methyl phenylacetate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Methyl vanillateCat. No.: HY-75342

Methyl vanillate, one of the ingredients inHovenia dulcis Thunb, is a Wnt/β-cateninpathway activator. A benzoate ester that is themethyl ester of vanillic acid. It has a role as anantioxidant and a plant metabolite.

Purity: 99.15%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Methyl β-D-GalactopyranosideCat. No.: HY-128737

Methyl β-D-Galactopyranoside is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Methylcobalamin (CH3-B12) Cat. No.: HY-B0586

Methylcobalamin (CH3-B12), a cobalamin, is a formof vitamin B12.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Methylmalonic acid (Methylpropanedioic acid; Methylmalonate) Cat. No.: HY-103395

Methylmalonic acid (Methylmalonate) is anindicator of Vitamin B-12 deficiency in cancer.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Mevalonic acidCat. No.: HY-113071

Mevalonic acid, a precursor in the mevalonatepathway, is essential for cell growth andproliferation.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Mevalonic acid lithium saltCat. No.: HY-113071A

Mevalonic acid lithium salt, a precursor in themevalonate pathway, is essential for cell growthand proliferation.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 50 mg, 100 mg, 250 mg, 500 mg

Miquelianin (Quercetin 3-O-glucuronide; Quercetin 3-glucuronide) Cat. No.: HY-13930

Miquelianin (Quercetin 3-O-glucuronide) is ametabolite of quercetin and a type of naturalflavonoid.

Purity: 99.83%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg, 25 mg, 50 mg

104 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Monobenzyl phthalate (2-((Benzyloxy)carbonyl)benzoic acid) Cat. No.: HY-W011848

Monobenzyl phthalate(2-((Benzyloxy)carbonyl)benzoic acid) is theurinary exposuring to phthalates,metabolitesuch as, diethylhexyl phthalate (DEHP).

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg

Monoisobutyl phthalic acidCat. No.: HY-113220

Monoisobutyl phthalic acid is a phthalatemetabolite that is in human semen and in meconium.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Monomethyl phthalate (2-(Methoxycarbonyl)benzoic acid) Cat. No.: HY-Y1097

Monomethyl phthalate is a phthalate .metaboliteMonomethyl phthalate acts as a urinary biomarkerof phthalates exposure and can be used as astandard for the determination of thyroid cancerand benign nodule.

Purity: 98.43%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

MonooleinCat. No.: HY-128754

Monoolein is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Moracin MCat. No.: HY-122942

Moracin M, a phenolic component in the skin ofMorus alba L., is a potent phosphodiesterase-4

inhibitor with values of 2.9, 4.5,(PDE4) IC50

>40, and >100 μM for PDE4D2, PDE4B2, PDE5A1,and PDE9A2, respectively. Moracin M hasanti-inflammatory activity.

Purity: 98.50%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Mycophenolic acid (Mycophenolate) Cat. No.: HY-B0421

Mycophenolic acid (Mycophenolate) is an animmunosuppresant drug and has potentanti-proliferative activity.

Purity: 99.63%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg, 1 g

Myricetin (Cannabiscetin) Cat. No.: HY-15097

Myricetin is a common plant-derived flavonoid witha wide range of activities including stronganti-oxidant, anticancer, antidiabetic andanti-inflammatory activities.

Purity: 98.80%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg, 200 mg, 500 mg

Myristic acidCat. No.: HY-N2041

Myristic acid is a saturated 14-carbon fatty acidoccurring in most animal and vegetable fats,particularly butterfat and coconut, palm, andnutmeg oils.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

N,N,O-TridesmethylvenlafaxineCat. No.: HY-W049735

N,N,O-Tridesmethylvenlafaxine is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg

N-(5-Aminopentyl)acetamide (Monoacetylcadaverine) Cat. No.: HY-101403

N-(5-Aminopentyl)acetamide is the acetylated formof the polyamine cadaverine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 105

 

N-Acetyl-5-hydroxytryptamine (N-Acetylserotonin; Normelatonin; O-Demethylmelatonin) Cat. No.: HY-107854

N-Acetyl-5-hydroxytryptamine is a Melatoninprecursor, and that it can potently activate TrkBreceptor.

Purity: 99.86%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

N-Acetyl-D-glucosamine (N-Acetyl-2-amino-2-deoxy-D-glucose) Cat. No.: HY-A0132

N-Acetyl-D-Glucosamine(N-Acetyl-2-amino-2-deoxy-D-glucose) is amonosaccharide derivative of glucose.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

N-Acetyl-DL-methionineCat. No.: HY-W019704

N-Acetyl-DL-methionine is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

N-Acetyl-L-arginine dihydrateCat. No.: HY-W014130A

N-Acetyl-L-arginine (dihydrate) is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

N-Acetyl-L-aspartic acidCat. No.: HY-113524

N-Acetyl-L-aspartic acid is a derivative ofaspartic acid.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

N-Acetyl-L-glutamic acidCat. No.: HY-W015240

N-Acetyl-L-glutamic acid, a N-acyl-L-amino acid,is a component of animal cell culturing media.N-Acetyl-L-glutamic acid is a metabolite of

and human.Saccharomyces cerevisiae

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

N-Acetyl-L-histidine monohydrateCat. No.: HY-W014180

N-Acetyl-L-histidine monohydrate, a histidinederivative, is a prominent biomolecule in brain,retina and lens of poikilothermic vertebrates.N-Acetyl-L-histidine monohydrate has a role as ananimal metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

N-Acetyl-L-leucineCat. No.: HY-59291

N-Acetyl-L-leucine is an endogenous metabolite.

Purity: 96.83%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

N-Acetyl-L-methionine (N-Acetylmethionine) Cat. No.: HY-W012499

N-Acetyl-L-methionine, a human metabolite, isnutritionally and metabolically equivalent toL-methionine. L-methionine is an indispensableamino acid required for normal growth anddevelopment.

Purity: 99.16%Clinical Data: No Development ReportedSize: 100 mg

N-Acetyl-L-phenylalanine (N-Acetylphenylalanine) Cat. No.: HY-Y0068

N-Acetyl-L-phenylalanine (N-Acetylphenylalanine),the principal acylamino acid in , isEscherichia colisynthesized from L-phenylalanine and acetyl-CoA.

Purity: 98.38%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

106 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

N-Acetyl-L-tryptophanCat. No.: HY-W011978

N-Acetyl-L-tryptophan is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

N-Acetyl-L-tyrosineCat. No.: HY-W012382

N-Acetyl-L-tyrosine originates from tyrosinethrough an AA acetylase, is associated witharomatic L-amino acid decarboxylase deficiency andtyrosinemia I.

Purity: 98.50%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

N-Acetylglycine (Aceturic acid; Acetamidoacetic acid) Cat. No.: HY-Y0069

N-Acetylglycine (Aceturic acid) is a minorconstituent of numerous foods with no genotoxicityor acute toxicity. N-acetylglycine is used inbiological research of peptidomimetics.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

N-Acetylhistamine (N-Omega-acetylhistamine) Cat. No.: HY-112175

N-Acetylhistamine is a histamine metabolite.N-acetylhistamine can be used as a potentialbiomarker of histidine metabolism foranaphylactoid reactions.

Purity: 99.79%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

N-Acetylneuraminic acid (NANA; Lactaminic acid) Cat. No.: HY-I0400

N-Acetylneuraminic acid is a nine-carbon, sialicacid monosaccharide commonly found inglycoproteins on cell membranes and in glycolipidssuch as gangliosides in mammalian cells.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 1 g

N-AcetylornithineCat. No.: HY-113080

N-Acetylornithine is an intermediate in theenzymatic biosynthesis of the amino acidL-arginine from L-glutamate.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

N-Acetylputrescine hydrochlorideCat. No.: HY-113100

N-Acetylputrescine hydrochloride is a putrescinederivative.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

N-FormylglycineCat. No.: HY-128735

N-Formylglycine is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

N-IsovaleroylglycineCat. No.: HY-W015464

N-Isovaleroylglycine is an acyl glycine and couldbe used as a biomarker for the predispositon forweight gain and obesity.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

N-MethylhydantoinCat. No.: HY-113382

N-Methylhydantoin is a product of degradation ofcreatinine by bacteria.

Purity: 99.92%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 107

 

N-MethylnicotinamideCat. No.: HY-124124

N-Methylnicotinamide is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

N-Methylsarcosine (Dimethylglycine; DMG; N,N-Dimethylglycine) Cat. No.: HY-Y0511

N-Methylsarcosine is an amino acid building blockfor protein, found in a small amount in the body.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

N-Oleoyl glycineCat. No.: HY-113204

N-Oleoyl glycine is a lipoamino acid, whichstimulates adipogenesis associated with activationof and signaling pathway inCB1 receptor Akt3T3-L1 adipocyte.

Purity: >99.0%Clinical Data:Size: 10 mM × 1 mL, 10 mg

N-β-alanyldopamine hydrochloride (NBAD hydrochloride) Cat. No.: HY-136537A

N-β-alanyldopamine hydrochloride (NBADhydrochloride) is the major dopamine derivative inhaemolymph.<br/>.

Purity: 98.31%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg, 50 mg, 100 mg

N-Carbamoyl-DL-aspartic acid (Ureidosuccinic Acid) Cat. No.: HY-128425

N-Carbamoyl-DL-aspartic acid (Ureidosuccinicacid) is a precursor of nucleic acid pyrimidines.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

N1,N8-DiacetylspermidineCat. No.: HY-129912

N1,N8-Diacetylspermidine is a polyamines in thehuman urine. N1,N8-Diacetylspermidine is useful asprognostic indicators after treatment and duringfollow-up examination of cancer patients.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

N1,N8-Diacetylspermidine hydrochlorideCat. No.: HY-129912A

N1,N8-Diacetylspermidine hydrochloride is apolyamines in the human urine.N1,N8-Diacetylspermidine hydrochloride is usefulas prognostic indicators after treatment andduring follow-up examination of cancer patients.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

N1-Acetylspermidine hydrochlorideCat. No.: HY-113056A

N1-Acetylspermidine hydrochloride is an acetylderivative of polyamine. N1-acetylspermine is thesubstrate for the polyamine oxidase (PAO).N1-Acetylspermidine hydrochloride selectivelyelevates its level in human colorectaladenocarcinomas.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

N2,N2-DimethylguanosineCat. No.: HY-113137

N2,N2-Dimethylguanosine is an urinary nucleoside,a primary degradation product of tRNA.

Purity: 99.30%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

N2-MethylguanosineCat. No.: HY-111647

N2-methylguanosine is a modified nucleoside thatoccurs at several specific locations in manytRNA's.

Purity: 98.07%Clinical Data: No Development ReportedSize: 10 mg

108 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

N4-AcetylcytidineCat. No.: HY-W019670

N4-Acetylcytidine is an endogenous metabolite.

Purity: 97.04%Clinical Data: No Development ReportedSize: 500 mg

N4-Acetylcytidine triphosphate sodium (ac4CTP sodium) Cat. No.: HY-111815A

N4-Acetylcytidine triphosphate sodium isefficiently used as a substrate in T7Polymerase-catalyzed in vitro transcription andcan be incorporated into multiple templates.

Purity: >90.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mg

N6-Methyladenosine (6-Methyladenosine; N-Methyladenosine) Cat. No.: HY-N0086

N6-Methyladenosine is the most prevalent internal(non-cap) modification present in the messengerRNA (mRNA) of all higher eukaryotes.N6-Methyladenosine can modifies and hasviral RNAsantiviral activities.

Purity: 99.07%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg

N8-Acetylspermidine dihydrochlorideCat. No.: HY-113253A

N8-Acetylspermidine dihydrochloride is apolyamine.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

NAD+ (β-DPN; β-NAD; β-Nicotinamide Adenine Dinucleotide) Cat. No.: HY-B0445

NAD+ is a coenzyme composed of ribosylnicotinamide5'-diphosphate coupled to adenosine 5'-phosphateby pyrophosphate linkage.

Purity: 99.99%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

NADH disodium salt (Disodium NADH) Cat. No.: HY-F0001

NADH disodium salt is a coenzyme of a large numberof oxidoreductases. NADH is a coenzyme thatfunctions as a regenerating electron donor incatabolic processes including glycolysis,beta-oxidation and the citric acid cycle.

Purity: 98.72%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg, 1 g

NADPCat. No.: HY-113325

NADP is nicotinamide adenine dinucleotidephosphate, acting as a key cofactor for electrontransfer in the metabolism of all organisms, beingalternately oxidized (NADP ) and reduced (NADPH).+

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

NaringeninCat. No.: HY-N0100

Naringenin is the predominant flavanone ingrapefruit; displays strong anti-inflammatory andantioxidant activities. Naringenin has anti-dengue

activity.virus (DENV)

Purity: 98.72%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg, 500 mg, 1 g, 5 g

Naringin (Naringoside) Cat. No.: HY-N0153

Naringin is a major flavanone glycoside obtainedfrom tomatoes, grapefruits, and many other citrusfruits. Naringin exhibits biological propertiessuch as antioxidant, anti-inflammatory, andantiapoptotic activities.

Purity: 99.79%Clinical Data: No Development ReportedSize: 200 mg, 10 g

Natamycin (Pimaricin) Cat. No.: HY-B0133

Natamycin (Pimaricin) is a macrolide antibioticagent produced by several strains.StreptomycesNatamycin inhibits the growth of viafungiinhibition of amino acid and glucose transportacross the plasma membrane.

Purity: 99.35%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg, 200 mg, 500 mg

www.MedChemExpress.com 109

 

NCX 1000Cat. No.: HY-U00023

NCX 1000 is a liver-specific NO donor compoundderived from ursodeoxycholic acid (UDCA).

Purity: 98.06%Clinical Data: Phase 2Size: 1 mg

neo-InositolCat. No.: HY-121962

neo-Inositol, a stereoisomer of inositol, has beenisolated from calf brain.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Neopterin (D-(+)-Neopterin; D-erythro-Neopterin) Cat. No.: HY-W040055

Neopterin (D-(+)-Neopterin), a catabolic productof guanosine triphosphate , serves as a(GTM)marker of cellular immune system activation.

Purity: 98.16%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Nepsilon-Acetyl-L-lysineCat. No.: HY-113426

Nepsilon-Acetyl-L-lysine is a derivative of theamino acid lysine.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

NerolCat. No.: HY-N7063

Nerol is a constituent of neroli oil. Nerol Neroltriggers mitochondrial dysfunction and inducesapoptosis via elevation of Ca and .2+ ROS

activity.Antifungal

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

NerolidolCat. No.: HY-N1944

Nerolidol is a natural membrane-activesesquiterpene, with antitumor, antibacterial,antifungal and antiparasitic activity.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Nervonic acid (Selacholeic acid; cis-15-Tetracosenoic acid) Cat. No.: HY-N2526

Nervonic acid is a monounsaturated fatty acidimportant in the biosynthesis of myelin.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Neuromedin BCat. No.: HY-P0241

Neuromedin B (NMB) is a member of Bombesin(BN)-like peptide family in mammals.

Purity: 98.11%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 25 mg

NHC-diphosphateCat. No.: HY-135867D

NHC-diphosphate is an activephosphorylated intracellular

 of β-d-N4-Hydroxycytidine (NHC)metabolite(HY-125033) as a diphosphate form. NHC is apyrimidine ribonucleoside and behaves as a potent

.anti-virus agent

Purity: 98.80%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg

NHC-triphosphateCat. No.: HY-135867

NHC-triphosphate is an active phosphorylated ofintracellular metabolite

β-d-N4-Hydroxycytidine (NHC) (HY-125033) as atriphosphate form. NHC-triphosphate is a weakalternative substrate for the viral polymeraseand can be incorporated into replicon RNA.HCV

Purity: 99.80%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

110 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

NHC-triphosphate tetrasodiumCat. No.: HY-135867A

NHC-triphosphate tetrasodium is an activephosphorylated ofintracellular metaboliteβ-d-N4-Hydroxycytidine (NHC) (HY-125033) as atriphosphate form.

Purity: 98.06%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Niacin (Nicotinic acid; Vitamin B3) Cat. No.: HY-B0143

Niacin (Vitamin B3) is a water-soluble vitamin andis part of the vitamin B group. Target: OthersNiacin (also known as vitamin B3 and nicotinicacid) is an organic compound with the formulaC6H5NO2 and, depending on the definition used, oneof the 20 to 80 essential human nutrients.

Purity: >99.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Nicotinamide (Niacinamide; Nicotinic acid amide) Cat. No.: HY-B0150

Nicotinamide is a form of vitamin B3 that playsessential roles in cell physiology throughfacilitating NAD+ redox homeostasis and providingNAD+ as a substrate to a class of enzymes thatcatalyze non-redox reactions. Nicotinamide is aninhibitor of .SIRT1

Purity: 99.86%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Nicotinamide N-oxideCat. No.: HY-101407

Nicotinamide N-oxide, an nicotinamidein vivometabolite, is a potent, and selective antagonistof the receptor.CXCR2

Purity: 99.93%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Nicotinuric acidCat. No.: HY-113353

Nicotinuric acid is an acyl glycine. Nicotinuricacid is a metabolite of nicotinic acid.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

NMDA (N-Methyl-D-aspartic acid) Cat. No.: HY-17551

NMDA is a specific agonistfor  mimicking theNMDA receptoraction of glutamate, the neurotransmitter whichnormally acts at that receptor.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

Noradrenaline tartrate (Levarterenol tartrate; L-Noradrenaline tartrate) Cat. No.: HY-13715C

Norepinephrine tartrate (Levarterenol tartrate), anaturally occurring chemical in the body that actsas both a stress hormone and neurotransmitter, isa -selective agonist withβ1 adrenergic receptor

of 5.37 μM.EC50

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Norepinephrine (Levarterenol; L-Noradrenaline) Cat. No.: HY-13715

Norepinephrine (Levarterenol; L-Noradrenaline) isa -selective agonist withβ1 adrenergic receptor

of 5.37 μM.EC50

Purity: 98.08%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

Norfloxacin (MK-0366) Cat. No.: HY-B0132

Norfloxacin (MK-0366) is a broad-spectrumantibiotic that is active against bothGram-positive and Gram-negative bacteria, whichfunctions by inhibiting DNA gyrase.

Purity: 98.29%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g, 10 g

Norharmane (Norharman; β-Carboline) Cat. No.: HY-W008566

Norharmane (Norharman), isolated from coffee, is apotent and selective monoamine oxidase A( ) inhibitor with a of 3.34 μM.MAO-A Ki

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 111

 

NSC 13138 (Cinchoninic acid (6CI,7CI,8CI); 4-Carboxyquinoline) Cat. No.: HY-Y0057

NSC 13138 is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

NSC 16590 (α,α-Dimethylglycine; α-Aminoisobutanoic acid) Cat. No.: HY-Y0124

NSC 16590 inhibits the production of endogenous in the cotyledonary segments of cocklebur.ethylene

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

NSC 42196Cat. No.: HY-B1476

NSC 42196 is an endogenous metabolite.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

NSC 8751 ((E)-2-Butenoic acid; (E)-Crotonic acid;

trans-2-Butenoic acid; trans-Crotonic acid) Cat. No.: HY-Y1644

NSC 8751 is an endogenous metabolite.

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

NSC 90469 (3,5-Diiodo-L-thyronine) Cat. No.: HY-114557

NSC 90469 is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

NT1-O12BCat. No.: HY-137499

NT1-O12B, an endogenous chemical and aneurotransmitter-derived lipidoid (NT-lipidoid),is an effective carrier for enhanced braindelivery of several blood-brain barrier(BBB)-impermeable cargos.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Nudifloramide (2PY) Cat. No.: HY-113432

Nudifloramide (2PY) is one of the end products ofnicotinamide-adenine dinucleotide (NAD)degradation. Nudifloramide significantly inhibits

activity inpoly(ADP-ribose) polymerase (PARP-1)vitro.

Purity: 99.27%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

Nε,Nε,Nε-Trimethyllysine chloride (Ne-(Trimethyl)-L-lysine chloride; H-Lys(Me)3-OH chloride) Cat. No.: HY-N7404

Nε,Nε,Nε-Trimethyllysine chloride serves as aprecursor for gut flora-dependent formation ofN,N,N-trimethyl-5-aminovaleric acid (TMAVA).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

O-Acetyl-L-serine hydrochlorideCat. No.: HY-101409A

O-Acetyl-L-serine hydrochloride is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

O-Acetylserine (O-Acetyl-L-serine) Cat. No.: HY-101409

O-Acetylserine (O-Acetyl-L-serine) is anintermediate in the biosynthesis of the amino acidcysteine in bacteria and plants.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg

112 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

O-DesmethylangolensinCat. No.: HY-N4075

O-Desmethylangolensin is a metabolite of soyisoflavone, daidzein metabolized by gutmicrobiota. O-Desmethylangolensin possessesantioxidant activity.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

O-Phospho-L-serine (L-Serine O-phosphate; L-SOP) Cat. No.: HY-15129

O-Phospho-L-serine is the immediate precursor toL-serine in the serine synthesis pathway, and anagonist at the group III mGluR receptors(mGluR4, mGluR6, mGluR7, and mGluR8);O-Phospho-L-serine also acts as a weak antagonistfor and a potent antagonist…mGluR1

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

OctadecanalCat. No.: HY-W004307

Octadecanal is a long-chain aldehyde, present inboth thigh and breast muscle.

Purity: >97.0%Clinical Data: No Development ReportedSize: 100 mg

Octadecanedioic acidCat. No.: HY-W005178

Octadecanedioic acid, an endogenous metabolite, isa long-chain dicarboxylic acid that has been foundin serum free fatty acid profile in Reye syndrome.

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

Octanoic acid (Caprylic acid) Cat. No.: HY-41417

Octanoic acid (Caprylic acid) is an oily liquidwith a slightly unpleasant rancid taste and usedcommercially in the production of esters used inperfumery and also in the manufacture of dyes.

Purity: >98.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 500 mg, 5 g

Octopamine hydrochloride ((±)-p-Octopamine hydrochlorid) Cat. No.: HY-B0528A

Octopamine hydrochloride ((±)-p-Octopaminehydrochlorid) is an endogenous biogenic amine thatis closely related to norepinephrine, and haseffects on the adrenergic and dopaminergicsystems.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Oglufanide (H-Glu-Trp-OH; L-Glutamyl-L-tryptophan) Cat. No.: HY-13718

Oglufanide (H-Glu-Trp-OH) is a dipeptideimmunomodulator isolated from calf thymus.Oglufanide inhibits vascular endothelial growth

. Oglufanide can stimulate thefactor (VEGF)immune response to andhepatitic C virus (HCV)intracellular bacterial infections.

Purity: 99.27%Clinical Data: Phase 2Size: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

OleamideCat. No.: HY-N2327

Oleamide is an endogenous fatty acid amide whichcan be synthesized de novo in the mammaliannervous system, and has been detected in humanplasma.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Oleanolic Acid (Oleanic acid; Caryophyllin) Cat. No.: HY-N0156

Oleanolic acid (Caryophyllin) is a naturalcompound from plants with anti-tumor activities.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Oleic acid (9-cis-Octadecenoic acid; 9Z-Octadecenoic acid) Cat. No.: HY-N1446

Oleic acid (9-cis-Octadecenoic acid) is anabundant monounsaturated fatty acid. Oleic acid isa activator.Na /K ATPase+ +

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 1 mg

www.MedChemExpress.com 113

 

OleoylcarnitineCat. No.: HY-113261

Oleoylcarnitine is an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 1 mg

Oleoylethanolamide (N-Oleoylethanolamide; Oleamide MEA; Oleic

acid monoethanolamide) Cat. No.: HY-107542

Oleoylethanolamide is a high affinity endogenous agonist, which plays an important role inPPAR-α

the treatment of obesity and arteriosclerosis.

Purity: 99.55%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Orotic acid (6-Carboxyuracil; Vitamin B13) Cat. No.: HY-N0157

Orotic acid (6-Carboxyuracil) is a precursor inbiosynthesis of pyrimidine nucleotides and RNA.Orotic acid is a marker for measurement in routinenewborn screening for urea cycle disorders. Oroticacid can induce hepatic steatosis and hepatomegalyin rats.

Purity: 95.75%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Orotic acid zincCat. No.: HY-N0157A

Orotic acid (zinc) is a precursor in biosynthesisof pyrimidine nucleotides and RNA. Orotic acid(zinc) is a marker for measurement in routinenewborn screening for urea cycle disorders. Oroticacid (zinc) can induce hepatic steatosis andhepatomegaly in rats.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Orotic acid-6-C14Cat. No.: HY-N0157S

Orotic acid-6-C14 is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Orotidine 5′-monophosphate (Orotidine monophosphate; Orotidylic acid) Cat. No.: HY-N8060

Orotidine 5′-monophosphate is a pyrimidineribonucleoside and plays a role as an endogenous

of human, or mouse. Orotidinemetabolite E. coli5′-monophosphate is an intermediate in thebiosynthesis of uridine monophosphate (UMP).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Oxalic Acid (Ethanedioic acid) Cat. No.: HY-Y0262

Oxalic Acid is a strong dicarboxylic acidoccurring in many plants and vegetables and can beused as an analytical reagent and general reducingagent.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Oxalic acid dihydrateCat. No.: HY-Y1297

Oxalic acid dihydrate is an endogenous metabolite.

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Oxaloacetic acid (2-Oxosuccinic acid) Cat. No.: HY-W010382

Oxaloacetic acid (2-Oxosuccinic acid) is ametabolic intermediate involved in several ways,such as citric acid cycle, gluconeogenesis, theurea cycle, the glyoxylate cycle, amino acidsynthesis, and fatty acid synthesis.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Oxoadipic acidCat. No.: HY-113227

Oxoadipic acid is a key metabolite of theessential amino acids tryptophan and lysine.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 10 mg, 50 mg

114 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Oxypurinol (Oxipurinol) Cat. No.: HY-19657

Oxipurinol (Oxipurinol), the major activemetabolite of Allopurinol, is an inhibitor of

. Oxipurinol can be used to regulatexanthine oxidaseblood urate levels and treat gout.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 50 mg

OxytetracyclineCat. No.: HY-B0275

Oxytetracycline is an antibiotic belonging to thetetracycline class. Oxytetracycline potentinhibits Gram-negative and Gram-positive

.bacteria

Purity: 98.07%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg

Oxytetracycline dihydrateCat. No.: HY-B0275B

Oxytetracycline dihydrate is an antibioticbelonging to the tetracycline class.Oxytetracycline dihydrate potent inhibits

.Gram-negative and Gram-positive bacteria

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Oxytetracycline hydrochlorideCat. No.: HY-B0275A

Oxytetracycline hydrochloride is an antibioticbelonging to the tetracycline class.Oxytetracycline hydrochloride potent inhibits

.Gram-negative and Gram-positive bacteria

Purity: 98.10%Clinical Data: LaunchedSize: 50 mg

p-Anisic acid (4-Methoxybenzoic acid; Draconic acid) Cat. No.: HY-N1394

p-Anisic acid (4-Methoxybenzoic acid) is one ofthe isomers of anisic acid, with anti-bacterialand antiseptic properties.

Purity: 99.81%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

p-Coumaric acid (trans-4-Hydroxycinnamic acid) Cat. No.: HY-N0351

p-Coumaric acid is the abundant isomer of cinnamicacid which has antitumor and anti-mutagenicactivities.

Purity: 99.44%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 1 g

p-HydroxybenzaldehydeCat. No.: HY-Y0313

p-Hydroxybenzaldehyde is a one of the majorcomponents in Dendrocalamus asper bamboo shoots,with antagonistic effect on ofGABA receptorA

the α β γ S subtype at high concentrations.1 2 2

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

p-Hydroxycinnamic acidCat. No.: HY-N2391

p-Hydroxycinnamic acid, a common dietary phenol,could activity, with of 371inhibit platelet IC s50

μM, 126 μM for thromboxane B production and2

lipopolysaccharide-induced prostaglandin E2

generation, respectively.

Purity: 99.85%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 500 mg

p-Hydroxymandelic acidCat. No.: HY-113027

p-Hydroxymandelic acid is a valuable aromatic finechemical and widely used for production ofpharmaceuticals and food additives.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

p-SynephrineCat. No.: HY-113236

p-Synephrine is an organic compound, found inmultiple biofluids, such as urine and blood.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

www.MedChemExpress.com 115

 

p-TolualdehydeCat. No.: HY-W012860

p-Tolualdehyde is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

p-Toluic acid (4-Methylbenzoic acid) Cat. No.: HY-76547

p-Toluic acid (4-Methylbenzoic acid) is asubstituted benzoic acid and can be usedas an for the synthesis ofintermediatepara-aminomethylbenzoic acid (PAMBA),p-tolunitrile, etc.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Palatinose hydrateCat. No.: HY-128739

Palatinose hydrate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Palmitic acidCat. No.: HY-N0830

Palmitic acid is a long-chain saturated fatty acidcommonly found in both animals and plants. PA caninduce the expression of glucose-regulated protein

and 78 (GRP78) CCAAT/enhancer binding protein in in mouse granulosahomologous protein (CHOP)

cells.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Palmitoleic acidCat. No.: HY-W011873

Palmitoleic acid, a composition of fatty acid, isimplicated in the prevention of death fromcerebrovascular disorders in SHRSP rats.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

PalmitoylcarnitineCat. No.: HY-126357

Palmitoylcarnitine is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Palmitoylcarnitine chlorideCat. No.: HY-101017

Palmitoylcarnitine chloride is a fattyacid-derived mitochondrial substrate, andselectively decreases cell survival in colorectaland prostate cancer cells by affecting onpro-inflammatory pathways, Ca influx, and2+

DHT-like effects.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Palmitoyldocosahexaenoyl phosphatidylcholineCat. No.: HY-126354

Palmitoyldocosahexaenoyl phosphatidylcholine is anendogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Pantethine (D-Pantethine; LBF disulfide) Cat. No.: HY-B1028

Pantethine is a dimeric form of pantothenic acid,is an intermediate in the production of CoenzymeA, is available as a dietary supplement, and isused to treat acne and improve theblood-cholesterol profile.

Purity: 99.90%Clinical Data: Phase 3Size: 10 mM × 1 mL, 100 mg, 500 mg

ParaxanthineCat. No.: HY-W016498

Paraxanthine, a caffeine metabolite, providesprotection against Dopaminergic cell death viastimulation of Ryanodine Receptor Channels.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg, 50 mg, 100 mg

116 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Paullinic acidCat. No.: HY-113094

Paullinic acid is a long-chain fatty acid that hasbeen detected in multiple biofluids, such as bloodand urine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg

PCL 016Cat. No.: HY-I0660

PCL 016 is a topical antiviral agent, whichinhibits adenovirus replication in rabbit.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Pentacosanoic acidCat. No.: HY-124422

Pentacosanoic acid is a 25-carbon long-chainsaturated fatty acid. Pentacosanoic is a conjugateacid of a pentacosanoate.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg

Pentadecanoic acidCat. No.: HY-W004283

Pentadecylic acid is a saturated fatty acid with a15-carbon backbone.

Purity: >98.0%Clinical Data: Phase 4Size: 10 mM × 1 mL, 1 g

Pentane-1,5-diamine dihydrochlorideCat. No.: HY-W016750

Pentane-1,5-diamine dihydrochloride is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Perillartine (DL-Perillartine) Cat. No.: HY-N2084

Perillartine is a sweetener, which activates thetaste receptor type 1 member 2 (Tas1r2) subunit ina species-dependent manner.

Purity: 98.94%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Perillyl alcoholCat. No.: HY-N7000

Perillyl alcohol is a monoterpene isolatedfrom the essential oils of lavendin, peppermint,spearmint, cherries, celery seeds, and severalother plants. Perillyl alcohol is active ininducing in tumor cells without affectingapoptosisnormal cells.

Purity: >95.0%Clinical Data: Phase 2Size: 100 mg

Petroselinic acidCat. No.: HY-113362

Petroselinic acid, a positional isomer of oleicacid, is isolated from the vegetable oil of

fruits.Coriandrum sativum

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Pharmatose DCL 14 (Pharmatose 200M; Pharmatose 450M) Cat. No.: HY-B1673

Pharmatose DCL 14 is an endogenous metabolite.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Phenolic acidCat. No.: HY-125909

Phenolic acid is an endogenous metabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

www.MedChemExpress.com 117

 

Phenoxyacetic acidCat. No.: HY-Y0267

Phenoxyacetic acid is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Phenyl acetateCat. No.: HY-128733

Phenyl acetate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Phenylacetylglutamine (NSC 203800; Phenylacetyl-L-glutamine) Cat. No.: HY-W050026

Phenylacetylglutamine is a colonic microbialmetabolite from amino acid fermentation.

Purity: 95.74%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg

Phenylephrine hydrochloride ((R)-(-)-Phenylephrine

hydrochloride; L-Phenylephrine hydrochloride) Cat. No.: HY-B0471

(R)-(-)-Phenylephrine hydrochloride is a selective agonist with of 5.86, 4.87α -adrenoceptor1 pK si

and 4.70 for α , α and α receptors1D 1B 1A

respectively.

Purity: 99.95%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Phenylglyoxylic acid (Benzoylformic acid) Cat. No.: HY-W010255

Phenylglyoxylic acid (Benzoylformic acid) is ametabolite of ethylbenzene and styrene (EB/S) andcan be used as a biomarker of exposure to EB/S inhuman.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Phenylpyruvic acidCat. No.: HY-W012530

Phenylpyruvic acid is used in the synthesis of3-phenyllactic acid (PLA) by lactatedehydrogenase.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Phloretin (NSC 407292; RJC 02792) Cat. No.: HY-N0142

Phloretin (NSC 407292; RJC 02792) is a flavonoidextracted from Prunus mandshurica, hasanti-inflammatory activities. Phloridzin is aspecific, competitive and orally active inhibitorof in thesodium/glucose cotransportersintestine (SGLT1) and kidney (SGLT2).

Purity: 99.78%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 250 mg, 500 mg

Phosphocreatine (Creatine phosphate; Creatinephosphoric acid) Cat. No.: HY-D0885

Phosphocreatine, primarily found in the skeletalmuscles of vertebrates and one of organiccompounds known as alpha amino acids andderivatives, is a substrate for the determinationof creatine kinase and used to regenerate ATPduring skeletal muscle contraction.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Phosphocreatine dipotassium (Creatine phosphate

(dipotassium); Creatinephosphoric acid (dipotassium)) Cat. No.: HY-D0885C

Phosphocreatine dipotassium, primarily found inthe skeletal muscles of vertebrates and one oforganic compounds known as alpha amino acids andderivatives, is a substrate for the determinationof creatine kinase and used to regenerate ATPduring skeletal muscle contraction.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Phosphocreatine disodium (Disodium creatine phosphate) Cat. No.: HY-D0885B

Phosphocreatine disodium, one of organic compoundsknown as alpha amino acids and derivatives, is asubstrate for the determination of creatine kinaseand used to regenerate ATP during skeletal musclecontraction.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 100 mg

118 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Phosphocreatine disodium hydrateCat. No.: HY-D0885D

Phosphocreatine disodium hydrate is an endogenousmetabolite.

Purity: >98%Clinical Data: Phase 3Size: 1 mg, 5 mg

Phosphocreatine disodium tetrahydrate (Creatine phosphate

(disodium tetrahydrate); …) Cat. No.: HY-D0885A

Phosphocreatine disodium tetrahydrate, primarilyfound in the skeletal muscles of vertebrates andone of organic compounds known as alpha aminoacids and derivatives, is a substrate for thedetermination of creatine kinase and used toregenerate ATP during skeletal muscle contraction.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Phosphonoacetic acidCat. No.: HY-128744

Phosphonoacetic acid is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Phosphorylcholine (Phosphocholine) Cat. No.: HY-B2233B

Phosphatidylcholine is the main phospholipidcomponent in eukaryotic biofilms.Phosphatidylcholine exists in commensal orpathogenic bacteria associated with eukaryotes inprokaryotes. Phosphorylcholine exhibits asurprising range of immunomodulatory properties.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Phosphorylcholine chloride calcium salt tetrahydrateCat. No.: HY-W011249

Phosphorylcholine chloride calcium salttetrahydrate is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Phosphorylethanolamine (Monoaminoethyl phosphate; NSC 254167;

O-Phosphoethanolamine) Cat. No.: HY-N5034

Phosphorylethanolamine is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Phthalic acid mono-2-ethylhexyl ester (MEHP) Cat. No.: HY-W018392

Phthalic acid mono-2-ethylhexyl ester (MEHP) is amajor bioactive metabolite of diethylhexylphthalate (DEHP), which inhibits the 17, 20 lyaseactivity of CYP17.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Phytic acid (Inositol hexaphosphate; myo-Inositol,

hexakis(dihydrogen phosphate)) Cat. No.: HY-N0814

Phytic acid is a phosphorus storage compound ofseeds and cereal grains. Phytic acid is known as afood inhibitor, which has a strong ability tochelate multivalent metal ions, specially zinc,calcium, iron and as with protein residue.

Purity: >95.0%Clinical Data: LaunchedSize: 250 mg (969.6 mM * 391 μL in Water)

Phytic acid dodecasodium salt hydrate (Inositol hexaphosphate

dodecasodium salt hydrate; …) Cat. No.: HY-N0814A

Phytic acid dodecasodium salt hydrate is aphosphorus storage compound of seeds and cerealgrains.

Purity: >98.0%Clinical Data: Phase 3Size: 250 mg

Phytic acid potassiumCat. No.: HY-W018059

Phytic acid potassium is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 119

 

Pi-Methylimidazoleacetic acidCat. No.: HY-113274

Pi-Methylimidazoleacetic acid is a potentialneurotoxin.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Pi-Methylimidazoleacetic acid hydrochlorideCat. No.: HY-113274A

Pi-Methylimidazoleacetic acid hydrochloride is apotential neurotoxin.

Purity: 99.47%Clinical Data:Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg

Pimelic acid (Heptanedioic acid; 1,5-Pentanedicarboxylic

acid; 1,7-Heptanedioic acid) Cat. No.: HY-Y1139

Pimelic acid is the organic compound and itsderivatives are involved in the biosynthesis ofthe amino acid called lysine.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Pipecolic acidCat. No.: HY-Y0669

Pipecolic acid, a metabolite of Lysine, is animportant precursor of many useful microbialsecondary metabolites. Pipecolic acid can be usedas a diagnostic marker of Pyridoxine-dependentepilepsy.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Piperine (Bioperine; 1-Piperoylpiperidine) Cat. No.: HY-N0144

Piperine, a natural alkaloid isolated from Piper L, inhibits and nigrum P-glycoprotein CYP3A4

activities with an value of 61.94±0.054 μg/mLIC50

in HeLa cell.

Purity: 98.94%Clinical Data: Phase 2Size: 10 mM × 1 mL, 200 mg, 1 g, 5 g

Poly(4-vinylphenol)Cat. No.: HY-23497

Poly(4-vinylphenol) is an endogenous metabolite.

Purity: 99.03%Clinical Data:Size: 100 mg

PorphobilinogenCat. No.: HY-W013495

Porphobilinogen could act as a phototoxin, aneurotoxin, and a metabotoxin.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Potassium 1-carboxyvinyl hydrogenphosphateCat. No.: HY-W008807

Potassium 1-carboxyvinyl hydrogenphosphate is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Potassium 1H-indol-3-yl sulfateCat. No.: HY-W011910

Potassium 1H-indol-3-yl sulfate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Potassium 2-hydroxy-2-methylsuccinateCat. No.: HY-23195

Potassium 2-hydroxy-2-methylsuccinate is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

120 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Potassium sorbate (Sorbic acid potassium) Cat. No.: HY-N0626A

Potassium sorbate (Sorbic acid potassium),isolated from , is a naturallySorbus aucupariaoccurring, highly efficient, andnonpoisonous foodpreservatives.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

PrednisoloneCat. No.: HY-17463

Prednisolone is a potent, orally activecorticosteroid and a glucocorticoid. Prednisolonepossesses about four times the anti-inflammatoryactivity of hydrocortisone while causing less saltand water retention. Prednisolone can be used forocular, anti-inflammatory research.

Purity: 99.92%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Pregnanediol (NSC 1612; NSC 47462) Cat. No.: HY-107850

Pregnanediol is the major ofmetaboliteprogesterone and can be excreted via urine.Pregnanediol offers an indirect way to measureprogesterone levels in vivo.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Pregnenolone (3β-Hydroxy-5-pregnen-20-one) Cat. No.: HY-B0151

Pregnenolone (3β-Hydroxy-5-pregnen-20-one) is apowerful neurosteroid, the main precursor ofvarious steroid hormones including steroidketones.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Pregnenolone monosulfate (3β-Hydroxy-5-pregnen-20-one monosulfate) Cat. No.: HY-B1739

Pregnenolone monosulfate(3β-Hydroxy-5-pregnen-20-one monosulfate) is apowerful neurosteroid, the main precursor ofvarious steroid hormones including steroidketones.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg

Pregnenolone monosulfate sodium salt (3β-Hydroxy-5-pregnen-20-one monosulfate sodium salt) Cat. No.: HY-110189

Pregnenolone monosulfate sodium salt(3β-Hydroxy-5-pregnen-20-one monosulfate sodiumsalt) is a powerful neurosteroid, the mainprecursor of various steroid hormones includingsteroid ketones.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mg

Progesterone (Pregn-4-ene-3,20-dione) Cat. No.: HY-N0437

Progesterone is a steroid hormone that regulatesthe menstrual cycle and is crucial for pregnancy.

Purity: 99.46%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g, 5 g

Propane-1,2,3-triyl tripalmitateCat. No.: HY-W013061

Propane-1,2,3-triyl tripalmitate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

PropionylcarnitineCat. No.: HY-113092

Propionylcarnitine is metabolized by carnitineacetyltransferase from propionyl-CoA. Increasedpropionylcarnitine is regarded as a biomarker ofvitamin B12 deficiency.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Propofol (2,6-Diisopropylphenol) Cat. No.: HY-B0649

Propofol potently and directly activates GABAA

receptor and inhibits glutamate receptor mediatedexcitatory synaptic transmission. Propofol hasantinociceptive properties and is used forsedation and hypnotic.

Purity: 99.52%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 121

 

Propylparaben (Propyl parahydroxybenzoate; Propyl 4-hydroxybenzoate) Cat. No.: HY-N2026

Propylparaben (Propyl parahydroxybenzoate) is anantimicrobial preservative which can be producednaturally by plants and bacteria. Propylparaben isprevalently used in cosmetics, pharmaceuticals,and foods.

Purity: 99.76%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 1 g

Propylparaben sodium (Propyl parahydroxybenzoate sodium;

Propyl 4-hydroxybenzoate sodium) Cat. No.: HY-N2026A

Propylparaben sodium (Propyl parahydroxybenzoate)is an antimicrobial preservative which can beproduced naturally by plants and bacteria.Propylparaben sodium is prevalently used incosmetics, pharmaceuticals, and foods.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Prostaglandin D2 (PGD2) Cat. No.: HY-101988

Prostaglandin D2 (PGD2) is one of the major PGsactively produced in the brain of various mammals.Prostaglandin D2 is one of the most potentendogenous sleep promoting substances. PGD2 playsa protective role by suppressing inflammation.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg

Prostaglandin E1 (PGE1) Cat. No.: HY-B0131

Prostaglandin E1 (PGE1) is a potent vasodilatorand activates the receptor.prostaglandin E1 (EP)

Purity: 98.03%Clinical Data: LaunchedSize: 5 mg, 10 mg, 50 mg

Prostaglandin E2 (Dinoprostone) Cat. No.: HY-101952

Prostaglandin E2 is a hormone-like substance thatparticipate in a wide range of body functions suchas the contraction and relaxation of smoothmuscle, the dilation and constriction of bloodvessels, control of blood pressure, and modulationof inflammation.

Purity: 98.36%Clinical Data: LaunchedSize: 10 mM × 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg

Protirelin (Synthetic thyrotropin-releasing factor; Synthetic

thyrotropin-releasing hormone; TRF; TRH; TSH-RF; …) Cat. No.: HY-P0002

Protirelin is a highly conserved neuropeptide thatexerts the hormonal control of thyroid-stimulatinghormone (TSH) levels as well as neuromodulatoryfunctions.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

ProtodioscinCat. No.: HY-N0799

Protodioscin, a major steroidal saponin indioscoreae rhizome, has been shown to exhibitmultiple biological actions, such asanti-hyperlipidemia, anti-cancer, sexual effectsand cardiovascular properties.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg

Protoporphyrin IXCat. No.: HY-B1247

Protoporphyrin IX is the final intermediate in theheme biosynthetic pathway.

Purity: >98.0%Clinical Data: LaunchedSize: 100 mg

Pseudoginsenoside F11 (Ginsenoside A1) Cat. No.: HY-N0541

Pseudoginsenoside F11 (Ginsenoside A1), acomponent of Panax quinquefolium (Americanginseng), has been demonstrated to antagonize thelearning and memory deficits induced byscopolamine, morphine and methamphetamine in mice.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

PseudouridineCat. No.: HY-113061

Pseudouridine, the most abundant modifiednucleoside in non-coding RNAs, enhances thefunction of transfer RNA and ribosomal RNA bystabilizing RNA structure.

Purity: 99.82%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg

122 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Pteridine-2,4(1H,3H)-dioneCat. No.: HY-W037619

Pteridine-2,4(1H,3H)-dione is an endogenousmetabolite.

Purity: 99.86%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

PulegoneCat. No.: HY-N1500

Pulegone, the major chemical constituent of (L.) Savi essential oil whichCalamintha nepeta

is an aromatic herb with a mint-oregano flavor, isone of avian repellents. The molecular target forthe repellent action of Pulegone in avian speciesis nociceptive .TRP ankyrin 1 (TRPA1)

Purity: 99.66%Clinical Data: No Development ReportedSize: 5 mg

Purine (Purine (6CI,8CI); 3,5,7-Triazaindole;

3H-Imidazo[4,5-d]pyrimidine; …) Cat. No.: HY-34431

Purine is an endogenous metabolite.

Purity: >98.0%Clinical Data: Phase 4Size: 10 mM × 1 mL, 100 mg

Pyridoxal 5'-phosphate hydrate (Pyridoxal phosphate hydrate) Cat. No.: HY-W011727

Pyridoxal 5'-phosphate hydrate is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Pyridoxal hydrochlorideCat. No.: HY-W027446

Pyridoxal hydrochloride is an endogenousmetabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 500 mg

Pyridoxal phosphate (Pyridoxal 5′-phosphate; Pyridoxyl phosphate) Cat. No.: HY-B1744

Pyridoxal phosphate is the active form of vitaminB6, acts as an inhibitor of reverse

, and is used for the treatment oftranscriptasestardive dyskinesia.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g

Pyridoxine (Pyridoxol) Cat. No.: HY-B1328

Pyridoxine (Pyridoxol) is a pyridine derivative.Pyridoxine exerts antioxidant effects in cellmodel of Alzheimer's disease via the Nrf-2/HO-1pathway.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Pyridoxine hydrochloride (Pyridoxol hydrochloride; Vitamin B6 hydrochloride) Cat. No.: HY-N0682

Pyridoxine hydrochloride (Pyridoxol; Vitamin B6)is a pyridine derivative. Pyridoxine (Pyridoxol;Vitamin B6) exerts antioxidant effects in cellmodel of Alzheimer's disease via the /HO-1Nrf-2pathway.

Purity: 99.92%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

PyridoxylamineCat. No.: HY-B1745

Pyridoxylamine is an advanced glycation endproduction and lipoxidation end products(AGEs)

inhibitor, to protect against(ALEs)diabetes-induced retinal vascular lesions.

Purity: 99.81%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Pyridoxylamine dihydrochlorideCat. No.: HY-B1745A

Pyridoxylamine dihydrochloride is an advancedglycation end production and lipoxidation(AGEs)end products inhibitor, to protect against(ALEs)diabetes-induced retinal vascular lesions.

Purity: 99.80%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

www.MedChemExpress.com 123

 

PyrimidineCat. No.: HY-Y0519

Pyrimidine is an endogenous metabolite.

Purity: >98%Clinical Data: Phase 2Size: 1 mg, 5 mg

Pyrithioxin (Pyritinol; Pyridoxine disulfide; Vitamin B6 disulfide) Cat. No.: HY-B0910

Pyrithioxin is a neurodynamic compound, combinedwith a short period of hyperventilation (HV) wasapplied in cerebral infarct patients withHemiplegia.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Pyrocatechuic acid (Catecholcarboxylic acid; NSC 27435) Cat. No.: HY-Y0202

Pyrocatechuic acid is a normal human benzoic acidmetabolite found in plasma, and has increasedlevels after aspirin ingestion.

Purity: 98.87%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

PyrogallolCat. No.: HY-N1579

Pyrogallol is a polyphenol compound, which hasanti-fungal and anti-psoriatic properties.Pyrogallol is a reductant that is able to generatefree radicals, in particular superoxide anions.

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Pyrrole-2-carboxylic acidCat. No.: HY-W001963

Pyrrole-2-carboxylic acid is a natural alkaloidfrom the marine bacterium sp.Pelomonas puraquaeNov.

Purity: 98.66%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Pyrroloquinoline quinone (PQQ; Methoxatin) Cat. No.: HY-100196

Pyrroloquinoline quinone (PQQ), a redox co-factor,is an anionic, redox-cycling orthoquinone.Pyrroloquinoline quinone is isolated from culturesof methylotropic bacteria and tissues of mammals.Pyrroloquinoline quinone is an essential nutrientfor mammals and is important for immune function.

Purity: 99.53%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

Pyrroloquinoline quinone disodium salt (PQQ disodium salt; Methoxatin disodium salt) Cat. No.: HY-100196A

Pyrroloquinoline quinone disodium salt, a redoxco-factor, is an anionic, redox-cyclingorthoquinone. Pyrroloquinoline quinone disodiumsalt is isolated from cultures of methylotropicbacteria and tissues of mammals.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Pyruvic acid (Acetylformic acid) Cat. No.: HY-Y0781

Pyruvic acid is an intermediate metabolite in themetabolism of carbohydrates, proteins, and fats.

Purity: >99.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 500 mg, 5 g

Pyruvic aldehydeCat. No.: HY-W020014

Pyruvic aldehyde is often used as a reagent inorganic synthesis, as a flavoring agent, and intanning.

Purity: >98%Clinical Data: No Development ReportedSize: 420 mg (5.8 M * 1 mL in Water)

Quinoline-2-carboxylic acidCat. No.: HY-W002011

Quinoline-2-carboxylic acid is an endogenousmetabolite.

Purity: 99.89%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

124 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Quinolinic acidCat. No.: HY-100807

Quinolinic acid is an endogenousN-methyl-D-aspartate ( ) agonistNMDA receptorsynthesized from L-tryptophan via the kynureninepathway and thereby has the potential of mediatingN-methyl-D-aspartate neuronal damage anddysfunction.

Purity: 99.81%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Raffinose (Melitose) Cat. No.: HY-N7088

Raffinose (Melitose), a non-digestibleshort-chain oligosaccharide, is atrisaccharide composed of galactose, glucose, andfructose and can be found in many plants.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Rapamycin (Sirolimus; AY-22989) Cat. No.: HY-10219

Rapamycin (Sirolimus; AY 22989) is a potent andspecific inhibitor with an of 0.1 nMmTOR IC50

in HEK293 cells. Rapamycin binds to FKBP12 andspecifically acts as an allosteric inhibitor of

. Rapamycin is an activator,mTORC1 autophagyan immunosuppressant.

Purity: 99.94%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg

Rebaudioside ACat. No.: HY-N0466

Rebaudioside A is a steviol glycoside,α-glucosidase inhibitor with IC50 of 35.01μg/ml.can inhibit ATP-sensitive K+-channels.

Purity: >98.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg, 500 mg

Rebaudioside C (Dulcoside B) Cat. No.: HY-N0467

Rebaudioside C(Dulcoside B) is used as naturalsweeteners to diabetics and others oncarbohydrate-controlled diets.

Purity: 96.39%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

rel-(2R,3S)-2,3-Dihydroxysuccinic acid hydrateCat. No.: HY-128732

rel-(2R,3S)-2,3-Dihydroxysuccinic acid (hydrate)is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Resolvin D1 (RvD1) Cat. No.: HY-125527

Resolvin D1 (RvD1), an endogenous pro-resolvingmediator of inflammation, is derived from omega-3docosahexaenoic acid during the resolution phaseof acute inflammation.

Purity: >99.0%Clinical Data: No Development ReportedSize: 25 μg

Resolvin E1 (RvE1) Cat. No.: HY-114041

Resolvin E1 (RvE1), a potent endogenouspro-resolving mediator of inflammation, is derivedfrom omega-3 fatty acid eicosapentaenoic acid(EPA).

Purity: >98.0%Clinical Data: No Development ReportedSize: 25 μg (285.3 μM * 250 μL in Ethanol)

Retinoic acid (Vitamin A acid; all-trans-Retinoic acid; ATRA) Cat. No.: HY-14649

Retinoic acid is a metabolite of vitamin A thatplays important roles in cell growth,differentiation, and organogenesis. Retinoic acidis a natural agonist of nuclear receptors,RARwith s of 14 nM for RARα/β/γ. Retinoic acidIC50

bind to with of 17 nM.PPARβ/δ Kd

Purity: 99.74%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg, 1 g, 5 g

Retinyl palmitate (Vitamin A palmitate; Retinol palmitate) Cat. No.: HY-B1384

Retinyl palmitate is an ester of Retinol and isthe major form of vitamin A found in theepidermis. Retinyl palmitate has been widely usedin pharmaceutical and cosmetic formulations.

Purity: >97.0%Clinical Data: LaunchedSize: 100 mg

www.MedChemExpress.com 125

 

RetrobradykininCat. No.: HY-P2039

Retrobradykinin has the reverse sequence ofBradykinin (HY-P0206). Retrobradykinin has nosignificant kinin activity and can be used as anegative control for Bradykinin.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Rhamnose (L-Rhamnose) Cat. No.: HY-N1420

Rhamnose (L-Rhamnose) is a monosaccharide found inplants and bacteria. Rhamnose-conjugatedimmunogens is used in immunotherapies. Rhamnosecrosses the epithelia via the transcellularpathway and acts as a marker of intestinalabsorption.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Ribitol (Adonitol; Adonite) Cat. No.: HY-100582

Ribitol is a crystalline pentose alcohol formed bythe reduction of ribose. Enhancing the flux ofD-glucose to the pentose phosphate pathway in

for the production ofSaccharomyces cerevisiaeD-ribose and ribitol.

Purity: >98.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 500 mg

Riboflavin (Vitamin B2; E101) Cat. No.: HY-B0456

Riboflavin is an easily absorbed micronutrientwith a key role in maintaining health in humansand other animals.

Purity: 96.52%Clinical Data: LaunchedSize: 500 mg, 1 g, 5 g

Riboflavin phosphate sodium (FMN-Na; Riboflavin 5'-phosphate

sodium; Vitamin B2 Phosphate Sodium Salt) Cat. No.: HY-B0964

Riboflavin phosphate sodium (FMN-Na) is aderivative of Riboflavin (vitamin B2) which is anessential nutrient for animals. Riboflavinphosphate sodium can be used for the research ofprogressive keratoconus, corneal ectasia andirregular astigmatism.

Purity: 92.04%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Riboflavine phosphate (Riboflavine 5'-phosphate) Cat. No.: HY-B0964A

Riboflavine phosphate is a very effectiveNAD -recycling agent.+

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Rosmarinic acid (Labiatenic acid) Cat. No.: HY-N0529

Rosmarinic acid is a widespread phenolic estercompound in the plants. Rosmarinic acid inhibits

, and enzymes with sMAO-A MAO-B COMT IC50

of 50.1, 184.6 and 26.7 μM, respectively.

Purity: 99.29%Clinical Data: Phase 4Size: 10 mM × 1 mL, 50 mg, 100 mg

Royal Jelly acid (Queen Bee Acid; (E)-10-Hydroxy-2-decenoic acid) Cat. No.: HY-N1363

Royal Jelly acid (Queen Bee Acid) is a fatty acidconstituent of royal jelly, promotes the growthand protection of neurons, reduces anxiety-likephenotypes.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg

S-Adenosyl-L-methionine (S-Adenosyl methionine; Ademetionine; AdoMet) Cat. No.: HY-B0617

S-Adenosyl-L-methionine (S-Adenosyl methionine) isproduced endogenously from methionine and ATP byaction of the enzyme methionineadenosyltransferase and is an important orallyactive methyl group donor.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

S-Adenosyl-L-methionine tosylate (S-Adenosyl methionine

tosylate; Ademetionine tosylate; AdoMet tosylate) Cat. No.: HY-B0617A

S-Adenosyl-L-methionine tosylate (S-Adenosylmethionine tosylate) is produced endogenously frommethionine and ATP by action of the enzymemethionine adenosyltransferase and is an importantorally active methyl group donor.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg

126 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Saccharopine (L-Saccharopine) Cat. No.: HY-W040307

Saccharopine (L-Saccharopine), a lysinedegradation intermediate, is a mitochondrialtoxin. Lysine and α-ketoglutarate are convertedinto Saccharopine by the lysine-ketoglutaratereductase.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

SAH (SAH (S-Adenosylhomocysteine)) Cat. No.: HY-19528

SAH is an amino acid derivative and a modulartorin several metabolic pathways. It is anintermediate in the synthesis of cysteine andadenosine. SAH is an inhibitor for METTL3-METTL14heterodimer complex (METTL3-14) with an ofIC50

0.9 µM.

Purity: 98.73%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg

SAICARCat. No.: HY-126585

SAICAR is an intermediate of purinede novonucleotide biosynthesis, activates pyruvate

in ankinase isoform M2 (PKM2)isozyme-selective manner, with an of 0.3EC50

mM. SAICAR stimulates PKM2 and promotes cancercell survival in glucose-limited conditions.

Purity: >98%Clinical Data: No Development ReportedSize: 500 μg

Salicylic acid (2-Hydroxybenzoic acid) Cat. No.: HY-B0167

Salicylic acid (2-Hydroxybenzoic acid) inhibitscyclo-oxygenase-2 ( ) activity independentlyCOX-2of transcription factor (NF-κB) activation.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 10 g, 50 g

Salicyluric acidCat. No.: HY-113295

Salicyluric acid is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Sarcosine (N-Methylglycine; Sarcosin) Cat. No.: HY-101037

Sarcosine is a glycine transporter type 1 ( )GlyTinhibitor and an N-methyl-D-aspartate ( )NMDAreceptor co-agonist at the glycine binding site.

Purity: >97.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 100 mg

Sarsasapogenin (Parigenin; Sarsagenin) Cat. No.: HY-N0073

Sarsasapogenin is a sapogenin from the Chinesemedical herb ,Anemarrhena asphodeloides Bungewith antidiabetic, anti-oxidative, anticancer andanti-inflamatory activities.

Purity: >98%Clinical Data: No Development ReportedSize: 25 mg, 50 mg, 100 mg

Scyllo-InositolCat. No.: HY-W010041

Scyllo-Inositol, an amyloid inhibitor, potentialyinhibits α-synuclein aggregation.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

SDMA (Symmetric dimethylarginine; NG,NG'-Dimethyl-L-arginine) Cat. No.: HY-101410

SDMA (Symmetric dimethylarginine) is an endogenousinhibitor of nitric oxide ( ) synthase activity.NO

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg

Secalciferol ((24R)-24,25-Dihydroxyvitamin D3) Cat. No.: HY-32343

Secalciferol is a metabolite of Vitamin D, apossibly anti-inflammatory steroid which isinvolved in bone ossification. IC50 value: Target:In addition, it is known that Secalciferolmediates calcium and phosphorus homeostasis.

Purity: 98.58%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 127

 

SecaubryenolCat. No.: HY-N1272

Secaubryenol is a class of 3,4-secocycloartanetriterpenes isolated from Coussarea macrophylla.Secaubryenol does not display any cytotoxic effect

.at a dose of 10 µg/mL.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Selenomethionine (Seleno-DL-methionine; DL-Selenomethionine) Cat. No.: HY-B1000

Selenomethionine is a naturally occurring aminoacid containing selenium, is a common natural foodsource of selenium.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Serotonin hydrochloride (5-Hydroxytryptamine hydrochloride; 5-HT hydrochloride) Cat. No.: HY-B1473

Serotonin hydrochloride is a monoamineneurotransmitter in the CNS and an endogenous

agonist. Serotonin hydrochloride5-HT receptoris also a ( )catechol O-methyltransferase COMTinhibitor with a of 44 μM.Ki

Purity: 99.97%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg

Shikimic acidCat. No.: HY-N0130

Shikimic acid is a key metabolic intermediate ofthe aromatic amino acid biosynthesis pathway,found in microbes and plants.

Purity: 99.14%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Simvastatin acid ammonium (Tenivastatin ammonium) Cat. No.: HY-119695A

Simvastatin ammonium is an active metabolite ofsimvastatin lactone mediated by CYP3A4/5 in theintestinal wall and liver (pKa=5.5).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Skatole (3-Methylindole; 3-Methyl-1H-indole) Cat. No.: HY-W007355

Skatole is produced by intestinal bacteria,regulates intestinal epithelial cellular functionsthrough activating andaryl hydrocarbon receptors

.p38

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

SmilageninCat. No.: HY-106353

Smilagenin (SMI) is a lipid-soluble small-moleculesteroidal sapogenin from Rhizoma

and widely used inanemarrhenae Radix asparagitraditional Chinese medicine for treating chronicneurodegeneration diseases.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

sn-Glycero-3-phosphocholine (Choline Alfoscerate; Alpha-GPC; L-α-GPC) Cat. No.: HY-17552

sn-Glycero-3-phosphocholine (Choline Alfoscerate)is a precursor in the biosynthesis of brainphospholipids and increases the bioavailability ofcholine in nervous tissue.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g, 10 g

sn-Glycerol 3-phosphateCat. No.: HY-113128

sn-Glycerol 3-phosphate is produced by cytosolicglycerol 3-phosphate dehydrogenase pathway throughthe reduction of dihydroxyacetone phosphate usingNADH formed during glycolysis.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg

sn-Glycerol 3-phosphate biscyclohexylammonium saltCat. No.: HY-113128B

sn-Glycerol 3-phosphate biscyclohexylammonium saltis produced by cytosolic glycerol 3-phosphatedehydrogenase pathway through the reduction ofdihydroxyacetone phosphate using NADH formedduring glycolysis.

Purity: >98%Clinical Data: No Development ReportedSize: 250 mg, 500 mg

128 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

sn-Glycerol 3-phosphate lithiumCat. No.: HY-113128A

sn-Glycerol 3-phosphate lithium is produced bycytosolic glycerol 3-phosphate dehydrogenasepathway through the reduction of dihydroxyacetonephosphate using NADH formed during glycolysis.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg

Sodium 2-hydroxybutanoateCat. No.: HY-W012790

Sodium 2-hydroxybutanoate is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 g

Sodium DemethylcantharidateCat. No.: HY-N2501

Sodium Demethylcantharidate is an endogenousmetabolite.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

SolanesolCat. No.: HY-N0576

Solanesol is an aliphatic terpene alcohol mainlyfound in Solanaceous plants, withanti-inflammatory, neuroprotective, andantimicrobial activities.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Sorbic acidCat. No.: HY-N0626

Sorbic acid, isolated from , is aSorbus aucuparianaturally occurring, highly efficient, andnonpoisonous food preservative. Sorbicacid generally is an effective inhibitor of most

and and some .molds yeasts bacteria

Purity: 99.88%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Spaglumic Acid (N-Acetylaspartylglutamic acid) Cat. No.: HY-100921

Spaglumic Acid (N-Acetylaspartylglutamic acid) isa neuropeptide found in millimolar concentrationsin brain.

Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

SpermidineCat. No.: HY-B1776

Spermidine maintains cell membrane stability,increases antioxidant enzymes activities,improving photosystem II (PSII), and relevant geneexpression. Spermidine significantly decreases theH O and O contents.2 2 2

.-

Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Spermine (NSC 268508; Neuridine) Cat. No.: HY-B1777

Spermine (NSC 268508) functions directly as a freeradical scabenger to protect DNA from free radicalattack. Spermine has antiviral effects.

Purity: >98.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg

Spermine tetrahydrochlorideCat. No.: HY-B1777A

Spermine tetrahydrochloride is an endogenousmetabolite.

Purity: >98%Clinical Data: Phase 1Size: 1 mg, 5 mg

SphingomyelinCat. No.: HY-113498

Sphingomyelin is a eukaryotic sphingolipid and oneof the major constituents of cell membranes andparticularly abundant in the myelin sheath thatsurrounds neuronal axons.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg

www.MedChemExpress.com 129

 

Sphingosine-1-phosphate (S1P) Cat. No.: HY-108496

Sphingosine-1-phosphate (S1P) is an agonist of and a ligand of GPR3, GPR6 andS1P receptors1-5

GPR12. Sphingosine-1-phosphate is anintracellular second messenger and mobilizes Ca2+

as an extracellular ligand for G protein-coupledreceptors.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Spinacine ((S)-Spinacine) Cat. No.: HY-W067716

Spinacine is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 100 mg

Squalene (Super Squalene; trans-Squalene; AddaVax) Cat. No.: HY-N1214

Squalene is an intermediate product in thesynthesis of cholesterol, and shows severalpharmacological properties such as hypolipidemic,hepatoprotective, cardioprotective, antioxidant,and antitoxicant activity.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg

StachydrineCat. No.: HY-N0298

Stachydrine is a major constituent of Chinese herbleonurus heterophyllus sweet used to promote bloodcirculation and dispel blood stasis. Stachydrinecan inhibit the signal pathway.NF-κB

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Stearic acidCat. No.: HY-B2219

Stearic acid is a long chain dietary saturatedfatty acid which exists in many animal andvegetable fats and oils.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

StearoylcarnitineCat. No.: HY-113202

Stearoylcarnitine, a fatty ester lipid molecule,is a human endogenous metabolite.Stearoylcarnitine acts as a metabolomics biomarkerfor early-onset-preeclampsia and late-onset-preeclampsia.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

StearoylethanolamideCat. No.: HY-113015

Stearoylethanolamide is an endocannabinoid-likecompound with pro-apoptotic activity.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

Stigmasterol (Stigmasterin) Cat. No.: HY-N0131

Stigmasterol is a plant sterol which has beenfocused on the cholesterol-lowering activity andis valued as an anti-stiffness factor in thetherapy of rheumatic diseases.

Purity: >98.0%Clinical Data: No Development ReportedSize: 100 mg

Streptolysin OCat. No.: HY-135416

Streptolysin O, a group A streptococcal toxin, isa well-characterized oxygen-labile prototype of acholesterol-binding bacterial exotoxin.Streptolysin O causes both lysis of cells andcardiotoxicity.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Suberic acid (Octanedioic acid) Cat. No.: HY-W015300

Suberic acid (Octanedioic acid) is found to beassociated with carnitine-acylcarnitinetranslocase deficiency, malonyl-Coa decarboxylasedeficiency.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

130 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

SuberylglycineCat. No.: HY-113367

Suberylglycine is an acyl glycine, which is anormally minor metabolite of fatty acid.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Substance P (Neurokinin P) Cat. No.: HY-P0201

Substance P (Neurokinin P) is a neuropeptide,acting as a neurotransmitter and as aneuromodulator in the CNS. The endogenous receptorfor substance P is neurokinin 1 receptor( , ).NK1-receptor NK1R

Purity: 99.60%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 25 mg

Succinic acid (Wormwood acid) Cat. No.: HY-N0420

Succinic acid is an intermediate product of thetricarboxylic acid cycle, as well as one offermentation products of anaerobic metabolism.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Succinyl phosphonate trisodium saltCat. No.: HY-12688A

Succinyl phosphonate trisodium salt is anα-ketoglutarate dehydrogenase ( ) inhibitor,KGDHCeffective inhibits ( ) in muscle, bacterial,KGDHCbrain, and cultured human fibroblasts.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Succinyladenosine (N6-Succinyl adenosine) Cat. No.: HY-113284

Succinyladenosine, the metabolic product ofdephosphorylation of intracellular adenylosuccinicacid (S-AMP) by cytosolic 5-nucleotidase, is abiochemical marker of adenylosuccinase (ASL)deficiency.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Sucralose (E955; Trichlorosucrose) Cat. No.: HY-N0614

Sucralose (E955; Trichlorosucrose) is a non-nutritive artificial sweetenerand sugar substitute. Sucralose can activate aconserved neural fasting response and therebyexerts an appetite-stimulating effect in rodents.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 100 mg, 500 mg

Sucrose (D-(+)-Saccharose) Cat. No.: HY-B1779

Sucrose (D-(+)-Saccharose) is a whichdisaccharideis composed of two monosaccharides, glucose andfructose. Sucrose can be applied in someanimal models, including metabolic disease,obesity, diet on preference, anddiabetes, et al.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Sulcatone (6-Methyl-5-hepten-2-one) Cat. No.: HY-W010435

Sulcatone is an endogenous metabolite.

Purity: 98.78%Clinical Data: No Development ReportedSize: 500 mg

SY-640Cat. No.: HY-106947

SY-640 is an Acetamide derivative and has potenthepatoprotective effect. SY-640 reducesPropionibacterium acnes andLipopolysaccharide-induced liver injury in mice.

Purity: 98.17%Clinical Data: No Development ReportedSize: 5 mg

Synephrine (Oxedrine) Cat. No.: HY-N0132

Synephrine (Oxedrine) is an andα-adrenergic agonist derived from the β-adrenergic Citrus

, it has sympathomimetic andaurantiumstructural similarities to ephedra and ephedrinealkaloids.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg

www.MedChemExpress.com 131

 

Synephrine hydrochloride (Oxedrine hydrochloride) Cat. No.: HY-N0132A

Synephrine hydrochloride (Oxedrine hydrochloride)is an and agonist derivedα-adrenergic β-adrenergicfrom the , it hasCitrus aurantiumsympathomimetic and structural similarities toephedra and ephedrine alkaloids.

Purity: 99.57%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg

Syringic acidCat. No.: HY-N0339

Syringic acid is correlated with high antioxidantactivity and inhibition of LDL oxidation.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

T-2 TriolCat. No.: HY-N6720

T-2 Triol is a trichothecene mycotoxin derived bythe metabolism of T-2 toxin. It is less toxic thanT-2 toxin.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

T3 Acyl glucuronideCat. No.: HY-135956

T3 Acyl glucuronide, an endogenous metabolite, isthe acyl glucuronide formation of triiodothyronine(T3).

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Tamarixetin (4'-O-Methyl Quercetin) Cat. No.: HY-N1181

Tamarixetin (4'-O-Methyl Quercetin) is a naturalflavonoid derivative of quercetin, withanti-oxidative and anti-inflammatory effects.Tamarixetin protects against cardiac hypertrophy.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg

Taurine (2-Aminoethanesulfonic acid) Cat. No.: HY-B0351

Taurine, a sulphur-containing amino acid and anorganic osmolyte involved in cell volumeregulation, provides a substrate for the formationof bile salts, and plays a role in the modulationof intracellular free calcium concentration.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Taurochenodeoxycholate-3-sulfateCat. No.: HY-111769

Taurochenodeoxycholate-3-sulfate is a bile saltfound in urine.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Taurochenodeoxycholic acid (12-Deoxycholyltaurine) Cat. No.: HY-N2027

Taurochenodeoxycholic acid (12-Deoxycholyltaurine)is one of the main bioactive substances ofanimals' bile acid. Taurochenodeoxycholic acidinduces and shows obviousapoptosisanti-inflammatory and immune regulationproperties.

Purity: 99.80%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg

Taurochenodeoxycholic acid sodium salt (12-Deoxycholyltaurine sodium salt) Cat. No.: HY-N1429

Taurochenodeoxycholic acid sodium salt(12-Deoxycholyltaurine sodium salt) is one of themain bioactive substances of animals' bile acid.Taurochenodeoxycholic acid induces andapoptosisshows obvious anti-inflammatory and immuneregulation properties.

Purity: >97.0%Clinical Data: LaunchedSize: 100 mg

Taurocholic acid (N-Choloyltaurine) Cat. No.: HY-B1788

Taurocholic acid (N-Choloyltaurine) is a bile acidinvolved in the emulsification of fats.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

132 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Taurocholic acid sodium salt hydrate (Sodium taurocholate

hydrate; N-Choloyltaurine sodium salt hydrate) Cat. No.: HY-B1131

Taurocholic acid sodium salt hydrate (Sodiumtaurocholate hydrate) is a bile acid involved inthe emulsification of fats.

Purity: >98.0%Clinical Data: No Development ReportedSize: 50 mg

Taurodeoxycholate sodium saltCat. No.: HY-128853

Taurodeoxycholate sodium salt is a bilesalt-related anionic detergent used for isolationof membrane proteins including inner mitochondrialmembrane proteins. Taurodeoxycholate (TDCA)inhibits various inflammatory responses .

Purity: >95.0%Clinical Data: No Development ReportedSize: 500 mg

Tauroursodeoxycholate (TUDCA; UR 906; Taurolite) Cat. No.: HY-19696

Tauroursodeoxycholate (TUDCA; UR 906; Taurolite)is an endoplasmic reticulum (ER) stress inhibitor.Tauroursodeoxycholate significantly reducesexpression of apoptosis molecules, such as

and . Tauroursodeoxycholatecaspase-3 caspase-12also inhibits .ERK

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

TeglicarCat. No.: HY-16482

Teglicar is a selective and reversible inhibitorof liver isoform of carnitinepalmitoyl-transferase 1 ( ). TeglicarL-CPT1reduces ketogenesis and glucose production,decreases gluconeogenesis and improves glucosehomeostasis.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg

Terephthalic acidCat. No.: HY-W010098

Terephthalic acid is one isomer of the threephthalic, a precursor to the polyester PET, usedto make clothing and plastic bottles.

Purity: 99.11%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 5 g

Ternidazole hydrochlorideCat. No.: HY-136436

Ternidazole hydrochloride is a of nitroimidazole, hashydroxymetabolite

antiprotozoic properties.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Terpinen-4-ol (4-Carvomenthenol) Cat. No.: HY-W017316

Terpinen-4-ol (4-Carvomenthenol), a naturallyoccurring monoterpene, is the main bioactivecomponent of tea-tree oil. Terpinen-4-olsuppresses inflammatory mediator production byactivated human monocytes.

Purity: >96.0%Clinical Data: Phase 1Size: 100 mg

Tetrac (Tetraiodothyroacetic acid;

3,3',5,5'-Tetraiodothyroacetic acid) Cat. No.: HY-W008859

Tetrac (Tetraiodothyroacetic acid), a derivativeof L-thyroxine (T4), is a thyrointegrin receptorantagonist. Tetrac blocks the actions of T4 and3,5,3'-triiodo-L-thyronine (T3) at the cellsurface receptor for thyroid hormone on integrin

.αvβ3

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg

Tetradecanedioic acidCat. No.: HY-W011819

Tetradecanedioic acid is an endogenous metaboliteand belongs to the class of organic compoundsknown as long-chain fatty acids. Tetradecanedioicacid can act as a candidate biomarker for organicanion-transporting polypeptide mediated drug-druginteractions .

Purity: >98%Clinical Data: No Development ReportedSize: 500 mg

TetradecanoylcarnitineCat. No.: HY-113201

Tetradecanoylcarnitine is a human carnitineinvolved in β-oxidation of long-chain fatty acids.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 133

 

Tetrahydro-2H-pyran-2-oneCat. No.: HY-W012997

Tetrahydro-2H-pyran-2-one is an endogenousmetabolite.

Purity: 99.64%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Tetrahydrobiopterin (Sapropterin) Cat. No.: HY-107383

Tetrahydrobiopterin is a of thecofactor andaromatic amino acid hydroxylases enzymes

also acts as an essential for all cofactor nitric (NOS) isoforms.oxide synthase

Purity: 99.87%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg

TetrahydrocortisolCat. No.: HY-129630

Tetrahydrocortisol is cortisol metabolite. Theurinary Tetrahydrocortisol/Tetrahydrocortisoneratio decreases with increasing 11β-hydroxysteroiddehydrogenase (11β-HSD) activity.

Purity: >96.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

TetrahydrocortisoneCat. No.: HY-113114

Tetrahydrocortisone is a stress-induced hormone.Tetrahydrocortisone is also a urinary metaboliteof Cortisone derived from the reduction ofCortisone by 5-reductase.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg

Tetrahydrocurcumin (HZIV 81-2) Cat. No.: HY-N0893

Tetrahydrocurcumin is a Curcuminoid found inturmeric ( ) that is produced by theCurcuma longareduction of Curcumin. Tetrahydrocurcumin inhibit

and .CYP2C9 CYP3A4

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

Tetrahydrofolic acid (L-5,6,7,8-Tetrahydrofolic acid; L-Tetrahydrofolic acid) Cat. No.: HY-14520

Tetrahydrofolic acid (L-5,6,7,8-Tetrahydrofolicacid) is the biologically active vitamin B9 folatederivative. Tetrahydrofolic acid is a donor ofone-carbon groups for amino acids, nucleic acids,and lipids.

Purity: >98%Clinical Data: No Development ReportedSize: 25 mg, 50 mg, 100 mg

Tetrahydrothiophen-3-oneCat. No.: HY-W010594

Tetrahydrothiophen-3-one is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg

TFAP (N-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide) Cat. No.: HY-112731

TFAP is a selective cyclooxygenase-1 (COX-1)inhibitor, with an of 0.8 μM.IC50

Purity: 99.97%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

TheaflavinCat. No.: HY-N0243

Theaflavin is a suitable natural inhibitor againstinfluenza A ( ) neuraminidase.H1N1

Purity: 99.69%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 2 mg, 5 mg, 10 mg, 25 mg

Theobromine (3,7-Dimethylxanthine) Cat. No.: HY-N0138

Theobromine is a methylxanthine found in cacaobeans which can inhibit adenosine receptor A1( ) signaling.AR1

Purity: 99.65%Clinical Data: LaunchedSize: 100 mg

134 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Theophylline (1,3-Dimethylxanthine; Theo-24) Cat. No.: HY-B0809

Theophylline is a nonselective phosphodiesterase inhibitor, blocker, and(PDE) adenosine receptor

activator.histone deacetylase (HDAC)

Purity: 99.94%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g

Thiamine hydrochloride (Thiamine chloride hydrochloride;

Vitamin B1 hydrochloride) Cat. No.: HY-N0680

Thiamine hydrochloride (Thiamine chloridehydrochloride) is an essential micronutrientneeded as a cofactor for many central metabolicenzymes.

Purity: 99.90%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g

Thiamine monophosphate chloride (dihydrate)Cat. No.: HY-128742

Thiamine monophosphate chloride (dihydrate) is anendogenous metabolite.

Purity: 99.31%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Thiamine pyrophosphateCat. No.: HY-113076

Thiamine pyrophosphate is the coenzyme form ofVitamin B1 and is a required intermediate in thepyruvate dehydrogenase complex and theketoglutarate dehydrogenase complex.

Purity: >97.0%Clinical Data: LaunchedSize: 100 mg

Thymidine (DThyd; NSC 21548) Cat. No.: HY-N1150

Thymidine, a specific precursor ofdeoxyribonucleic acid, is used as a cellsynchronizing agent. Thymidine is a DNA synthesisinhibitor that can arrest cell at G1/S boundary,prior to DNA replication.

Purity: 99.96%Clinical Data: Phase 2Size: 10 mM × 1 mL, 500 mg, 1 g

Thymidine-5'-monophosphate disodium saltCat. No.: HY-128738

Thymidine-5'-monophosphate disodium salt is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

ThymineCat. No.: HY-W010450

Thymine is one of the four nucleobases in thenucleic acid of DNA and can be a target foractions of 5-fluorouracil (5-FU) in cancertreatment, with a K of 2.3 μM.m

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Thyminose (Deoxyribose) Cat. No.: HY-77956

Thyminose is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

ThymopentinCat. No.: HY-N7122

Thymopentin is a biologically active peptidesecreted mainly by the epithelial cells of thymiccortex and medulla. Thymopentin is an effectiveimmunomodulatory agent with a short plasmahalf-life of 30 seconds.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Thymopentin acetateCat. No.: HY-N7122A

Thymopentin acetate is a biologically activepeptide secreted mainly by the epithelial cells ofthymic cortex and medulla. Thymopentin acetate isan effective immunomodulatory agent with a shortplasma half-life of 30 seconds.

Purity: 99.65%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg

www.MedChemExpress.com 135

 

Thyroxine sulfate (T4 Sulfate) Cat. No.: HY-101406

Thyroxine sulfate is a thyroid hormone metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 5 mg, 10 mg

Tiglic acidCat. No.: HY-W012999

Tiglic acid is a monocarboxylic unsaturatedorganic acid found in croton oil and in severalother natural products. Tiglic aci has a role as aplant metabolite.

Purity: 99.97%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Tiglyl carnitineCat. No.: HY-113408

Tiglyl carnitine is found to be associated withceliac disease and mitochondrial acetoacetyl-CoAthiolase (T2) deficiency.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg

Toltrazuril sulfoxideCat. No.: HY-136438

Toltrazuril sulfoxide is a short-lived of Toltrazurilintermediary metabolite

(HY-B0175), and then can be metabolized to thereactive toltrazuril sulfone (TZR-SO2) in vivo.Toltrazuril is an that actsantiprotozoal agentupon parasites.Coccidia

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

trans-2-Hexadecenoyl-L-carnitineCat. No.: HY-133871

trans-2-Hexadecenoyl-L-carnitine is an endogenousmetabolite in urine.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mg

trans-3-Indoleacrylic acidCat. No.: HY-W015273A

trans-3-Indoleacrylic acid is an endogenousmetabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

trans-Aconitic acidCat. No.: HY-W016813

trans-Aconitic acid is present in normal humanurine, and it has been suggested that is presentin larger amounts with Reye's syndrome and organicaciduria. trans-Aconitic acid is a substrate ofenzyme trans-aconitate 2-methyltransferase.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Trans-Anethole ((E)-Anethole) Cat. No.: HY-N0367

Trans-Anethole ((E)-Anethole), a phenylpropenederivative isolated from , showsPimpinellaestrogenic activity at lower concentrations andcytotoxic at higher concentrations in cancer celllines.

Purity: 99.70%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

trans-CinnamaldehydeCat. No.: HY-W019711

trans-Cinnamaldehyde can be used to prepare highlypolyfunctionalized furan ring by reaction of alkylisocyanides with dialkyl acetylenedicarboxylate.

Purity: 99.41%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

trans-Cinnamic acid (trans-3-Phenylacrylic acid) Cat. No.: HY-N0610

trans-Cinnamic acid is a natural antimicrobial,with minimal inhibitory concentration (MIC) of 250μg/mL against fish pathogen , SY-AS1.A. sobria

Purity: 99.91%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

136 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

trans-Cyclohexane-1,2-diolCat. No.: HY-W010514

trans-Cyclohexane-1,2-diol is an endogenousmetabolite.

Purity: 99.94%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

trans-trans-Muconic acidCat. No.: HY-113247

trans-trans-Muconic acid is a urinary metaboliteof benzene and has been used as a biomarker ofexposure to benzene in human.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

trans-Vaccenic acidCat. No.: HY-113427

trans-Vaccenic acid is a precursor for thesynthesis of saturated fatty acid in the rumen andof conjugated linoleic acid (CLA) at the tissuelevel.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 25 mg

trans-ZeatinCat. No.: HY-19700

trans-Zeatin is a plant cytokinin, which plays animportant role in cell growth, differentiation,and division; trans-Zeatin also inhibitsUV-induced activation.MEK/ERK

Purity: 99.54%Clinical Data: No Development ReportedSize: 10 mg, 50 mg

Trans-2-butene-1,4-dicarboxylic acidCat. No.: HY-128426

Trans-2-butene-1,4-dicarboxylic acid is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Transcrocetin (trans-Crocetin) Cat. No.: HY-N2072

Transcrocetin (trans-Crocetin), extracted fromsaffron ( ), acts as an Crocus sativus L. NMDA

antagonist with high affinity.receptorTranscrocetin (trans-Crocetin) is capable ofcrossing the blood-brain barrier and reach thecentral nervous system (CNS).

Purity: 98.60%Clinical Data: Phase 2Size: 5 mg, 10 mg

Triacetin (Glyceryl triacetate; 1,2,3-Triacetoxypropane) Cat. No.: HY-B0896

Triacetin is an artificial chemical compound, isthe triester of glycerol and acetic acid, and isthe second simplest fat after triformin.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

TriarachidinCat. No.: HY-125671

Triarachidin is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Tricaprilin (Trioctanoin; Glyceryl trioctanoate) Cat. No.: HY-B1804

Tricaprilin (Trioctanoin) is used in study forpatients with mild to moderate Alzheimer's diseaseand has a role as an anticonvulsant and a plantmetabolite.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Tricaprin (Glyceryl tridecanoate) Cat. No.: HY-N6660

Tricaprin (Glyceryl tridecanoate) is anorally available precursor of decanoic acid (DA)and can be hydrolyzed to DA. Tricaprin (Glyceryltridecanoate) is a major component of medium chaintriglyceride (MCT) with antiandrogen andantihyperglycemic properties.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

www.MedChemExpress.com 137

 

Tricosanoic acidCat. No.: HY-W009081

Tricosanoic acid is a long-chain fatty acid andshown to be a hair growth stimulant.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Tridecanedioic acidCat. No.: HY-128421

Tridecanedioic acid is an endogenous metabolite.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

Tridecanoic acid (N-Tridecanoic acid) Cat. No.: HY-Y1718

Tridecanoic acid (N-Tridecanoic acid), a 13-carbonmedium-chain saturated fatty acid, can serve as anantipersister and antibiofilm agent that may beapplied to research bacterial infections.Tridecanoic acid inhibits Escherichia colipersistence and biofilm formation.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 250 mg, 500 mg, 1 g

TrierucinCat. No.: HY-N7055

Trierucin is a trierucic acid triglyceride fromthe seed oil.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mg, 25 mg, 50 mg, 100 mg

Trigonelline (Trigenolline) Cat. No.: HY-N0414

Trigonelline, an alkaloid with potentialantidiabetic activity, is present in considerableamounts in coffee. Trigonelline is an efficient

inhibitor capable of blocking Nrf2-dependentNrf2proteasome activity and thereby apoptosisprotection in pancreatic cancer cells.

Purity: 99.98%Clinical Data: No Development ReportedSize: 10 mg, 50 mg, 100 mg

TrilinoleinCat. No.: HY-128393

Trilinolein is an endogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Trimethylamine N-oxideCat. No.: HY-116084

Trimethylamine N-oxide is a gut microbe-dependentmetabolite of dietary choline and othertrimethylamine-containing nutrients.Trimethylamine N-oxide induces inflammation byactivating the .ROS/NLRP3 inflammasome

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Trimethylamine N-oxide dihydrateCat. No.: HY-108915

Trimethylamine N-oxide dihydrate is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Trimethylammonium chloride (Hegzadesil; Trimethylamine

hydrochloric acid; Trimethylamine monohydrochloride) Cat. No.: HY-Y0504

Trimethylammonium chloride is an endogenousmetabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

TrimyristinCat. No.: HY-N2511

Trimyristin, an active molluscicidal componentof   Houtt,Myristica fragranssignificantly inhibits acetylcholinesterase( ), and ( )AChE acid alkaline phosphatase ACP/ALPactivities in the nervous tissueof  .Lymnaea acuminata

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mg

138 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

TrioleinCat. No.: HY-N1981

Triolein is a symmetrical triacylglycerol, reduces upregulation, with strong antioxidant andMMP-1

anti-inflammatory properties.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

TryptamineCat. No.: HY-B2132

Tryptamine is a monoamine alkaloid, similar toother trace amines, is believed to play a role asa neuromodulator or neurotransmitter.

Purity: 99.77%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

TuftsinCat. No.: HY-P0240

Tuftsin is a tetrapeptide. Tuftsin is amacrophage/microglial activator.

Purity: 98.40%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg

TuranoseCat. No.: HY-113334

Turanose is an isomer of Sucrose that naturallyexists in honey. Turanose has anti-inflammatoryand regulates adipogenesis effect. Turanose haspotential for obesity and related chronic diseasesresearch.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

TyramineCat. No.: HY-W007606

Tyramine is an amino acid that helps regulateblood pressure. Tyramine occurs naturally in thebody, and it's found in certain foods.

Purity: 99.77%Clinical Data: Phase 3Size: 10 mM × 1 mL, 500 mg, 1 g

Tyramine hydrochlorideCat. No.: HY-W016823

Tyramine hydrochloride is an amino acid that helpsregulate blood pressure. Tyramine hydrochlorideoccurs naturally in the body, and it's found incertain foods.

Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 250 mg, 500 mg

TyrosolCat. No.: HY-N0474

Tyrosol is a derivative of phenethyl alcohol.Tyrosol attenuates pro-inflammatory cytokines fromcultured astrocytes and activation.NF-κBAnti-oxidative and anti-inflammatory effects.

Purity: 99.28%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Ubiquinol (Ubiquinol-10; CoQH2-10) Cat. No.: HY-B1720

Ubiquinol (Ubiquinol-10) is a reduced form ofcoenzyme Q10 (CoQ10). Ubiquinol is a potentantioxidant that has the capacity to protectVitamin E, and also helps to regenerate depletedvitamin E and Vitamin C.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Ubiquinone-1Cat. No.: HY-113449

Ubiquinone-1 is an intermediate in the synthesisof Coenzyme Q.

Purity: >99.0%Clinical Data: No Development ReportedSize: 5 mg (40 mM * 500 μL in Ethanol)

Umbelliferone (7-Hydroxycoumarin; Hydrangin; NSC 19790) Cat. No.: HY-N0573

Umbelliferone, a natural product of the coumarinfamily, is a fluorescing compound which can beused as a sunscreen agent.

Purity: 99.06%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 139

 

Undecanedioic acidCat. No.: HY-W014125

Undecanedioic acid is associated withintercellular matrix macromolecules andspecifically with elastin.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Undecanoic acid (Undecanoate; Hendecanoic acid) Cat. No.: HY-W004282

Undecanoic acid (Undecanoate) is a monocarboxylicacid with antimycotic property, which inhibits theproduction of exocellular keratinase, lipase andthe biosynthesis of several phospholipids in T.

.rubrum

Purity: 99.90%Clinical Data: Phase 4Size: 10 mM × 1 mL, 100 mg

UracilCat. No.: HY-I0960

Uracil is a common and naturally occurringpyrimidine derivative and one of the fournucleobases in the nucleic acid of RNA.

Purity: 98.80%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g

Urea (Carbamide; Carbonyldiamide) Cat. No.: HY-Y0271

Urea is a powerful protein denaturant via bothdirect and indirect mechanisms. A potent emollientand keratolytic agent. Used as a diuretic agent.Blood urea nitrogen (BUN) has been utilized toevaluate renal function.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Ureidopropionic acid (3-Ureidopropionic acid) Cat. No.: HY-113285

Ureidopropionic acid (3-Ureidopropionic acid) isan intermediate in the metabolism of uracil.

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Uric acidCat. No.: HY-B2130

Uric acid is an endogenous antioxidant thatscavenges reactive oxygen species (ROS) includingsinglet oxygen, oxygen radicals, andperoxynitrite.

Purity: 99.54%Clinical Data: Phase 3Size: 500 mg, 1 g

Uridine (β-Uridine) Cat. No.: HY-B1449

Uridine (β-Uridine) is a glycosylatedpyrimidine-analog containing uracil attached to aribose ring (or more specifically, aribofuranose)via a β-N1-glycosidic bond.

Purity: 99.99%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg

Uridine 5'-diphosphate sodium saltCat. No.: HY-W010820

Uridine 5'-diphosphate sodium salt is a potent,selective receptor native agonistP2Y6

( =300 nM; =6.52) and a potent EC50 pEC50 P2Y14

antagonist ( =7.28).pEC50

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Uridine 5'-monophosphate (5'-Uridylic acid) Cat. No.: HY-101981

Uridine 5'-monophosphate (5'-Uridylic acid), amonophosphate form of UTP, can be acquired eitherfrom a pathway or degradation products ofde novonucleotides and nucleic acids in vivo and is amajor nucleotide analogue in mammalian milk.

Purity: 99.77%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Uridine 5'-triphosphate tris saltCat. No.: HY-128752

Uridine 5'-triphosphate tris salt is an endogenousmetabolite.

Purity: >98%Clinical Data:Size: 1 mg, 5 mg

140 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) Cat. No.: HY-N7032

Uridine 5′-diphosphoglucose disodium salt(UDP-D-Glucose disodium salt) is the precursor ofglucose-containing oligosaccharides,polysaccharides, glycoproteins, and glycolipids inanimal tissues and in some microorganisms.

Purity: 99.52%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Uridine diphosphate glucoseCat. No.: HY-113044

Uridine diphosphate glucose is the precursor ofglucose-containing oligosaccharides,polysaccharides, glycoproteins, and glycolipids inanimal tissues and in some microorganisms. Uridinediphosphate glucose is an agonist of the P2Y14

receptor, a neuroimmune system GPCR .1</aup>.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Uridine triphosphate (UTP; Uridine 5'-triphosphate) Cat. No.: HY-107372

Uridine triphosphate (UTP;Uridine 5'-triphosphate)is a nucleotide that regulates the functions ofthe pancreas in endocrine and exocrine secretion,proliferation, channels, transporters, andintracellular signaling under normal and diseasestates.

Purity: >98.0%Clinical Data: Phase 3Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Uridine-5'-diphosphate disodium saltCat. No.: HY-W010832

Uridine-5'-diphosphate disodium salt is a potent,selective receptor native agonistP2Y6

( =300 nM; =6.52) and a potent EC50 pEC50 P2Y14

antagonist ( =7.28).pEC50

Purity: 98.01%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Urocanic acidCat. No.: HY-113008

Urocanic acid, produced in the upper layers ofmammalian skin, is a major absorber of ultravioletradiation (UVR).

Purity: 99.73%Clinical Data:Size: 10 mM × 1 mL, 500 mg, 1 g

Urolithin ACat. No.: HY-100599

Urolithin A, a gut-microbial metabolite of ellagicacid, exerts anti-inflammatory, antiproliferative,and antioxidant properties. Urolithin A induces

and , suppresses cell cycleautophagy apoptosisprogression, and inhibits .DNA synthesis

Purity: 98.05%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Urolithin BCat. No.: HY-126307

Urolithin B is one of the gut microbialmetabolites of ellagitannins, and hasanti-inflammatory and antioxidant effects.

Purity: 99.86%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Urolithin CCat. No.: HY-135897

Urolithin C, a gut-microbial metabolite of Ellagicacid, is a glucose-dependent activator of insulin

. Urolithin C is a secretion L-type Ca channel2+

opener and enhances influx.Ca2+

Purity: 99.66%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Ursocholic acidCat. No.: HY-113212

Ursocholic acid, a bile acid found predominantlyin bile of mammals, is transformed intodeoxycholic acid by the intestinal microflora inmice. Ursodeoxycholic acid is an inhibitor of7α-hydroxysteroid dehydrogenase and hepatocytenuclear factor 1α.

Purity: >98.0%Clinical Data:Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Ursodiol (Ursodeoxycholic acid; UDCA) Cat. No.: HY-13771

Ursodiol (Ursodeoxycholic acid; UDCA) is a potentliver-specific fatty acid transport protein 5

inhibitor. Ursodiol inhibit LCFA uptake(FATP5)by primary hepatocytes in a FATP5-dependentmanner.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

www.MedChemExpress.com 141

 

Ursolic acid (Prunol; Urson; Malol) Cat. No.: HY-N0140

Ursolic acid (Prunol) is a natural pentacyclictriterpenoid carboxylic acid, exerts anti-tumoreffects and is an effective compound for cancerprevention and therapy.

Purity: 99.27%Clinical Data: Phase 2Size: 10 mM × 1 mL, 5 mg, 10 mg

Ursonic acid (3-Ketoursolic acid) Cat. No.: HY-N1486

Ursolic acid, a naturally occurring triterpenoid,induces the apoptosis of human cancer cellsthrough multiple signaling pathways.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg

ValerylcarnitineCat. No.: HY-113266

Valerylcarnitine is an endogenous metabolite,belonging to the short-chain acylcarnitines.

Purity: >99.0%Clinical Data: No Development ReportedSize: 1 mg

Vanillic acidCat. No.: HY-N0708

Vanillic acid is a flavoring agent found in edibleplants and fruits. Vanillic acid inhibits NF-κBactivation. Anti-inflammatory, antibacterial, andchemopreventive effects.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

Vanillin (p-Vanillin; m-Methoxy-p-hydroxybenzaldehyde;

p-Hydroxy-m-methoxybenzaldehyde) Cat. No.: HY-N0098

Vanillin (p-Vanillin) is a single moleculeextracted from vanilla beans and also a popularodor used widely in perfume, food and medicine.

Purity: 99.95%Clinical Data: LaunchedSize: 10 mM × 1 mL, 200 mg, 5 g

Vanilpyruvic acid (Vanylpyruvic acid) Cat. No.: HY-101416

Vanilpyruvic acid is a catecholamine metaboliteand precursor to vanillactic acid.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg

VerucopeptinCat. No.: HY-P2657

Verucopeptin is a potent  ( =0.22 μM)HIF-1 IC50

inhibitor and decreases the expression of HIF-1target genes and HIF-1α protein levels.

Purity: >98%Clinical Data: No Development ReportedSize: 25 μg

Vitamin B12 (Cyanocobalamin) Cat. No.: HY-B0315

Vitamin B12 is a water soluble vitamin with a keyrole in the normal functioning of the brain andnervous system, and for the formation of blood.

Purity: 99.86%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

Vitamin D2 (Ergocalciferol; Calciferol; Ercalciol) Cat. No.: HY-76542

Vitamin D2 (Ergocalciferol), drived from plantsources or dietary supplements, could be used assupplement of Vitamin D.<br/>.

Purity: 99.53%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g, 10 g

Vitamin D3 (Cholecalciferol; Colecalciferol) Cat. No.: HY-15398

Vitamin D3 (Cholecalciferol; Colecalciferol) is anaturally occuring form of vitamin D. Vitamin D3induces cell differentiation and preventsproliferation of cancer cells.

Purity: 99.42%Clinical Data: LaunchedSize: 100 mg, 1 g, 5 g

142 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

Vitamin D3 octanoateCat. No.: HY-N8357

Vitamin D3 octanoate is an octanoate ester ofvitamin D3. Vitamin D3 (Cholecalciferol; HY-15398)is a naturally occuring form of vitamin D. VitaminD3 induces cell differentiation and preventsproliferation of cancer cells.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Vitamin K1 (Phylloquinone; Phytomenadione) Cat. No.: HY-N0684

Vitamin K1 a fat-soluble, naturally occurringvitamin required for blood coagulation and boneand vascular metabolism.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g

Vitamin K2Cat. No.: HY-109569

Vitamin K2 is an endogenous metabolite.

Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg

Vitamin K4 (acetomenaphthone) Cat. No.: HY-B1508

Vitamin K4 is a chemically synthesized Vitamin Kwhich plays an important role in the normal bloodcoagulation system.

Purity: 99.80%Clinical Data: LaunchedSize: 10 mM × 1 mL, 200 mg, 1 g

VomifoliolCat. No.: HY-N1077

Vomifoliol, a compound related to abscisie acid(ABA), has a modified 2,4-pentadiene side chainand has activity equal to that displayed by ABA.Vomifoliol exhibits antiacetylcholinesteraseactivity and displays moderate antileishmanialactivity.

Purity: >98%Clinical Data: No Development ReportedSize: 5 mg

XanthineCat. No.: HY-W017389

Xanthine, a plant alkaloid found in tea, coffee,and cocoa, is a mild stimulant of the centralnervous system. Xanthine also acts as anintermediate product on the pathway of purinedegradation.

Purity: >95.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 500 mg, 1 g

XanthosineCat. No.: HY-W011527

Xanthosine is a nucleoside derived from xanthineand ribose. Xanthosine can increase mammary stemcell population and milk production in cattle andgoats.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg

Xanthosine dihydrateCat. No.: HY-W013803

Xanthosine dihydrate is a nucleoside derived fromxanthine and ribose. Xanthosine dihydrate canincrease mammary stem cell population and milkproduction in cattle and goats.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

Xanthotoxol (8-Hydroxypsoralen) Cat. No.: HY-30152

Xanthotoxol (8-Hydroxypsoralen) is a biologicallyactive linear furocoumarin, shows strongpharmacological activities as anti-inflammatory,antioxidant, antagonistic, and5-HTneuroprotective effects.

Purity: 99.58%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

Xanthurenic acidCat. No.: HY-W014666

Xanthurenic acid is a putative endogenous Group agonist, onII metabotropic glutamate receptor

sensory transmission in the thalamus.

Purity: 98.17%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

www.MedChemExpress.com 143

 

Xylitol (Xylite) Cat. No.: HY-N0538

Xylitol is a chemical categorized as a polyalcoholor sugar alcohol. Target: Others Xylitol is achemical categorized as a polyalcohol or sugaralcohol (alditol). Xylitol has the formula(CHOH)3(CH2OH)2 and is an achiral isomer ofpentane-1,2,3,4,5-pentol.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

Xylose (D-(+)-Xylose; (+)-Xylose; Wood sugar) Cat. No.: HY-N0537

Xylose, a natural product, can be catalyzed intoxylulose by xylose isomerase, and it is the keystep for anaerobic ethanolic fermentation ofxylose.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg

ZeaxanthinCat. No.: HY-120318

Zeaxanthin, a diet-obtained carotenoid, presentsin the macula region of the eye. Zeaxanthin showsantioxidant effects.

Purity: >98%Clinical Data: Phase 3Size: 1 mg, 5 mg, 10 mg

Zinc Protoporphyrin (Zn(II)-protoporphyrin IX; ZnPP; Zinc Protoporphyrin-9) Cat. No.: HY-101193

Zinc Protoporphyrin (Zn(II)-protoporphyrin IX) isan orally active and competitive heme

inhibitor and markedlyoxygenase-1 (HO-1)attenuates the protective effects ofPhloroglucinol (PG) against H O .2 2

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg

[(3R)-3-Hydroxydodecanoyl]-L-carnitineCat. No.: HY-133872

[(3R)-3-Hydroxydodecanoyl]-L-carnitine is anendogenous metabolite.

Purity: >98%Clinical Data: No Development ReportedSize: 10 mg

[Leu5]-Enkephalin (Leu-enkephalin; Leucine enkephalin; Leucyl-enkephalin) Cat. No.: HY-P0288

[Leu5]-Enkephalin is a pentapeptide with morphinelike properties. [Leu5]-Enkephalin is a five aminoacid endogenous peptide that acts as an agonist at

.opioid receptors

Purity: 99.81%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg

α-D-Glucose-1-phosphate disodiumCat. No.: HY-128747

α-D-Glucose-1-phosphate disodium is used as astarting material for synthesis of glucuronicacid.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

α-D-Glucose-1-phosphate disodium hydrateCat. No.: HY-128747A

α-D-Glucose-1-phosphate disodium hydrate is usedas a starting material for synthesis of glucuronicacid.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 25 mg, 50 mg, 100 mg

α-Lipoic Acid (Thioctic acid; (±)-α-Lipoic acid; DL-α-Lipoic acid) Cat. No.: HY-N0492

α-Lipoic Acid is an antioxidant, which is anessential cofactor of enzymemitochondrialcomplexes. α-Lipoic Acid inhibits -dependentNF-κB

LTR activation. α-Lipoic Acid inducesHIV-1endoplasmic reticulum (ER) stress-mediated

in hepatoma cells.apoptosis

Purity: 98.03%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg

α-Muricholic acidCat. No.: HY-115433

α-Muricholic acid is the most abundant primarybile acid in rodents.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

144 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com

 

α-Pyridone (Pyridin-2-one; α-Hydroxypyridine) Cat. No.: HY-Y0191

α-Pyridone is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

α-Vitamin E ((+)-α-Tocopherol; D-α-Tocopherol) Cat. No.: HY-N0683

α-Vitamin E ((+)-α-Tocopherol), a naturallyoccurring vitamin E form, is a potent lipidsoluble antioxidant.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g

β-Alanine (2-Carboxyethylamine; 3-Aminopropanoic acid) Cat. No.: HY-N0230

β-Alanine is a non-essential amino acid that isshown to be metabolized into carnosine, whichfunctions as an intracellular buffer.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg

β-Carotene (Provitamin A; beta-Carotene) Cat. No.: HY-N0411

β-Carotene (Provitamin A) is an organic compoundand classified as a terpenoid. It is a precursor(inactive form) of vitamin A.

Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg

β-Caryophyllene ((-)-(E)-Caryophyllene; (−)-β-caryophyllene;

(−)-trans-Caryophyllene) Cat. No.: HY-N1415

β-Caryophyllene is a agonist.CB2 receptor

Purity: >95.0%Clinical Data: No Development ReportedSize: 500 mg

β-Cryptoxanthin ((3R)-β-Cryptoxanthin) Cat. No.: HY-108059

β-Cryptoxanthin ((3R)-β-Cryptoxanthin), isolatedfrom Satsuma mandarin orange, is an oxygenatedcarotenoid and a potent antioxidant.β-Cryptoxanthin has an anti-stress effect.

Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg

β-Nicotinamide mononucleotide (β-NM; NMN) Cat. No.: HY-F0004

β-nicotinamide mononucleotide (β-NM) is a productof the nicotinamide phosphoribosyltransferase(NAMPT) reaction and a key NAD(+) intermediate.

Purity: 99.93%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg

γ-Aminobutyric acid (4-Aminobutyric acid) Cat. No.: HY-N0067

γ-Aminobutyric acid (4-Aminobutyric acid) is amajor inhibitory neurotransmitter in the adultmammalian brain, binding to the ionotropic GABAreceptors ( ) and metabotropicGABA receptorsA

receptors ( ).GABA receptorsB

Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg

γ-CyclodextrinCat. No.: HY-W040040

γ-Cyclodextrin is an endogenous metabolite.

Purity: >98.0%Clinical Data: No Development ReportedSize: 500 mg

γ-Globulins from human bloodCat. No.: HY-118870

γ-Globulins from human blood are a class ofproteins in the blood. γ-Globulin is a proteinfraction of blood serum containing many antibodiesthat protect against bacterial and viralinfectious diseases. γ-Globulins from human bloodis used for common variable immunodeficiency.

Purity: >99.0%Clinical Data: LaunchedSize: 10 mg, 50 mg, 250 mg

www.MedChemExpress.com 145

 

γ-Glu-Phe (γ-Glutamylphenylalanine) Cat. No.: HY-101399

γ-Glu-Phe (γ-Glutamylphenylalanine) is synthesizedby Bacillus amyloliquefaciens (GBA) andAspergillus oryzae (GAO). γ-Glu-Phe or thepost-enzymatic reaction mixture enhances the umamiintensity of commercial soy sauce and modelchicken broth.

Purity: 99.85%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mg

γ-L-Glutamyl-L-alanineCat. No.: HY-112171

γ-L-Glutamyl-L-alanine, composed ofgamma-glutamate and alanine, is a proteolyticbreakdown product of larger proteins.

Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg

146 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales@MedChemExpress.com